Exploring the relationship between Helicobacter pylori and host cell invasion: from phenotypes to molecular mechanisms by Ângela Margarida Amorim Costa

  
 Doutoramento em Biomedicina 
Faculdade de Medicina da Universidade do Porto 
 
 
 
 
Exploring the relationship between Helicobacter pylori 
and host cell invasion: from phenotypes to molecular 
mechanisms 
 
 
 
 
Relação entre Helicobacter pylori e invasão das células do 
hospedeiro: dos fenótipos aos mecanismos moleculares  
 
 
 
 
 
 
                  Ângela Margarida Amorim Costa 
 
Porto, Portugal 
2012 
 
 
 
 
Supervisor: Prof. Céu Figueiredo (University of Porto) 
Co-Supervisor: Prof. Thomas F Meyer (Max Planck Institute for Infection Biology) 
 
 
 
 
 
 
Thesis committee: 
 
Prof. Agostinho Marques (University of Porto) 
Prof. Bianca Bauer (Max Planck Institute for Infection Biology) 
Prof. Peter Jordan (National institute of Health” Dr. Ricardo Jorge”) 
Prof. Manuel Sobrinho Simões (University of Porto) 
Prof. Raquel Seruca (University of Porto) 
Prof. Mário Dinis Ferreira (University of Porto) 
Prof. Céu Figueiredo (University of Porto) 
 
 
 
 
 
 
  
 
 
 
 
 
On the front cover: Helicobacter pylori strain SS1. Adapted by permission from PLoS 
One (Marta Correia et al.) © 2012. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial support by: 
 
SFRH/BD/36013/2007 
 
 
 
i 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISSERTAÇÃO DE CANDIDATURA AO GRAU DE DOUTOR EM 
BIOMEDICINA APRESENTADA À FACULDADE DE MEDICINA DA 
UNIVERSIDADE DO PORTO. 
 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Artigo 48º, § 3º - A Faculdade não responde pelas doutrinas expendidas 
na dissertação. (Regulamento da Faculdade de Medicina do Porto – 
Decreto-Lei Nº 19 337, de 29 de Janeiro de 1931). 
 
 iii 
 
 
 
 
 
 
 
                    Este trabalho é dedicado à Célia e ao Ricardo, por me terem 
empurrado para a frente quando eu queria ter ficado pelo caminho 
 
 
 
 
 
 
 
 
 
“ Nunca me resignaria na profissão ao absurdo constante de semelhantes situações 
catastróficas, em que a teimosia de um micróbio ou a rebeldia de uma célula 
desafiavam caprichosamente todas as forças mobilizadas do engenho humano.” 
 
Miguel Torga 
in “A Criação do Mundo IV” 
 iv 
 
 
AGRADECIMENTOS / ACKNOWLEDGEMETS 
v 
 
 
Um doutoramento é muito mais que a tese ou a defesa, é um conjunto imenso de 
alegrias e frustrações que escritas dariam um livro bem maior que este. Para que o meu 
percurso de estudante de doutoramento (e de pré-estudante de doutoramento como BIC 
nos Pyloris) chegasse a bom termo tive a ajuda de muita gente, a quem tenho a 
obrigação de agradecer!  
Desde logo gostava de agradecer a toda a comunidade do IPATIMUP, e ao seu Director, 
Professor Sobrinho, por ter tornado tudo isto possível. Durante estes anos o IPATIMUP 
foi a minha segunda casa, não só pela quantidade de tempo lá passada, mas sobretudo 
por sentir que faço parte de uma Família. Podemos não publicar na Sience e na Natura 
(ainda…), mas temos os melhores colegas e ambiente de trabalho que se pode 
encontrar. Desde logo um agradecimento especial ao Pessoal do Cancer Genetics por 
proporcionarem diariamente aquela dose de insanidade mental necessária para manter a 
sanidade! 
Queria deixar um agradecimento muito especial à minha orientadora Céu, por me ter 
dado a oportunidade de trabalhar no seu Grupo, e aí fazer o meu trabalho de 
doutoramento. Obrigada pelas discussões científicas, por todo o teu apoio, por aturares 
o meu mau feitio, e por compreenderes que por detrás de um cientista está sempre uma 
pessoa “normal”. Céu és uma pessoa que admiro muito. 
A todos os meus coleguinhas do grupo do Helicobacter, os de hoje e os de ontem, pela 
amizade e pelos conhecimentos científicos, uma muito obrigada! Um agradecimento à 
Ana Costa por me ter recebido no Grupo, ao Nuno Guimarães um muito obrigada 
especial por desencantares os artigos a que mais ninguém tem acesso, e também pelas 
descobertas não científicas, mas não menos espectaculares, de músicas que não 
lembram nem ao Menino Jesus. À Ana Machado que apareceu como colega e foi para 
as Dinamarcas como amiga, ao Rui pela paciência, apoio, disponibilidade com a bicheza 
e por me ter ensinado a fazer Real-times. À Marina pelas discussões científicas. E aos 
caçulas Miguel e Inês por me aturarem nos últimos tempos. E agora um agradecimento 
mesmo muito especial às ex-pyloris e agora inebianas Maria e Marta! À Maria porque 
para além de ser colega é também amiga, e é uma pessoa extraordinária com quem 
podemos aprender a ser melhores pessoas e cientistas, e porque é a minha mãe 
científica na Biologia Celular. Muito do que sou no laboratório devo-o a ti. Um obrigado 
também por conseguires ver coisas para além do óbvio e conseguires entusiasmar as 
pessoas com resultados que à primeira vista parecem uma caca. À Marta tenho a 
AGRADECIMENTOS / ACKNOWLEDGEMETS 
 
vi 
 
agradecer a ajuda das suas mãozinhas mágicas quando foram precisa (obrigada por me 
tomares conta dos 500 mil clones do shRNA quando estava de férias). Mas sobretudo 
tenho a agradecer a amizade, o ombro amigo, e especialmente a paciência com que me 
foste aturando. Mesmo não tendo trabalhado directamente contigo nas “minhas coisas” 
foste sempre uma peça essencial para manter o equilíbrio e conseguir chegar ao fim 
desta jornada. Muito obrigada mesmo. 
Queria também agradecer a todos os co-autores dos artigos que fazem parte desta tese, 
pelo trabalho e sugestões!  
Queria agradecer à Babi, Joana Carvalho, Renata e Hugo Pinheiro pela ajuda com as 
coisas dos shRNA, vectores, clonagens e bicharada necessária. E às meninas da Mama: 
Babi outra vez, Diana e Madalena pela ajuda com as iminohistoquímicas. Um 
agradecimento à doutora Fátima pela ajuda com as lâminas, e, é claro, um obrigado 
especial à Dina pela paciência e disponibilidade. 
A todas as pessoas que já fizeram e ainda fazem parte do Cancer Genetics um muito 
obrigado. Desde logo aos PI Raquel Seruca, Zé Carlos, Carla Oliveira e Joana Paredes 
por estarem sempre disponíveis quando eram solicitados. E um obrigado aos 
coleguinhas cá de baixo, os melhores do mundo, por fazerem com que o ambiente fosse 
espectacular, dentro e fora do lab. Um muito obrigado par o pessoal do Cancer Genetics 
que ainda não referi: Ana Sofia, André Vieira (obrigada pelas ajudas informático-
burocráticas), Sílvia Carvalho, Ritinha, Nair, António Carlos, Gonçalo, Marta Correia e 
Carlos. E um agradecimento especial à Cecilia pela correcção didáctica do inglês da tese 
(que paciência!). Um obrigado muito grande aos vizinhos e ex-vizinhos da frente: 
Joaninha, Sérgia, Lara, Cirnes, Soraia, Bic, Xu, Sofia, Patrícia Carneiro, Margarida, 
Cristina e Marta Teixeira Pinto. E claro um agradecimento ao pessoal da ponta do lab 
Patrícia Oliveira, Mafalda, Denisa e Verónica. E um agradecimento em particular ao 
pessoal do Taizé pelas jantaradas no Piolho e por me acompanharem no recarregar de 
baterias.  
E aos meus colegas do IPATIMUP extra Cancer Genetics um obrigado muito grande: à 
Isabel, companheira de jornada desde o inicio e ao Filipe (obrigada por ajudares a 
resolver os problemas informáticos), à Dina, Catarina Salgado, Hugo Prazeres, e à 
Joana Silva pela partilha de problemas. E um agradecimento às inebianas Ana Pinto e 
AGRADECIMENTOS / ACKNOWLEDGEMETS 
vii 
 
Marta Oliveira por me irem recebendo no seu lab, quando queria ou precisava de “ir dar 
um passeio”. 
E como não podia deixar de ser, um agradecimento às pessoas que fazem tudo 
funcionar: Mafalda, Nuno Mendes, Sr. Mário, Sr. Oliveira, Sr. Mendes, Zezinha e Cátia, 
pessoal da Secretaria e Informática.  
A very big thank to the Berliners Yura and Malvika for the support in the lab, and to 
Professor Meyer for the opportunity of being part of the team. A special thank for Tim, 
Nicola, Manuela and Charlotte and for the extra Max Planck friends Sandra and Inês, 
Francesca and Pritesh. 
Um agradeciemnto especial aos meus amigos da FCUP que me foram acompanhando 
neste caminho. Um muito obrigada à Ana bela, Helena, Virgínia, Zé, Sandro, Cláudia e 
Manel. 
Um agradecimento muito grande à trupe do Renascer: Serginho, Paulinho, Ana, Litos, 
Susana, Kika, Fabricio, Gisela, Zé, Marta, Sofia, Berto, Ju, Bruno e Ruizinho. Um 
beijinho muito grande à Beta e à Natália pela companhia nos terapêuticos passeios a pé. 
Um muito obrigada à minha Família porque sempre me deu o seu apoio incondicional, 
mesmo sem saber muito bem do que consta uma célula, e não compreendendo muito 
bem essa coisa da investigação. Um beijo muito grande ao meu Pai, à minha Mãe e à 
Tia Nide. 
E uma palavra especial para a minha maninha, que também se quis meter na ciência e 
me compreende como irmã e como cientista. Não me ajudando directamente no trabalho 
tiveste uma importância enorme para que este trabalho se finalizasse. Muito obrigada 
por não me teres deixado desistir. 
E a última palavra vai para o meu Amigo mais que especial e companheiro de jornada, 
Ricardo, porque acompanhaste o processo desde o início, porque estiveste sempre ao 
meu lado nos bons e nos maus momentos. Porque sem teres noção do que é uma via 
sinalização celular nem saberes a diferença de uma célula eucariótica de uma 
procariotica, tiveste aquele saber necessário para ter a palavra certa no momento exacto. 
É também muito por tua causa que estou hoje aqui. Obrigada por me teres empurrado 
para a frente.
 
 viii 
 
LIST OF PUBLICATIONS 
 
 
ix 
 
 
 
De acordo com o Artigo 8º do Decreto-Lei nº388/70, fazem parte integrante desta 
dissertação os seguintes trabalhos publicados ou em publicação: 
 
 
I. Costa AM, Ferreira RM, Oliveira MJ,  Carneiro F, Leite M, Figueiredo C. Helicobacter 
pylori CagA activates matrix metalloproteinase-10 in gastric epithelial cells through ERK 
and JNK-mediated pathways. In preparation. 
 
 
II. Costa AM *, Oliveira MJ *, Costa AC, Ferreira RM, Sampaio P, Machado JC, Seruca R, 
Mareel M, Figueiredo C. CagA associates with c-Met, E-cadherin, and p120-catenin in a 
multiproteic complex that suppresses Helicobacter pylori-induced cell-invasive phenotype. 
Journal of Infectious Diseases 2009 Sep 1; 200(5):745-55.  
* co-autoria principal partilhada 
 
 
III. Costa AM, Leite M, Figueiredo C. Adherens junctions as targets of microorganisms: a 
focus on Helicobacter pylori. Submitted for publication. 
 
 
IV. Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS, Caldeira J, 
Costa AM, Simões-Correia J, Oliveira MJ, Pinheiro H, Pinho SS, Mateus R, Reis CA, 
Leite M, Fernandes MS, Schmitt F, Carneiro F, Figueiredo C, Oliveira C, Seruca R. 
Epithelial E- and P-cadherins: Role and clinical significance in cancer. Biochimica et 
Biophysica Acta - Reviews on Cancer 2012 May 19; 1826(2):297-311. 
 
 
 
Em cumprimento do disposto no referido Decreto-Lei  a aluna declara que participou 
activamente na recolha e estudo do material incluído em todos os trabalhos acima 
referidos. A dissertação inclui também resultados ainda não publicados. Os artigos III e IV 
foram parcialmente usados na elaboração da Introdução desta dissertação. 
  
x 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTA EXPLICATIVA 
 
 
 
A presente dissertação foi escrita em Inglês na sua quase totalidade 
devido ao facto de alguns dos trabalhos terem sido realizados em 
colaboração internacional. 
 
 
 
 
 
 LIST OF ABBREVIATIONS 
xi 
 
 
Abl Abelson leukemia viral oncogene 
ADAM10 A desintegrin and metalloproteinase domain-containing protein 10 
AJ adherens junction 
Ala alanine 
APC adenomatous polyposis coli 
ATCC American type culture collection 
BabA blood-group antigen-binding protein A 
cagA cytotoxin-associated gene A  
cag PAI cag pathogenicity island 
cDNA complementary DNA 
Ck1α casein kinase 1α 
cPLA2 cytosolic phospholipase A2 
Csk c-Src tyrosine kinase 
C-terminal carboxylic terminal 
DAPI 4',6-diamidino-2-phenylindole 
DMEM Dulbecco’s modified Eagle´s medium 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
Dvl dishevelled 
E-cadherin epithelial cadherin 
EGF epidermal growth factor 
EGFR epidermal growth factor receptor 
Egr-1 early growth response protein 1 
EHEC enterohemorrhagic Escherichia coli 
EMT epithelial to mesenchymal transition 
EPEC enteropathogenic Escherichia coli 
ERK extracellular signal regulated kinase 
FAK focal adhesion kinase 
FBS fetal bovine serum 
FGFR fibroblast growth factor receptor 
FITC fluorescein isothiocyanate 
FRET fluorescence resonance energy transfer 
Glu glutamic acid 
  
LIST OF ABBREVIATIONS 
xii 
 
GPCR G-protein-coupled receptors 
Grb2 growth factor receptor-bound protein 2 
GSK3β glycogen synthase kinase 3β 
GTP guanosine-5’-triphosphate 
hBD3 human beta-defensin 3 
HB-EGF heparin binding epidermal growth factor 
HER human epidermal growth factor receptor 
HGF hepatocyte growth factor 
H. pylori Helicobacter pylori 
HRP horseradish peroxidase 
HtrA high temperature requirement A 
IF immunofluorescence 
IFN-γ interferon γ 
IGFBP insulin-like growth factor binding protein 
IHC immunohistochemistry 
IL interleukin 
IL-1ra interleukin-1 receptor antagonist 
Ile isoleucine 
IP immunoprecipitation 
IQGAP IQ motif containing GTPase activating protein 
JAM junctional adhesion molecule 
JNK c-Jun N-terminal kinase 
Kb kilobase 
kDa kiloDalton 
LIME Lck-interacting membrane kinase 
LRP6 low density lipoprotein receptor-related protein 6 
MALT mucosal-associated lymphoid tissue 
MLC myosin light chain 
MMP metalloproteinase 
MOI multiplicity of infection 
mRNA messenger RNA 
MUC mucin 
MW molecular weight 
N-cadherin neuronal cadherin 
 LIST OF ABBREVIATIONS 
xiii 
 
NF-kB nuclear factor kappa-light-chain-enhancer of activated B cells 
Nod1 nucleotide-binding oligomerization domain protein 1 
NTAL non-T cell activation linker 
N-terminal amino terminal 
PDFG platelet derived growth factor 
PDFGR platelet derived growth factor receptor 
PI3K phosphatidylinositol 3-kinase 
PLC-γ phospholipase C γ 
Pro proline 
PTP1B protein tyrosine phosphatase 1B 
OipA outer inflammatory protein A 
PBS phosphate buffered saline 
PKC protein kinase C 
PP1α phosphoprotein phosphatase 1α 
P-Tyr phospho tyrosine 
RNA ribonucleic acid 
RPMI Roswell Park Memorial Institute medium 
RTK receptor tyrosine kinase 
qRT-PCR quantitative real time polymerase chain reaction 
SabA sialyl-Lewis X binding protein A 
SD standard deviation 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SE standard error 
SF scatter factor 
SH2 Src homology 2 
siRNA small interference RNA 
STAT3 signal transducer and activator of transcription 3 
T4SS type IV secretion system 
TCF-LEF T-cell factor-lymphoid enhancer factor 
TGF transforming growth factor 
TIMP tissue inhibitor of metalloproteinase 
Tir Translocated intimin receptor 
TNF-α tumor necrosis factor α 
TSA trypticase soy agar 
  
LIST OF ABBREVIATIONS 
xiv 
 
Tyr tyrosine 
vacA vacuolating cytotoxin gene A 
WB western blot 
ZO-1 zonula occludens 
  
 
 
 
 
 
 
 
  
  
 
 xvii 
 
 
LIST OF PUBLICATIONS ………………………………………………………………………………... iii 
LIST OF ABBREVIATIONS ……………………………………………………………………............... v 
 
TABLE OF CONTENTS ………………………………………………………………………………….. xi 
INTRODUCTION …………………………………………………………………………………………... 1 
1. Helicobacter pylori ……………………………………………………………………………………... 3 
1.1. H. pylori virulence factors ………………………………………………………………………… 4 
1.2. Clinical outcomes of H. pylori infection………………………………………………………….. 6 
 1.2.1. H. pylori-associated gastric carcinoma ………………………………………………….. 6 
1.3. H. pylori and host epithelial cell-cell junctions……………………………………………………… 7 
 1.3.1. H. pylori and adherens junctions disruption……………………………………………...... 8 
 H. pylori  and E-cadherin ……………............................................................................................ 10 
 
H. pylori  and  β-catenin ................................................................................................................. 12 
 
H. pylori and p120-catenin.............................................................................................................. 13 
2.     H. pylori infection and epithelial cell signaling …………………………………………………... 14 
2.1. c-Met signaling pathway ………………………………………………………............................ 15 
2.2. EGFR signaling pathway …………………………………………………………………………... 17 
3.     Metalloproteinases …………………………………………………………………......................... 19 
3.1. H. pylori infection and MMPs ……………………………………………………………............... 24 
OUTLINE AND AIMS ……………………………………………………………………………………... 27 
MATERIALS AND METHODS …………………………………………………………………………... 31 
1. Cell culture ………………………………………………………………………………………...... 33 
2. H. pylori strains and growth conditions ………………………………...................................... 33 
3. Infection of gastric cells ……………………………………………………………………………. 34 
4. Invasion assay …………………………………………………………………………................. 34 
5. Small interference RNA (siRNA) transfection ………………………………………………….. 35 
6. Cell treatment with growth factors, cytokines and chemical inhibitors ………………………… 35 
  
7. Preparation of cell lysates and co-immunoprecipitation ………………………………………. 36 
8. Immunoblot analysis ……………………………………………………………………………….. 36 
9. Antibodies ………………………………………………………………………………………....... 37 
10. Quantification of mRNA by real-time PCR ……………………………………………………….. 38 
11. Preparation of conditioned medium …………………………………………………………… 39 
12. MMP-10 activity assay ……………………………………………………………………………. 39 
13. Immunocitochemistry and confocal microscopy ……………………………………………….. 39 
14. Transduction of AGS cell line with human E-cadherin cDNA ………………………………… 40 
15. Aggregation assay …………………………………………………………………………………. 40 
16. Statistical analysis …………………………………………………………………………………. 41 
RESULTS …………………………………………………………………………………………………. 43 
Part I 45 
1.
   
Analysis of the effects of H. pylori in host gastric epithelial cell invasion ………………………..... 47 
1.1. Role of H. pylori and bacterial virulence factors in host cell invasion………………………. 47 
1.2. Role of c-Met receptor in H. pylori-mediated cell invasion …………………………………...... 48 
1.3. Role of c-Met downstream targets in H. pylori-mediated cell invasion………………………… 49 
1.4. Role of H. pylori and of c-Met in Nck, c-Src, and PLC-γ activation …………………………… 52 
2. Analysis of the effect of H. pylori in modulation of matrix metalloproteinase 10 (MMP-10)……..... 55 
2.1. Up-regulation of MMPs by H. pylori………………………………………………………………… 55 
2.2. Analysis of the effect of H. pylori in MMP-10 protein secretion and activity ……………… 56 
2.3. Role of bacterial virulence factors in H. pylori-induced MMP-10 expression ………………. 57 
2.4. MMP-10 is involved in H. pylori-mediated cell invasion……………………………………… 59 
2.5. Role of c-Met and EGFR in H. pylori-induced MMP-10 expression………………………... 60 
2.6. Role of c-Met and EGFR downstream targets in H. pylori-induced MMP-10 expression.. 62 
2.7. Analysis of the participation of ERK1/2, JNK, and p38 signaling pathways in H. pylori-
induced MMP-10 expression …………………………………………………………………….. 63 
2.8. Analysis of MMP-10 modulation by cytokines produced by H. pylori infection…………… 64 
2.9. Role of MMP-10 in MMP-1 activation in H. pylori infection ………………………………….. 65 
Part II 67 
 xix 
 
1.   Analysis of the effects of E-cadherin in H. pylori-mediated cell invasion and signaling …... 69 
1.1. H. pylori-mediated invasive phenotype in cells with intact adherens junctions ………….. 69 
1.2. Generation and characterization of the AGSEcad cell line ………………………………..... 70 
1.3. Role of E-cadherin in H. pylori-mediated cell invasion ………………………………………. 72 
1.4. Role of E-cadherin in H. pylori-mediated c-Met and p120-catenin tyrosine 
phosphorylation…………………………………………………………………………………..... 72 
1.5. Effect of H. pylori on the localization of elements of the E-cadherin-catenin complex….. 74 
1.6. Analysis of H. pylori CagA interactions with E-cadherin and with p120-catenin ………………. 75 
DISCUSSION ………………………………………………………………………………………………. 81 
Part I.
 
Analysis of the effects of H. pylori in host gastric epithelial cell invasion and in modulation of 
matrix metalloproteinase 10 (MMP-10)……...…………………………………………………………… 83 
Part II. Analysis of the effects of E-cadherin in H. pylori-mediated cell invasion and signaling ……… 90 
Concluding remarks……………………………………………………………………………................. 94 
REFERENCES ……………………………………………………………………………………………. 97 
SUMMARY ………………………………………………………………………………………………… 117 
SUMÁRIO ………………………………………………………………………………………………..... 121 
PAPERS ………………………………………………………………………………………………….... 125 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
  
INTRODUCTION 
3 
 
1. Helicobacter pylori  
 
Helicobacter pylori (H. pylori) is a spiral shaped microaerophilic Gram-negative bacterium 
that colonizes the human stomach (Figure 1). These bacteria were first isolated from 
human stomachs of patients with gastritis and peptic ulcers in 1983 (Marshall et al., 1984), 
and are thought to have coevolved with humans for thousands of years (Ghose et al., 
2002, Falush et al., 2003). H. pylori infects more than half of the human population 
worldwide, with the highest rates of infection in developing countries (Rothenbacher et al., 
2003). The infection is acquired mainly in childhood and is transmitted from person to 
person mainly by fecal-oral, gastro-oral and oral-oral routes (Azevedo et al., 2007), 
persisting throughout the host lifetime if not treated. One single individual may be 
colonized with different H. pylori strains, as well as with variants of those strains (Kuipers 
et al., 2000). 
In the gastric mucosa, H. pylori can be found within the mucus layer and in close contact 
with the epithelial cells, preferentially at the apical side of the intercellular contacts (Hazell 
et al., 1986, Necchi et al., 2007, Tan et al., 2009). Although not so frequently described in 
the literature, it has also been observed that H. pylori reaches the intercellular spaces 
below the tight junctions, and even penetrates the epithelium towards the lamina propria 
in the basolateral side of the cells (Necchi et al., 2007), showing that H. pylori is able to 
disrupt the adherens junctions. Interestingly, there are also reports demonstrating the 
presence of H. pylori inside the host cells, both in biopsies and in in vitro models (Noach 
et al., 1994, el-Shoura, 1995, Engstrand et al., 1997, Wilkinson et al., 1998, Su et al., 
1999, Petersen et al., 2000, Necchi et al., 2007).  
The colonization of the stomach by H. pylori alters the gastric epithelial tissue since the 
bacteria use host resources and produce toxins that may function as signals to the 
eukaryotic cells.  
 
 
Figure 1. Electron micrograph of H. pylori, a Gram-negative spiral-shaped bacterium with flagella that confer 
motility. Adapted by permission from Antimicrobial Agents and Chemotherapy (Iwahi et al.) © 1991. 
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1.1. H. pylori virulence factors  
 
H. pylori has different virulence factors that allow bacteria to colonize an aggressive 
habitat as the human stomach, with very low pH. Examples of virulence factors are the 
flagella, which allow the bacteria to move through the mucus layer of the stomach, and 
the urease enzyme that is able to catalyze urea into carbon dioxide and ammonia, and, in 
that way, increase the gastric pH. Other virulence factors are the BabA and SabA 
adhesins, important for the bacteria adhesion to the epithelial cells, and OipA, an outer 
membrane protein that contributes to the inflammatory response induced by the bacteria 
(Kusters et al., 2006). 
Three of the most well studied virulence factors are VacA, CagA and the cag 
pathogenicity island (cag PAI), which codifies for a Type 4 Secretion System (T4SS) as 
well as for CagA. While the presence of T4SSs is common to other bacteria, such as 
Agrobacterium tumefaciens (Cascales et al., 2003), the cagA and vacA genes do not 
have homologues in other species. 
All the H. pylori strains express VacA, a multimeric high-molecular weight secreted toxin, 
which causes vacuole formation in epithelial cells in vitro (Cover et al., 1992). VacA has 
the ability to form pores in the membrane of the host cells, allowing the release of anions 
and urea (Iwamoto et al., 1999, Tombola et al., 2001), and may have an important role in 
the pH regulation of the stomach. VacA is also important for the nutrient acquisition by the 
bacteria due to its role in loosening epithelial tight junctions (Papini et al., 1998). It is also 
reported that VacA is involved in cytoskeleton organization, cell migration, and in 
apoptosis, either by vacuole formation or by its capacity to interfere with mitochondria, 
inducing the release of the cytochrome c, a pro-apoptotic signal (Pai et al., 1999, Kuck et 
al., 2001, Cover et al., 2003, Galmiche et al., 2000) (Figure 2). The gene encoding VacA 
has three different variable regions: s (signal), i (intermediate) and m (middle), with two 
allelic types in each region. The VacA s1/i1/m1 combination is more frequently observed 
in strains associated with disease (Atherton et al., 1995, van Doorn et al., 1998, Nogueira 
et al., 2001, Rhead et al., 2007, Basso et al., 2008). 
The cag PAI is a 40 Kb region that encodes a T4SS and is present in about 60% of H. 
pylori strains in Western countries (Censini et al., 1996). The T4SS system functions like 
a needle through which the bacteria can inject effector molecules into the host cell. The 
only two recognized effectors translocated by the T4SS are the CagA toxin and 
peptidoglycan components (Odenbreit et al., 2000, Viala et al., 2004). The latter are 
recognized by the Nod1 receptor, leading to the activation of the NF-kB pathway and to 
increased IL-8 production by the host cell (Viala et al., 2004). Either through its effectors 
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or by the contact of the structure with epithelial cells the T4SS induces several alterations 
in the cellular signaling machinery of the host, such as the transcription of pro-apoptotic 
and pro-inflammatory mediators (Viala et al., 2004). It has also been reported that strains 
which lack the cag PAI have little interaction with the host cells (Guillemin et al., 2002) 
The CagA effector, after injection into the host cell localizes close to the cell membrane 
(Segal et al., 1999, Asahi et al., 2003). CagA can be tyrosine phosphorylated by c-Src 
and c-Abl kinases (Selbach et al., 2002, Tammer et al., 2007) at conserved EPIYA (Glu-
Pro-Ile-Tyr-Ala) motifs (Hatakeyama, 2004). Both phosphorylated and non-
phosphorylated CagA are able to interact with several host proteins. Upon 
phosphorylation, CagA is able to interact with Csk, FAK, and SHP-2 leading to increased 
cell proliferation, cytoskeletal reorganization and motility (Higashi et al., 2002, Tsutsumi et 
al., 2003, Tsutsumi et al., 2006)(Figure 2). Non-phosphorylated CagA interacts with c-Met, 
Grb2, PAR-1, and ZO-1. These interaction with the host signaling molecules result in 
cytoskeleton rearrangements, named “hummingbird phenotype,” characterized by 
spreading and elongation of the host cells, and in junctional and polarity defects (Mimuro 
et al., 2002, Amieva et al., 2003, Churin et al., 2003, Saadat et al., 2007, Segal et al., 
1999) (Figure 2). 
 
 
Figure 2. Overview of the CagA, T4SS and VacA-induced host cell alterations. Adapted by permission from 
Cancer Letters (Wen and Moss) © 2009. 
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1.2. Clinical outcomes of H. pylori infection  
 
H. pylori infection induces an inflammatory process that results in the establishment of 
chronic superficial gastritis. In the initials steps of H. pylori colonization, both innate and 
acquired immune systems are activated (Peek et al., 1995), but with the chronicity of the 
infection the immune stimulation remains constant, with the levels of antibodies remaining 
constant for 20 years (Perez-Perez et al., 2002). The continuous stimulation of the 
immune system results in the infiltration of neutrophils and lymphocytes into the gastric 
mucosa, and in the production of cytokines by the host cells. The response is more 
pronounced in the case of cag PAI positive strains (Crabtree et al., 1991a, Peek et al., 
1995, Atherton et al., 1996). It is described that H. pylori up-regulates pro-inflammatory 
cytokines  such as IL-8, IL-6, TNF-α, INF-γ, TGF-β, as well as anti-inflammatory cytokines 
like IL-10 (reviewed by (Romero-Adrian et al., 2010). 
In the majority of the infected individuals, H. pylori infection results in chronic superficial 
gastritis only. However, in some individuals the infection can lead to more severe 
diseases such as peptic ulcer disease, gastric mucosal-associated lymphoid tissue 
(MALT) lymphoma, or gastric carcinoma.  
 
 
1.2.1. H. pylori-associated gastric carcinoma 
 
The World Health Organization has considered H. pylori as a type I carcinogen. This is 
particularly relevant since recent reported data revealed that about 16% (2 million cases) 
of cancers registered in the world per year, are attributable to infections (de Martel et al., 
2012), in which H. pylori, hepatitis B and C viruses, and human papillomaviruses were 
responsible for 1.9 million cases . 
H. pylori is associated with the two main histological types of gastric cancer: intestinal and 
diffuse (Nomura et al., 1991, Correa, 1992, Uemura et al., 2001). However, in the case of 
the intestinal type the mechanisms of H. pylori induced gastric cancer are better 
characterized. The bacteria function as an initiator factor of a cascade that begins with 
chronic superficial gastritis, and evolves to atrophic gastritis, characterized by loss of the 
glands that produce the gastric acid, and by infiltration of inflammatory cells in the 
glandular zone. Some individuals with atrophic gastritis may develop intestinal metaplasia, 
a premalignant lesion characterized by the substitution of the gastric cells by cells with 
intestinal markers. Intestinal metaplasia can evolve to dysplasia and finally to gastric 
carcinoma (Correa, 1992, Suerbaum et al., 2002) (Figure 3). 
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There is a considerable amount of data pointing to the role of H. pylori in the 
establishment of gastric carcinoma. Experiments with Mongolian gerbils where among the 
first demonstrate that the infection with H. pylori results in the development of gastric 
carcinoma (Watanabe et al., 1998). Studies in humans also showed that in patients with 
no precancerous lesions, gastric carcinoma only arose in H. pylori-infected individuals 
(Uemura et al., 2001, Wong et al., 2004). Another important indication for the importance 
of H. pylori in gastric carcinoma development are the studies that show that anti-microbial 
therapy directed to H. pylori prevented or delayed the development of gastric carcinoma 
(Correa et al., 2000, Uemura et al., 2001). In a prospective randomized placebo-
controlled population study in China, enrolling 988 infected individuals without 
precancerous lesions, gastric carcinoma only arose in those individuals who were not H. 
pylori eradicated (Wong et al., 2004). In another study, H. pylori-infected gastric 
carcinoma patients that underwent endoscopic resection of the tumor and that were either 
H. pylori eradicated or left untreated after surgery were analyzed (Uemura et al., 1997). 
The eradication of H. pylori resulted in regression of precancerous lesions and no 
development of gastric carcinoma, while the non-eradicated group reported 9% of new 
early stage intestinal type gastric carcinomas (Uemura et al., 1997). Although still a 
matter of debate, H. pylori eradication in some studies appears to lead to regression of 
gastric atrophy and intestinal metaplasia (Correa et al., 2000). 
Gastric carcinoma development occurs in a very small proportion of the H. pylori-infected 
individuals, and this has been attributed to variations in host, bacterial, and environmental 
factors. Host polymorphisms that increase the IL-1β or TNF-α inflammatory response, are 
associated with an increased risk of developing atrophy, hypochlorhydria, and gastric 
carcinoma (Machado et al., 2001b, El-Omar et al., 2000, El-Omar et al., 2003, Machado 
et al., 2003). Environmental factors such as cigarette smoking and diets with high salt 
intake increase the risk of gastric carcinoma development, whereas diets with high levels 
of antioxidants are protective (Hansson et al., 1993). H. pylori virulence factors that vary 
among strains are also associated with differences in risk of disease. The VacA s1/i1/m1 
strains cause greater damage in the epithelial cells and are associated with increased risk 
for gastric carcinoma (Atherton et al., 1995, Kidd et al., 1999, Miehlke et al., 2000). In the 
same line, cag PAI positive strains induce more inflammation and pronounced effects on 
cell cycle and cytoskeleton organization. These constitute the majority of the strains 
isolated from patients with severe diseases (Crabtree et al., 1995, Censini et al., 1996, 
Segal et al., 1999, Peek et al., 2002). 
Although association studies show that H. pylori (and specific virulence factors), host, and 
environmental factors confer increased risk for the development of gastric carcinoma, the 
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molecular mechanisms behind this process are not well known. 
H. pylori affects the epithelium in a multistep degenerative process that starts with the 
inflammation associated with the gastric colonization, with relevance for the action of the 
interleukins and reactive oxygen and nitrogen species produced in that context. At the 
same time, H. pylori promotes epithelial damage at the site of attachment on the host cell, 
both by altering the cell to cell adhesion and by the production of urease, lipases and 
toxins. In these conditions, the subepithelial tissue and the extracellular matrix are 
exposed, promoting the formation of ulcers. The disruption of epithelial junctions by H. 
pylori leads to a cell scattering phenotype, and causes cell elongation and increased 
motility (Montecucco et al., 2001). These alterations in the epithelium can lead to the 
disruption of the balance between epithelial cell proliferation and apoptosis (Cover et al., 
2003). Indeed H. pylori has been associated with increased host cell apoptosis and with 
increased proliferation (Moss et al., 1996, Brenes et al., 1993). Additionally, H. pylori 
infection has been associated with DNA damage. This may occur either by the direct 
action of H. pylori virulence factors or by indirect action of reactive oxygen and nitrogen 
species produced by inflammatory cells (Smoot et al., 2000, Kim et al., 2002b, Maeda et 
al., 2002). In agreement with these observations, it has been shown that H. pylori 
downregulates mismatch repair systems of the host cells (Kim et al., 2002a, Machado et 
al., 2009). 
Overall, alterations in the balance of epithelial cell apoptosis and compensatory 
hyperproliferation induced by H. pylori may render these cells more susceptible to acquire 
mutations which may not be repaired, and therefore have increased risk for malignant 
transformation. 
 
 
 
Figure 3. Host, environmental and bacterial factors involved in the cascade leading to gastric carcinoma. 
Adapted by permission from Gastroenterology (Ernst et al.) © 2006. 
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1.3. H. pylori and host epithelial cell-cell junctions 
 
The gastric epithelium functions as a physical barrier, and seal the lumen preventing 
gastric acid and pathogens to reach the interstitial space and the blood stream. 
Epithelial cells are polarized structures linked to each other and to the extracellular matrix 
by cellular junctions. The function of the epithelium is mainly accomplished by the 
existence of these cell-cell junctions – tight junctions, adherens junctions, desmosomes, 
and gap junctions – which are essential components of epithelial integrity (Moens et al., 
Turnberg, 1985) (Figure 4). Defects of the junctional complexes are characteristic of 
several diseases, including cancer. The loss of cell-cell adhesion may induce loss of 
contact inhibition (Pignatelli et al., 1994), contributing to the early phases of malignant 
transformation of epithelial cells.  
 
 
 
 
Figure 4. Organization of the intercellular junctions. Epithelia are composed of a layer of cells attached to the 
basement membranes by focal contacts and to the adjacent cells by tight junctions, adherens junctions, and 
desmosomes. Adapted by permission from Cell (Perez-Moreno et al.) © 2003. 
 
 
The tight junctions are the most apical set of cell-cell junctions that separate the apical 
and the basolateral domains of the plasma membrane. Tight junctions functions, as a 
barrier that impairs the mixing of lipids and proteins from the apical and basolateral parts 
of the epithelial cells, and at the same time, control the paracellular flux of ions and small 
molecules (Tsukita et al., 2001, Balda et al., 2008). They are composed of 
transmembrane proteins occludin, claudins, and junctional adhesion molecules (JAMs), 
and cytosolic proteins, zona ocludens (ZO)-1, -2, and 3, that bridge transmembrane 
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proteins with the cytoskeleton (Tsukita et al., 2001). It has been shown that H. pylori 
infection of epithelial cells induces internalization of occludin and claudins, and increases 
myosin light chain phosphorylation, leading to tight junction relaxation and increased 
epithelial barrier permeability (Wroblewski et al., 2009, Fedwick et al., 2005, Lapointe et 
al., 2010). Further, CagA interacts with ZO-1 and JAM-A, and recruits these proteins to 
the sites of bacteria attachment, altering the composition and function of the tight-
junctional complex (Amieva et al., 2003). The VacA toxin was also described to decrease 
the transepithelial resistance, a process mediated by the tight junctions complexes 
(Papini et al., 1998, Pelicic et al., 1999).  
Gap junctions are formed by channels constituted by connexins that allow intercellular 
passage of ions and small molecules such as calcium, ATP and cAMP (Laird, 2006). In 
addition, gap junctions also have a role in regulating cell morphology, establishing 
polarity, and rearrangement of the cytoskeleton (Matsuuchi et al., 2012). There are few 
reports addressing the role of H. pylori in gap junction modulation. Both CagA-positive 
and negative strains affect the gap-junctional function, with a more significantly effect in 
the case of CagA-positive strains (Tao et al., 2007, Xu et al., 2008), and bacteria 
eradication leads to promotion of cell junction formation (Xu et al., 2008). 
Desmosomes provide mechanical stability and intercellular communication to neighboring 
cells. They are composed by transmembrane desmoglein and desmocollin cadherins, 
which bind cytoplasmatic plakoglobin and plakophilin, which in turn bind to desmoplakin. 
The latter anchors intermediate filaments, which establish a mechanical continuum 
across cells (Odland, 1958, Matter et al., 2003, Johnson, 2005). The infection with H. 
pylori resulted in no alteration in the components of the desmosomes, in patients with 
gastroesophageal reflux disease (Wex et al.).  
 
 
1.3.1. H. pylori and adherens junctions disruption 
 
Adherens junctions are localized immediately below tight junctions and their main 
function is to maintain cell-cell adhesion. The major component of the adherens junctions 
is the transmembrane protein E-cadherin. The extracellular part of E-cadherin 
establishes homophilic interactions with E-cadherin molecules of neighboring cells, 
promoting cohesion of the epithelium. E-cadherin may also establish heterophilic 
interactions, namely with the receptor tyrosine kinases EGFR and c-Met (Hoschuetzky et 
al., 1994, Mateus et al., 2007, Hiscox et al., 1999, Reshetnikova et al., 2007), modulating 
their signaling properties. The cytoplasmic domain of E-cadherin is associated with β-, 
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p120-, and α-catenins, and the latter establishes a connection between E-cadherin and 
the actin cytoskeleton (Figure 5). These protein-protein interactions, as well as the 
phosphorylation status of the catenins, are important in junction stabilization (Reynolds 
et al., 2004b, Yanagisawa et al., 2006). The alterations in the phosphorylation status of 
the adherens junctions components can be mediated by RTKs such as EGFR, c-Met and 
FGFR or by the non-receptor tyrosine kinase c-Src, resulting in the disassembly of the 
cytoplasmatic adhesion complex, disruption of cadherin-mediated cell adhesion and cell 
scattering (Behrens et al., 1993, Hamaguchi et al., 1993, Fujita et al., 2002).  
Apart from the adhesive function, adherens junctions are important in regulation and 
maintenance of cellular polarity, actin cytoskeleton and organelles organization, motility, 
tight junction formation, signal transduction, inhibition of proliferation, prevention of 
apoptosis, and are important to suppress epithelial cell invasion and metastatic spread in  
a cancer context. In the absence of E-cadherin the other members of the complex are not 
able to promote cell-cell adhesion (Jamora et al., 2002, Bilder et al., 2000).  
 
 
 
Figure 5. Schematic representation of the adherens junction complex. Adapted by permission from Nature 
Reviews Genetics (Fuchs and Raghavan) © 2002. 
 
 
Disruption of the intercellular junctions is a strategy used by several microorganisms as a 
means of adhering to, entering cells, and/or exploiting host signaling to their advantage. 
Although the first line of defense against infectious agents in mucosal epithelia are tight 
junctions, microorganisms also explore cell-cell junctions at levels below the tight 
junctions. Indeed, E-cadherin is used as a receptor for adhesion and/or internalization by 
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several microorganisms, allowing microbial persistence in the host, avoidance of 
mechanical clearance, and increased pathogenesis (Mengaud et al., 1996, Lecuit et al., 
2000, Lecuit et al., 2001, Phan et al., 2007, Wu et al., 1998, Katz et al., 2000, Inoshima et 
al., 2011). 
Several lines of evidence show that H. pylori interferes with cell-cell junctional complexes, 
although the importance of this phenomenon for gastric disease development is not fully 
understood. 
The known mechanisms underlying H. pylori-mediated adherens junctions disruption are 
diverse and directed towards different components of the complex. 
 
H. pylori and E-cadherin 
 
Studies have shown that H. pylori targets E-cadherin by several mechanisms. Promoter 
methylation of the CDH1 gene (encoding E-cadherin) is frequently observed in H. pylori-
infected individuals (Chan et al., 2003a, Leung et al., 2006, Perri et al., 2007). The 
importance of this epigenetic mechanism of gene silencing in the context of H. pylori 
infection is reinforced by studies showing that eradication of H. pylori reduces CDH1 
promoter methylation levels (Leung et al., 2006, Perri et al., 2007, Chan et al., 2006). 
Although the molecular mechanisms through which H. pylori mediates E-cadherin 
promoter methylation are not fully understood, Qian et al. have shown that CDH1 
promoter methylation could be induced by infection with H. pylori or treatment of gastric 
cancer cell lines with interleukin-1β (IL-1β), a cytokine up-regulated in the context of H. 
pylori infection (Qian et al., 2008). This effect was inhibited by treatment with an 
interleukin-1 receptor antagonist (IL-1ra) antibody, suggesting that IL-1β may play a role 
in E-cadherin methylation (Qian et al., 2008). More recently, the same group has 
extended the study and showed that H. pylori- and IL-1β-mediated CDH1 promoter 
methylation, led to decreased E-cadherin expression and concomitant increase in DNA 
methyltransferase activity (Huang et al., 2012). Nevertheless, other studies have failed to 
show a decrease in E-cadherin expression associated with H. pylori infection both in cell 
lines and in the gastric mucosa (Bebb et al., 2006, Conlin et al., 2004, Chan et al., 
2003a). Of note, no CDH1 mutations have been described associated to H. pylori 
infection. 
In addition to epigenetic silencing, H. pylori has been associated with other mechanisms 
of disturbance of E-cadherin functions, such as proteolytic cleavage of its extracellular 
domain (also known as ectodomain shedding), and protein delocalization from the cell 
membrane. 
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Weidig et al. and Schirmeister et al. reported E-cadherin ectodomain shedding upon H. 
pylori infection in two different cell line models, the breast cancer MCF-7 and the gastric 
cancer NCI-N87 cells, respectively (Schirrmeister et al., 2009, Weydig et al., 2007). In 
both reports, ectodomain shedding of E-cadherin was neither dependent on H. pylori 
CagA nor on the presence of a functional T4SS. This finding is in keeping with a recent 
report showing that H. pylori-positive patients had significantly higher serum levels of 
soluble E-cadherin than uninfected controls, independently of the CagA status of the 
infecting strain (O'Connor et al.). There is evidence that the host disintegrin 
metalloproteinase ADAM10 contributes to H. pylori-induced shedding of E-cadherin in 
NCI-N87 cells, but since specific inhibition of ADAM10 led to a partial inhibition of E-
cadherin shedding, it is possible that other proteases are also involved in this process 
(Schirrmeister et al., 2009). In fact, Hoy et al. have recently identified the high-
temperature requirement A (HtrA), a serine protease from H. pylori, as a new secreted 
virulence factor which cleaves the ectodomain of the E-cadherin. E-cadherin shedding by 
HtrA leads to epithelial barrier disruption and may allow H. pylori to access the 
intercellular spaces (Hoy et al., 2010). HtrA-mediated E-cadherin cleavage may be a 
pathogenic mechanism of multiple Gram-negative bacteria, as is has recently been 
shown for pathogens such as enteropathogenic Escherichia coli, Shigella flexneri, and 
Campylobacter jejuni (Hoy et al., 2012). 
Studies have shown that H. pylori also induces E-cadherin translocation from the cell 
membrane to the cytoplasm (Schirrmeister et al., 2009, Conlin et al., 2004). Conlin et al. 
have demonstrated that H. pylori-induced redistribution of E-cadherin to intracellular 
vesicles was accompanied by the translocation from the cytoplasm to intracellular tubular 
structures of IQGAP-1, a protein that regulates the formation of adherens junctions. The 
results of E-cadherin internalization mediated by H. pylori in the NCI-N87 gastric cell line 
were confirmed in primary gastric cells. After 48 hours of bacterial infection, the presence 
of a reduced level of E-cadherin at the cell membrane was demonstrated, mediating a 
reduced level of cell-cell adhesion. These alterations to epithelial cell adhesion molecules 
induced by H. pylori were paralleled by increased levels of Rho-GTP and cell migration 
(Conlin et al., 2004). Using the human breast cancer MCF-7 cell line, Weidig et al. also 
reported internalization of E-cadherin upon H. pylori infection, simultaneously with E-
cadherin cleavage (Weydig et al., 2007). A rapid dissociation of the E-cadherin/β-
catenin/p120 complex from the actin cytoskeleton was observed upon infection, by 
disruption of the interaction between E-cadherin and α-catenin (Weydig et al., 2007). 
Although E-cadherin alterations mediated by H. pylori are independent of CagA, physical 
interaction between these proteins has been described (Murata-Kamiya et al., 2007). 
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Murata-Kamiya et al. used the gastric cancer cell line MKN28 transfected with CagA 
expression vectors, and showed that CagA was able to interact with E-cadherin. This led 
to β-catenin release from the adherens junctions and nuclear translocation, with 
transactivation of genes encoding intestinal specific proteins like MUC2, contributing to 
the development of intestinal metaplasia (Murata-Kamiya et al., 2007). This effect was 
independent of the CagA tyrosine phosphorylation status but dependent on a specific 
region of CagA known as the multimerization sequence (Kurashima et al., 2008). 
 
H. pylori and β-catenin 
 
The binding of catenins to the intracellular domain of E-cadherin has a crucial role in the 
adherens junctional complex stabilization, connection to the cell cytoskeleton, and cell 
signaling. 
When not tethered at the membrane in the adherens junctions, β-catenin is 
phosphorylated by a multiproteic complex comprising the serine/threonine kinase 
glycogen synthase kinase 3β (GSK3β), and the scaffolding proteins adenomatous 
polyposis coli (APC), axin, and casein kinase 1α (Ck1α) and targeted to degradation via 
the ubiquitin/proteasome pathway (Aberle et al., 1997, Gooding et al., 2004). This 
degradation pathway is counteracted when the Wnt pathway is active, resulting in β-
catenin stabilization in the cytoplasm. Cytoplasmic stabilized β-catenin may be 
translocated into the nucleus where it forms a nuclear complex with the transcription 
factors of the T cell factor⁄lymphoid enhancer-binding factor (TCF/LEF) family, promoting 
the expression of a wide-range of genes important for carcinogenesis (Gooding et al., 
2004, Bierie et al., 2003, Marchenko et al., 2002, Polakis, 2000). 
Several studies have addressed the effect of H. pylori infection in β-catenin signaling and 
have shown that H. pylori leads to the delocalization of β-catenin from the cell membrane 
(Bebb et al., 2006, Weydig et al., 2007, Suzuki et al., 2005, Franco et al., 2005, Murata-
Kamiya et al., 2007, Franco et al., 2008, Sokolova et al., 2008, Suzuki et al., 2009, 
Nakayama et al., 2009, Hung et al., 2009, Gnad et al., 2010, Kurashima et al., 2008). H. 
pylori phosphorylates and inactivates GSK3β (Tabassam et al., 2009, Sokolova et al., 
2008, Nakayama et al., 2009, Suzuki et al., 2009) and, by suppressing GSK3β activity H. 
pylori leads to inhibition of β-catenin phosphorylation and ubiquitin-dependent 
degradation (Sokolova et al., 2008). H. pylori-mediated GSK3β suppression occurs 
through activation of the phosphatidylinositol 3-kinase⁄protein kinase B (PI3K) ⁄ (Akt) 
signaling pathway via EGFR and c-Met receptor (Nagy et al., 2011, Tabassam et al., 
2009, Sokolova et al., 2008, Yan et al., 2009, Nakayama et al., 2009, Suzuki et al., 2009).  
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In one report however, β-catenin stabilization was described to occur in a 
phosphorylation-independent process (Franco et al., 2005). 
The canonical Wnt-signaling pathway appears to be involved in the regulation of β-
catenin in the context of H. pylori infection. In fact, it has been shown that after H. pylori 
infection there is increased synthesis of Wnt10A by the epithelial cells (Kirikoshi et al., 
2001). Additionally, H. pylori-induced activation of β-catenin was shown to involve the 
phosphorylation of the Wnt pathway co-receptor low density lipoprotein receptor-related 
protein LRP6 and proteins of the dishevelled family, namely Dvl2 and Dvl3 (Gnad et al., 
2010). 
Several studies report β-catenin translocation to the nucleus after H. pylori infection 
(Suzuki et al., 2005, Franco et al., 2005, Murata-Kamiya et al., 2007, Franco et al., 2008, 
Sokolova et al., 2008, Suzuki et al., 2009, Nakayama et al., 2009, Hung et al., 2009, 
Gnad et al., 2010). There are however two studies in non-gastric cell lines that did not 
show nuclear translocation or activation of β-catenin signaling after infection (Bebb et al., 
2006, Ogden et al., 2008). β-catenin nuclear translocation induced by H. pylori leads to 
TCF/LEF-dependent transcription of genes involved in carcinogenesis, including cyclin 
D1 (Murata-Kamiya et al., 2007, Sokolova et al., 2008, Nakayama et al., 2009, Gnad et 
al., 2010, Kurashima et al., 2008). This effect was shown to be CagA-dependent in the 
majority of studies (Suzuki et al., 2005, Franco et al., 2005, Murata-Kamiya et al., 2007, 
Suzuki et al., 2009, Hung et al., 2009, Kurashima et al., 2008), with the exception of one 
study performed in a non-human, non-gastric cell line (Sokolova et al., 2008). Additional 
effectors of the T4SS, like peptidoglycan (Nagy et al., 2011, Viala et al., 2004), and other 
H. pylori virulence factors, such as the multifunctional toxin VacA (Nakayama et al., 2009, 
Cover et al., 2005) and the outer membrane protein OipA (Franco et al., 2008, Yamaoka, 
2011), may also be involved. The use of the Mongolian gerbil model has shown that H. 
pylori infection induces gastric carcinoma precursor lesions, with aberrant β-catenin 
expression, that led to transcriptional up-regulation of genes implicated in carcinogenesis. 
In this model-system, and in agreement with most of the cell-line models, aberrant β-
catenin expression was associated with infection with H. pylori CagA-positive strains 
(Franco et al., 2005, Franco et al., 2008). 
 
H. pylori and p120-catenin 
 
p120-catenin (p120) is another important component in adherens junctional complex 
stability and signaling (Hartsock et al., 2008). p120 binds to the juxtamembrane domain of 
E-cadherin (Yap et al., 1998), and mutations in this domain abolish E-cadherin-mediated 
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cell-cell adhesion (Kaurah et al., 2007). In addition to E-cadherin stabilization, p120 can 
also interact with the transcription factor Kaiso (Daniel et al., 1999, van Hengel et al., 
1999, Roczniak-Ferguson et al., 2003). 
Two reports show that H. pylori alters the cellular localization and the phosphorylation 
status of p120, but not total p120 protein levels (Krueger et al., 2007, Ogden et al., 2008). 
Krueger et al. showed that after six hours of infection of primary gastric epithelial cells, 
there was a recruitment of the non-phosphorylated p120 to perinuclear vesicles, whereas 
the fraction of phosphorylated p120 increased and could be detected in the nucleus, at 
the cell membrane, and at the leading edge of migrating cells (Krueger et al., 2007). 
Those alterations were associated with elongation of cells and increased migration. 
Ogden et al. also showed nuclear translocation of p120 after H. pylori infection of MKN28 
cells and of ex vivo mouse gastric glands. Nuclear translocation of p120 induced by H. 
pylori was associated with increased MMP-7 mRNA, and occurred by release of the 
MMP-7 transcriptional repressor Kaiso. These changes were associated with reduced 
levels of p120 tyrosine phosphorylation, while total p120 remained unchanged (Ogden et 
al., 2008). H. pylori-mediated p120 nuclear translocation was dependent on factors of the 
T4SS, but independent of the T4SS effector CagA (Ogden et al., 2008). 
 
 
 
2. H. pylori infection and host epithelial cell signaling  
 
Due to its close interaction with host cells, H. pylori has the capacity to induce alterations 
in the normal host cell signaling pathways. The alterations in the normal cell signaling by 
H. pylori can result in the induction of apoptosis, morphological changes, like the 
establishment of the “hummingbird phenotype,” disruption of the epithelial barrier, 
alteration in cell proliferation, and production of pro-inflammatory cytokines (Chen et al., 
1997, Segal et al., 1999, Amieva et al., 2003, Fan et al., 1996, Crabtree et al., 1995) 
As a result of its localization at the cell membrane receptors tyrosine kinase (RTKs) are 
among of the first host cell molecules to be in contact with H. pylori during infection.  
The RTKs are transmembrane proteins that, typically, after activation by their ligands, 
dimerize or oligomerize (Lemmon et al., 1994, Lemmon et al., 1998, Hubbard et al., 2000, 
Schlessinger, 2000), making possible an efficient cross-phosphorylation of  their 
adjacent cytoplasmic tyrosine kinase domains. The phosphorylation of the tyrosine 
residues, a characteristic of the transmembrane signaling, creates docking sites for 
several molecules involved in a plethora of signal transduction pathways. 
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Overexpression and mutations of the RTKs signaling pathways elements are associated 
with carcinogenesis and are targets for anticancer therapy (Brunelleschi et al., 2002). 
RTKs such as EGFR and c-Met are basolateral localized in polarized cells (Crepaldi et 
al., 1994, Maratos-Flier et al., 1987). After the disruption of cellular junctions mediated by 
H. pylori, the polarity of host cell is altered and the RTKs may be now localized apically, 
in a cellular localization more accessible to the bacteria. Because of these facts, the 
study of the H. pylori-mediated alterations in host cell signaling is critical to understand 
the outcomes of the infection. 
 
 
2.1. c-Met signaling pathway 
 
The c-Met receptor is initially synthesized as a 170-kDa single chain intracellular 
precursor that after processing yields a mature 190 kDa disulfide-linked heterodimer 
form, which is cell surface-associated. The heterodimer is constituted of a 50 kDa α-
chain, entirely extracellular, and a 140 kDa β-chain, that spans the membrane, and 
consists of an extracellular domain, a membrane spanning domain, and a cytoplasmic 
tyrosine kinase domain (Giordano et al., 1989) (Figure 6). 
In a non-pathological context, c-Met activation by its natural ligand, the hepatocyte 
growth factor (HGF) also known as scatter factor (SF), occurs in a wide range of tissues, 
and is required for embryonic development (Uehara et al., 1995, Borowiak et al., 2004), 
liver regeneration (Borowiak et al., 2004, Huh et al., 2004), and wound healing 
(Chmielowiec et al., 2007). These cellular processes involve cytoskeleton reorganization, 
cell motility, proliferation, morphogenesis, invasion, and angiogenesis (Birchmeier et al., 
2003, Jiang et al., 2005, Peruzzi et al., 2006). 
 In a pathological context, abnormal c-Met signaling contributes to tumorigenesis, 
particularly to the invasive and metastatic phenotype (Furge et al., 2000). Deregulation of 
c-Met signaling by mutations, overexpression, and autocrine and paracrine activation, is 
associated with the severity of human cancers, including gastric carcinoma (Kuniyasu et 
al., 1992, Kaji et al., 1996, Amemiya et al., 2000, Birchmeier et al., 2003). It is known that 
the disruption of the c-Met multifunctional docking site impairs oncogenic transformation 
and invasive growth of tumor cells (Bardelli et al., 1998). In addition, c-Met 
phosphorylation stimulates epithelial to mesenchymal transition (EMT), a key feature of 
metastization (Birchmeier et al., 2003, Benvenuti et al., 2007). 
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Figure 6. Activation of c-Met results in the recruitment of adaptor molecules that activate signaling pathways 
resulting in different cellular phenotypes. Adapted by permission from Nature Reviews in Molecular Cell 
Biology (Birchmeier et al.) © 2003. 
 
Regarding the association of H. pylori infection with c-Met, studies in which human 
biopsies were analyzed, showed that an increase in c-Met and HGF expression was 
associated with the presence of the infection, both in pre-neoplasic and in neoplasic 
lesions (Hori et al., 2000, Zhuang et al., 2001). However, there are also studies 
indicating that no correlation exists between c-Met expression and H. pylori infection in 
gastric carcinoma (Kubicka et al., 2002). 
It was demonstrated that H. pylori infection triggers HGF-independent activation of the c-
Met receptor. After injection, CagA can directly bind to the intracellular part of the 
receptor, functioning as an adaptor protein (Churin et al., 2003) and leading to the 
activation of the downstream targets PLC-γ and ERK (Churin et al., 2003, Franke et al., 
2008). As a result of the activation of these pathways, H. pylori induces a motogenic 
response in host cells (Churin et al., 2003). By mimicking the action of HGF, H. pylori is 
able to modulate the host cell function, thus contributing to the establishment of an 
invasive phenotype. 
It has also been shown that H. pylori is able to induce the interaction of the lipid raft-
associated transmembrane adaptor proteins NTAL and LIME with c-Met, leading to the 
activation of a c-Met-Grb2-ERK-cPLA2 signaling cascade at early stages of infection 
independently of the T4SS (Rieke et al., 2010). 
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2.2. EGFR signaling pathway 
 
EGFR is a 170 kDa transmembrane protein with a ligand binding domain, a 
transmembrane domain, and an intracellular tyrosine kinase domain (Carpenter, 1987). 
This receptor is part of a family of human epidermal growth factors receptors, composed 
of four members: HER1/erbB1 (EGFR), HER2/erbB2, HER3/erbB3, and HER4/erbB4). In 
contrast with the c-Met receptor, several natural ligands of EGFR are known: EGF, 
amphiregulin, TGF-α, betacellulin, heparin binding EGF (HB-EGF), and epiregulin 
(Yarden, 2001). Upon ligand binding, EGFR homo or heterodimerizes, causing 
autophosphorylation of the tyrosine kinase domain and activation of downstream signal 
transduction pathways. EGFR can also be transactivated by G-protein-coupled receptors 
(GPCRs) and adhesion molecules (Prenzel et al., 1999, Pece et al., 2000). 
In a non-pathological context, EGFR that is expressed in several cell types, is involved in 
normal cell proliferation, differentiation, growth, cell death, motility, and matrix adhesion 
(Yarden et al., 2001).    
In a pathological context, EGFR, which is codified by the pro-oncongene c-erbB, can be  
deregulated either by overexpression or mutations, leading to activation of the PI3K, the 
Ras-Raf-MAPK, and the PLC pathways (Gusterson et al., 1984, Wong et al., 1992, van 
der Geer et al., 1994, Moscatello et al., 1995, Lynch et al., 2004), a set of alterations 
associated with multiple cancer types (Normanno et al., 2006).  In gastric carcinoma, 
EGFR is commonly overexpressed, and amplifications of the gene are associated with 
poor prognosis (Zheng et al., 2004). In the stomach, the signaling pathway triggered by 
EGF is associated with inhibition of gastric acid secretion and with impaired wound 
healing (Konturek et al., 1990, Shaw et al., 1987).  
Regarding the role of EGFR in cancer, it is also known that the treatment with EGFR 
monoclonal antibodies or the stable transfection of EGFR antisense results in growth 
arrest of gastric cell lines or tumors of xenografted mice when EGFR overexpression 
exists (Teramoto et al., 1996, Hirao et al., 1999). 
Concerning the connection between EGFR and H. pylori, there are several reports 
indicating that the infection is associated with an increase in the EGFR and EGF levels, 
which return to normal after bacteria eradication (Coyle et al., 1999, Wong et al., 2001, 
Ashktorab et al., 2007). In the same line, the bacteria itself is able to induce an increase 
in EGFR mRNA levels (Ashktorab et al., 2007, Keates et al., 2007). 
 It is described that H. pylori infection, or purified VacA, are able to activate the EGFR 
(Wallasch et al., 2002, Caputo et al., 2003). EGFR activation can be achieved, in a 
T4SS-independent manner, by the HB-EGF up-regulation and release through the action 
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of proteases (Wallasch et al., 2002), or by transactivaction of TLR4 (Basu et al., 2008). 
In a process similar to a feedback loop, it has also been described that H. pylori-induced 
IL-8 is involved in the mechanism of processing of EGFR ligands and in EGFR activation 
(Joh et al., 2005, Beswick et al., 2008). 
To prolong the action of the EGFR-activated receptor, H. pylori is also able to block its 
endocytosis, and receptor degradation, in a process dependent on CagA and on the 
tyrosine kinase c-Abl that is able to phosphorylate the receptor (Bauer et al., 2009) 
(Figure 7).  
The EGFR activation after infection with H. pylori results in the activation of PI3K, Akt, 
Raf, MEK and ERK (Du et al., 2007, Tabassam et al., 2009, Wiedemann et al., 2012) 
(Figure 7). However, is it also described that VacA is able to inactivate EGFR, and 
consequently ERK, inhibiting cell scattering and elongation (Tegtmeyer et al., 2009).  
H. pylori-mediated activation of EGFR results in several cellular alterations, stressing the 
involvement of different downstream pathways. The EGFR activation is reported to be 
involved in enhancement of IL-8 production (Wallasch et al., 2002), and in up-regulation of 
VEGF, through the action of the H. pylori protein HP0175 (Caputo et al., 2003, Basu et al., 
2008). EGFR activation by the bacteria also leads to induction of Egr-1 (Keates et al., 
2005), activation of human beta-defensin 3 (hBD3) (Boughan et al., 2006), and paxillin 
phosphorylation (Tabassam et al., 2011). H. pylori-induced EGFR activation results in 
alteration of cytoskeleton and motility, as well as in an anti-apoptotic mechanism, involving 
Akt and Bcl family members (Yan et al., 2009), and in gastrin induction (Wiedemann et al., 
2012).  
Overall, these results suggest that the signaling pathways activated by EGFR influenced 
by H. pylori may result in increased risk for neoplasic transformation of epithelial cells. 
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Figure 7. Transactivation of EGFR by H. pylori and host cellular induced alterations. Adapted by permission 
from Nature Reviews in Cancer (Polk and Peek) © 2010. 
 
 
 
3. Metalloproteinases 
 
Metalloproteinases (MMPs) are a family of zinc dependent enzymes that share a catalytic 
and a pro-domain, and possess the ability to degrade all the components of the 
extracellular matrix. MMPs are divided in subfamilies: collagenases, gelatinases, 
stromelysins and membrane-type MMPs, depending on their structure and subtract  
(Chakraborti et al., 2003) (Figure 8). After transcription, the majority of MMPs are 
secreted in an inactive form, a pro-enzyme (zymogen) that has to be processed to 
become active, both autocatalytically and by other proteinases (Chakraborti et al., 2003, 
Visse et al., 2003).  
 
Figure 8. Members of the matrix metalloproteinase family of degrading enzymes. Adapted by permission 
from Progress in Histochemistry and Cytochemistry (Mannello and Medda) © 2012. 
 
 
Latent MMPs contain a conserved cysteine residue in the pro-enzyme domain with the 
ability to bind the catalytic zinc. Whenever this bound exists, the enzymatic activity of the 
MMP is impaired. The physical activation occurs when this binding is disrupted, in a 
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process named “cysteine switch,” which can occur by physical and chemical means, for 
example by the action of mercuric compounds, reactive oxygen species or even other 
MMPs (Chakraborti et al., 2003) (Figure 9). 
 
Figure 9. Mechanism of pro-MMP activation. Latent MMP is catalytic inactive due to the interaction between 
the cysteine of the pro-domain and zinc ion of the catalytic domain. Proteolytic cleavage of the pro-domain 
leads to MMP activation. Adapted by permission from Matrix Biology (Ra and Parks) © 2007. 
 
 
MMPs are tightly regulated at several levels: transcription, compartimentalization, pro-
enzyme activation and inactivation, and by the action of specific inhibitors, the tissues 
inhibitors of MMPs (TIMPs) (Parks et al., 2004).  
The main function of MMPs is extracellular matrix degradation, but they are also 
responsible for the release of growth factors, the modification of cell surface receptors, 
and the regulation of inflammation and immunity (McCawley et al., 2001, Egeblad et al., 
2002, Parks et al., 2004). MMPs are involved in physiological processes such as uterine 
involution, and in pathological conditions such as tissue damage in inflammatory disease 
such as arthritis, and cancer invasion (Chakraborti et al., 2003).  
Invasion is a complex cell phenotype that implicates various cellular activities that 
mobilizes multiple molecular pathways within the cell, in which MMPs play an important 
role. Cell invasion occurs both in non-pathological conditions such as embryonic 
development and normal immune response, and in pathological conditions such as 
cancer (Monteagudo et al., 1990, Takeichi, 1991, Pyke et al., 1992, Brooks et al., 1996), 
in tightly regulated processes. For invasion to occur, cells have to undergo several 
changes in cell-cell and cell-matrix adhesion, migration, proteolysis, and ectopic survival. 
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The loss of cell-cell adhesion is essential for invasion and involves alteration in the 
components of adherens junctions, tight junctions, and desmossomes. One of the key 
molecules in this process is E-cadherin, that can be downregulated either 
transcriptionally, by mutations and by promoter methylation, and post-transcryptionally 
by phosphorylation, glycosilation, proteolysis, endocytosis and sterical hindrance 
(Vleminckx et al., 1991, Boterberg et al., 2000, Noe et al., 2001, Piedra et al., 2001, Zhu 
et al., 2001, Machado et al., 2001a).  
For cell migration, usually described as formation of stress fibers, membrane ruffles, 
lamellipodia and filopodia (Nobes et al., 1999), the cell-matrix adhesion has to be altered. 
Cell-matrix bounds have to be broken, and new transient cell-matrix connections that 
allow the cell to move are established (Sheetz et al., 1999). Key components of this 
process are the integrin family of receptors and the components of the focal adhesion 
complexes formed when a new cell-matrix bound is established, such as FAK, c-Src, and 
vinculin.  
For invasion, cells also need to overcome the matrix, which is constituted by laminins, 
collagens and proteoglycans. This process occurs through a tightly regulated proteolysis 
mechanism, in which MMPs have a pivotal role. MMPs are able to degrade all 
components of the extracellular matrix, eliminating the physical barrier to the cell 
movement, and creating the route to the migrating cells. Furthermore, MMPs are 
important because of their involvement in the release and activation of latent proteases, 
growth factors, and chemotactic agents. Through the action of MMPs, new integrin 
binding sites on ECM can become exposed and available to transmit migratory and 
survival signals. At the same time, MMPs are able to cleave cell surface receptor 
molecules, such as E-cadherin, contributing to the invasive potential of the cells, or 
promote the ectodomain shedding of transmembrane receptors with pro-invasive 
properties (Mareel et al., 2003, Noe et al., 1999, Ryniers et al., 2002).  
After reaching a new environment, the invasive cells need to remain viable, a condition 
achieved through the stimulating of anti-apoptotic signals (Raff, 1992). Curiously, many 
of the antiapoptotic signals are the same signals that drive migration (Mareel et al., 2003).  
In the above mentioned mechanisms, several molecules are involved such as c-Met, c-
Src, Rho GTPases, PI3K, members of the ERK/MAPK signaling and calpain, which have 
also been associated with tumors with high invasive potential (Carragher et al., 2004).  
Therefore, the cell invasive phenotype is the result of multiple molecular pathways that 
branch and interact with each other, establishing a complex but also flexible intracellular 
system.  
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3.1. H. pylori infection and MMPs  
 
H. pylori infection up-regulates the expression and activity of several MMPs both in vitro 
and in vivo. Although the molecular mechanisms that lead to MMP modulation are not 
well established, the role of MMPs in H. pylori-mediated cell invasion, migration and 
processing of growth factors has been reported (Wallasch et al., 2002, Wroblewski et al., 
2003, Wu et al., 2005, McCaig et al., 2006, Oliveira et al., 2006, Yin et al., 2010).  
The majority of the data associating MMPs up-regulation and H. pylori infection came 
from analysis of cDNA arrays that compared infected versus non-infected conditions. 
These studies showed that H. pylori is associated with upregulation of all MMP 
subfamilies, namely MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-10, MMP-
12, MMP-13, MMP-14, MMP-15, and MMP-19 (Yokoyama et al., 2000, Guillemin et al., 
2002, Gooz et al., 2003, Kitadai et al., 2003, Mori et al., 2003, Wroblewski et al., 2003, 
Krueger et al., 2006). In addition, H. pylori itself is able to secrete a MMP-3 like enzyme 
(Windle et al., 1997, Gooz et al., 2001). Modulation of MMPs by H. pylori is best 
documented for MMP-1, MMP-7 and the gelatinases MMP-2 and MMP-9. 
It is reported that H. pylori up-regulate MMP-1 both in fibroblasts (Yokoyama et al., 2000) 
and in epithelial cells from infected individuals with gastritis and gastric cancer (Krueger 
et al., 2006, Wu et al., 2006, Pillinger et al., 2007). MMP-1 expression is dependent on 
the T4SS, OipA (Krueger et al., 2006, Wu et al., 2006), or CagA (Pillinger et al., 2007), 
depending on the cell line and strains used in different studies.   
MMP-1 up-regulation occurs in an ERK and JNK-dependent manner (Krueger et al., 
2006, Pillinger et al., 2007), through activation of the Ras/Raf/RhoA/MAPK pathway (Wu 
et al., 2006), and under the regulation of PKC (Sokolova et al., 2012). The increase in 
MMP-1 in the context of H. pylori infection has been associated with increased basement 
membrane degradation and cell invasion (Krueger et al., 2006, Sokolova et al., 2012).  
H. pylori-mediated MMP-7 expression has been reported and the bacterial virulence 
factors VacA, T4SS, CagA, and OipA may play a role in this process (Bebb et al., 2003, 
Crawford et al., 2003, Wroblewski et al., 2003, Koyama, 2004, Yanagisawa et al., 2005, 
Chung et al., 2010, Eftang et al., 2012, Wu et al., 2006, Ogden et al., 2008).  
In vitro, MMP-7 is expressed in epithelial cells at the advancing edge of migrating cells 
(Wroblewski et al., 2003) and in vivo at the epithelial cells surface, and in the proliferative 
zone of the gastric glands (Wroblewski et al., 2003, Koyama, 2004, Bebb et al., 2003), 
and is also expressed in lymphocytes (Koyama, 2004).  
The signaling pathways underlying the H. pylori-mediated in MMP-7 expression are also 
controversial. H. pylori-associated cytokines IL-8, TNF-α and IL-6, as well as EGFR 
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ligands, may have a role in the process due to their ability to induce MMP-7 expression, 
and a role for gastrin has also been suggested (Wroblewski et al., 2003). MMP-7 
expression occurs in a pathway involving Rho, Rac and the NF-kB (Wroblewski et al., 
2003), in a ERK-dependent manner (Crawford et al., 2003), or through aberrant p120 
catenin activation, that after nuclear translocation relieves the MMP-7 repressor Kaiso 
(Ogden et al., 2008).  
MMP-7 is involved in H. pylori-induced migration and invasion (Wroblewski et al., 2003), 
in the processing of insulin-like growth factor binding protein (IGFBP)-5 (McCaig et al., 
2006) and in HB-EGF shedding (Yin et al., 2010). IGFBP-5 and HB-EGF have a role, 
respectively, in proliferation and migration of gastric myofibroblast (McCaig et al., 2006), 
and in EGFR activation and IL-8 production (Yin et al., 2010, Wallasch et al., 2002).    
H. pylori infection is associated with increased expression of the MMP-2 and MMP-9 
gelatinases (Bergin et al., 2004, Kundu et al., 2006). MMP-2 and MMP-9 are expressed 
in epithelial cells and lymphocytes and MMP-9 is also expressed in fibroblast and 
macrophages (Koyama, 2004, Mori et al., 2003, Danese et al., 2004, Bergin et al., 2004). 
MMP-2 expression is induced by H. pylori in a CagA and T4SS-dependent manner 
(Yanagisawa et al., 2005), and is stimulated by the H. pylori-induced IL-21, in a process 
NF-kB dependent (Caruso et al., 2007).  
H. pylori-mediated MMP-9 expression is dependent on different bacterial virulence 
factors such as T4SS, CagA, OipA, HP-NAP, HpaA, urease, or LPS, depending on the 
cell line models and bacterial strains used (Yanagisawa et al., 2005, Mori et al., 2003, 
Wu et al., 2006, Nam et al., 2011, Kundu et al., 2006, Bergin et al., 2005).   
H. pylori-induced MMP-9 up-regulation in epithelial cells occurs via NF-kB (Mori et al., 
2003, Nam et al., 2011, Wu et al., 2005, Caruso et al., 2007), COX-2 (Wu et al., 2005), 
CagA phosphorylation, SHP-2 and ERK (Nam et al., 2011). In addition, the infection-
associated cytokines TNF-α, IL-1β, IL-6, and IL-21 are able to induce MMP-9 secretion 
(Caruso et al., 2007, Kundu et al., 2006). Furthermore, H. pylori eradication leads to 
decreased MMP-9 in patients with chronic gastritis and gastric ulcers (Danese et al., 
2004, Kubben et al., 2007, Kundu et al., 2011).  
H. pylori-induced increase in MMP-2 and MMP-9 activities results in increased cell 
invasion (Oliveira et al., 2006, Wu et al., 2005). 
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The general aim of the work presented in this thesis was to evaluate the role of H. 
pylori infection in the induction of host gastric epithelial cell invasion. The initial 
approach consisted on the evaluation of the invasive capacity through extracellular 
matrix components of the non-invasive human gastric cancer cell line AGS after 
infection with H. pylori. The role of the bacterial virulence factors CagA, T4SS, and 
VacA was also evaluated. After establishing that the c-Met receptor was important for H. 
pylori-mediated AGS cell invasion, the role of the downstream targets of c-Met was also 
elucidated. Additionally, and after demonstrating that Nck, PLC-γ, and c-Src were 
involved in H. pylori-mediated cell invasion, the activation of these molecules by H. 
pylori was studied. Studies in this section included in vitro infections of cell lines with 
H. pylori strains, followed by assessment of cell invasion in Matrigel assays. Studies 
also included transient transfection of cell lines with siRNAs for gene silencing, as 
well as co-immunoprecipitation and western blot analyses. Data obtained are 
presented in Part I.1 of the Results.  
 
Based on the results from Part I.1 pointing to a role of H. pylori in inducing 
extracellular matrix degradation by host cells, and since matrix metalloproteinases 
are important for that process, the next aim was to evaluate the role of H. pylori in 
MMP expression. Studies started with the validation of a panel of MMPs shown to be 
up-regulated in a cDNA expression microarray performed by our Group. After 
confirmation that H. pylori increased the expression of MMP-1, MMP-7, and MMP-10, 
a more detailed investigation of the effect of H. pylori on MMP-10 modulation was 
performed. Quantitative real-time polymerase chain reaction, western blot, and 
enzymatic activity assays were used in uninfected and H. pylori-infected cells. The 
role of the H. pylori virulence factors CagA and T4SS was addressed using bacterial 
mutants, and was further confirmed using a panel of H. pylori clinical isolates with 
known cagA and T4SS status. The involvement of specific host cell signaling 
pathways and of receptor tyrosine kinases in the modulation of MMP-10 expression 
by H. pylori was evaluated in experiments with siRNA gene silencing and with 
chemical inhibitors. The role of MMP-10 in H. pylori-mediated cell invasion was 
assessed with Matrigel assays.These results are presented in Part I.2 of the Results 
and in Paper I. 
 
Since the E-cadherin-catenin complex functions as an invasion suppressor, the next 
aim was to evaluate whether the complex had a role in H. pylori-mediated cell 
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invasion and signaling. For that, gastric cell lines with intact E-cadherin-catenin 
complex were used. Also, and for the purpose of comparison with previous data 
obtained in the AGS background, an AGS cell line with a wild-type E-cadherin was 
established. For the characterization of the structure and function of the adherens 
junctions, immunofluorescence, confocal microscopy and aggregation assays were 
used. The phosphorylation and interactions between proteins of the adherens 
junctions were evaluated by co-immunoprecipitation and western blot. The invasion 
capacity of the different cell lines was assessed with Matrigel assays. Data generated 
in this part of the thesis is presented in Part II of the Results and in Paper II. 
 
In this Thesis, a paper summarizing the findings of the literature regarding H. pylori 
infection and the adherens junctions (Paper III) and a paper reviewing the role of E- and 
P-cadherins in cancer (Paper IV) are also included, and have been partially used in the 
Introduction. 
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1. Cell cultures  
 
 AGS (ATCC CRL-1739), NCI-N87 (ATCC CRL-5822), and IPA220 cells (Gartner et al., 
1996), all derived from human gastric carcinomas were maintained in RPMI 1640 
(Gibco), with 10% fetal bovine serum (FBS) (Hyclone), 2.5 µg/ml fungizone (Gibco), 200 
µg/ml streptomycin, and 200 IU/ml penicillin (Gibco) at 37ºC, under a 5% CO2 
humidified atmosphere. The AGSEcad cell line was maintained in the same conditions 
with supplementation with 5 µg/ml of blasticidin (Invitrogen) for clonal selection.The 
adherent cells were detached using trypsin (Gibco).  
 
 
2. H. pylori strains and growth conditions  
 
 Bacteria were grown in tryptic soy agar (TSA)  supplemented with 5% sheep blood (BD 
Bioscience) and incubated 48 hours at 37ºC under a microaerophilic atmosphere.  
Experiments were performed with wild-type H.pylori strains 60190 (ATCC 49503), 
26695 (ATCC 700392), 84183 (ATCC 53726), Tx30a (ATCC 51932), and G27 (Xiang et 
al., 1995), as well as with the mutant strains 60190∆vacA, 60190∆cagA, 60190∆cagE, 
84183∆cagA and 84183∆cagE (all mutant strains were kindly provided by Professor 
John Atherton, Nottingham University, UK). A panel of clinical isolates with known vacA, 
cagA and cag PAI statuses was also used for some experiments (CI-7, CI-43, CI-45, 
CI-50, CI-51, CI-59, CI-60, CI-62, CI-63, and CI-69).  
 
Table I: Characterization of H. pylori strains in terms of virulence factors vacA, cagA 
and cag PAI  
 
Bacterial strain 
 
Virulence factor 
vacA cagA cag PAI 
26695 s1/m1                       +   + 
60190 s1/m1                       + + 
60190∆cagA             s1/m1                       -                           + 
60190∆cagE             s1/m1                       +                           - 
60190∆vacA                  -                           +   +   
84183 s1/m1                       +   + 
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84183∆cagA             s1/m1                       -                           + 
60190∆cagE             s1/m1                       +                           - 
CI-7 s2/m2                       - - 
CI-43 s1/m1                       + + 
CI-45 s2/m2                       - - 
CI-50 s1/m1                       + + 
CI-51 s2/m2                       - - 
CI-59 s1/m1                       + + 
CI-60 s1/m1                       + + 
CI-62 s1/m1            - nd 
CI-63 s1/m2                       - - 
CI-69 s1/m1                       + + 
G 27 s1/m1                       + + 
Tx30a s2/m2                       - - 
(+: present;   -  : absent; nd: not determined) 
 
 
3. Infection of gastric cells  
 
80% confluent monolayers were washed in phosphate-buffered saline (PBS), pH=7.4, and 
incubated in serum and antibiotic-free medium (Gibco) at least 3 hours before the 
infection. To perform the infections, the bacteria were collect from the agar plate with PBS, 
and the bacterial density was estimated by absorbance at 600 nm (OD=0.1 represents 
2x106 bacteria/µ l). H. pylori were added to the host cells at a multiplicity of infection (MOI) 
of 100. Cultures were maintained at 37ºC under a 5% CO2 atmosphere. After the 
infection periods, and depending on the specific experiment, conditioned media were 
collected, and the cells were lysed or used to extract RNA. 
 
 
4. Invasion assay 
 
The cell invasive phenotype was assessed using 24-well Matrigel-coated invasion inserts 
of 8 µm pore-size filters (BD Biosciences). Inserts were incubated 1 hour at 37ºC with 
antibiotic-free medium. After re-hydration, 5x104 cells ressuspended in a final volume of
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500µL of medium with 10% FBS and without antibiotics were incubated 24 hours at 
37ºC, on top of the filters, in the presence or absence of H. pylori. After incubation, 
filters were washed with PBS and fixed in 4% paraformaldehyde. Non-invasive cells 
were removed with a cotton swab at the top of the chamber, and invasive cells in the 
bottom part were stained and mounted in Vectashield with DAPI (Vector Laboratories). 
The number of invasive cells was assessed by measuring the number of nuclei in the 
bottom part of the filter, in at least 25 microscopic fields (20X objective), using a Zeiss 
Imager Z1 fluorescence microscope. 
 
 
5. Small interference RNA (siRNA) transfection 
 
For siRNA transfection, cells seeded in 6-well plates at 50% confluence were washed 
with PBS, pH 7.4, and incubated in serum- and antibiotic-free medium. siRNAs 
targeting c-Src, c-Met, Fer, MMP-10, Nck, PLC-γ and Non-silencing siRNA were 
obtained from Qiagen, and  all the others from the siRNA platform of Max-Planck 
Institute for Infection Biology, and prepared according to the manufacturer’s 
instructions. Transient transfection of AGS cells with siRNA was performed using 
Lipofectamine 2000 (Invitrogen) as transfection reagent. All siRNAs were used at a 
concentration of 100 nM, with the exception of c-Met and PLC-γ at 80 nM, and Nck at 
50 nM. The efficiency of siRNA was evaluated 48 hours after transfection by western 
blot for all the siRNAs used, except for MMP-10, which was evaluated by qRT-PCR. 
 
 
6. Cell treatment with growth factors, cytokines, and chemical inhibitors  
 
Pharmacological inhibitors U-0126, SB203580, SP600125, and AG-1478 were 
obtained from Cayman Chemicals, PP2 from Calbiochem, and NK4 was kindly 
provided by W. Jiang (Department of Surgery, University of Wales College of Medicine, 
Cardiff UK). The concentrations of inhibitors used were 25 µM for U-0126, 20 µM for 
SB203580 and SP600125, 5µM for PP2 and AG-1478, and 100 ng/mL for NK4. The 
cells were treated with the inhibitors 1 hour before the infection, and the inhibitors were 
not removed from the medium during the experiments. 
Recombinant IL-1β and TGF-β (Sigma), IL-10 (Immunotools), and TNF-α (PeproTech) 
were used at a final concentration of 10 ng/mL, IL-8 at 8 ng/mL, and INF-γ at 100U/mL. 
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HGF (Immunotools) at 250 ng/mL and EGF (Sigma) at 50 ng/mL were used to treat the 
cells for 24 hours. 
Control monolayers were processed similarly but substituting those compounds by an 
equivalent volume of PBS or DMSO (in the case of the chemical inhibitors).  
 
 
7. Preparation of cell lysates and co-immunoprecipitation 
 
At the end of infection period, cells were lysed using cold Catenin lysis buffer (1% Triton 
X-100, 1% NP-40 in PBS, pH 7.4) with proteases and phosphatases inhibitors (3mM 
sodium vanadate, 20mM NaF, 1mM phenylmethylsulfonyl fluoride, 10 µg/ml aprotinin, and 
10µg/ml leupeptin). Cells were scraped with cold lysis buffer on ice, centrifuged at 14000 
rpm for 10 minutes at 4ºC, and soluble proteins were quantified using the Bio-Rad DCTM 
Protein Assay (Bio-Rad). For analysis of total lysates, 25 µg of protein were used. For co-
immunoprecipitation 750 µg of proteins were incubated overnight at 4ºC with mouse 
monoclonal anti-phosphotyrosine (PY-20), anti-E-cadherin, anti-p120-catenin, anti-c-Met 
antibodies, or, as a negative control, with an IgG from the same species of the 
immunoprecipitation antibody. Immunoprecipitated complexes were incubated 1 hour with 
protein G-sepharose beads (GE Healthcare) washed and pre-incubated in 1% BSA 
solution. Proteins were separated by reducing 7.5 or 10% SDS-PAGE electrophoresis. 
The Precision Plus ProteinTM Standard Dual Color protein marker (Bio-Rad) was used to 
identify the molecular weights.  
 
 
8. Immunoblot analysis 
 
    Proteins were transferred onto Hybond nitrocellulose membranes (GE Healthcare), 
stained with Ponceau S (Sigma), and blocked 30 min with 5% non-fat milk in PBS +0.1% 
Twen-20 (PBS-T) and incubated overnight at 4ºC with primary antibody, in 5% non-fat 
milk or 4% BSA (phospho antibodies) in PBS-T. Unbound antibody was washed four 
times with PBS-T. The membranes were incubated with secondary antibody, in PBS-T 
with 5% non-fat milk for 45 min at room temperature and washed six times with PBS-T, 
and then detected using LuminataTM Forte Western HRP Substract (Millipore). For total 
lysates, equal loading control was determined by reprobing the same membrane with a 
mouse anti-α-tubulin antibody (Sigma). The ECL membrane images were quantified 
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using the Image J tool. Immunoblots are representative replicates from at least three 
experiments.  
 
 
   9. Antibodies 
 
  Table 2 presents the information relative to the antibodies used for western blot,   co-
immunoprecipitation, immunofluorescence, immunohistochemistry, and functional 
inhibitory assays. 
 
     Table 2: Antibodies used during experimental work  
 
Target 
molecule 
Serum 
MW 
(KDa) 
Dilutions 
IP Functional 
assay 
Supplier 
WB IF IHC 
Primary antibodies 
c-Cbl mouse 120 1:1000 - - - - BD Bioscience 
c-Met rabbit 145 1:1000 - - - - Santa Cruz 
c-Met mouse - - - - + - Upstate 
CagA rabbit 120 1:500 1:50 - - - Santa Cruz 
E-cadherin mouse 120 1:1000 1:100 - +  BD Bioscience 
E-cadherin 
(MB2) 
Hybrido-
ma 
- - - - - 
Slow 
aggrega-
tion 
Gift (Mark 
Bracke) 
F-actin 
(Phalloidin
-FITC) 
- - - 1:500 - - - Sigma 
FAK mouse 125 1:1000 - - - - BD Bioscience 
Fer rabbit 94 1:500 - - - - Santa Cruz 
Gab-1 rabbit 110 1:500 - - - - Santa Cruz 
MMP-1 rabbit 54 / 42 1:1000 - - - - Millipore 
MMP-2 rabbit 72 / 64 1:500 - - - - 
Labvision 
Neomarkers 
MMP-9 mouse 92 / 86 1:500 - - - - Calbiochem 
MMP-10 goat 54 / 44 1:2000 - - - - Santa Cruz 
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MMP-10 mouse - - - 1:500  - Abcam 
Nck mouse 48 1:1000 - - - - BD Bioscience 
PLC-γ mouse 155 1:1000 - - - - BD Bioscience 
PY-20 mouse - - - - + - BD Bioscience 
p120 
catenin mouse 120 1:2000 1:250 - + - BD Bioscience 
Shc mouse  66/52/46 1:1000 - - - - BD Bioscience 
Shp-2 rabbit 72 1:500 - - - - Santa Cruz 
Src rabbit 60 1:1000 - - - - Cell Signaling 
P-Tyr416-
Src rabbit 60 1:1000 - - - - Cell Signaling 
α-catenin rabbit 100 1:2500 1:500 - - - Sigma 
α-tubulin mouse 52 1:10000 - - - - Sigma 
β-catenin rabbit 92 1:2500 1:500 - - - Sigma 
 
Secondary antibodies 
Goat IgG 
(HRP) donkey - 1:2000 - - - - Santa Cruz 
Mouse IgG 
(HRP) sheep - 1:3000 - - - - GE Healthcare 
Rabbit IgG 
(HRP) donkey - 1:5000 - - - - GE Healthcare 
Mouse IgG 
(Alexa488) goat - 1:1000 - - - - 
Molecular 
Probes 
Rabbit  IgG 
(Alexa488) goat - 1:1000 - - - - 
Molecular 
Probes 
Rabbit  IgG 
(Alexa594) goat - 1:1000 - - - - 
Molecular 
Probes 
(MW: molecular weight; WB: western blot; IF: immunofluorescence; IHC: immunohistochemistry; IP: 
Immunoprecipitation) 
 
 
 
10. Quantification of mRNA by quantitative real-time PCR (qRT-PCR) 
 
The total RNA from the cells was extracted using TriPure Isolation Reagent (Roche). The 
RNA concentration and purity were determined using a NanoDrop Spectrophotometer 
ND-1000. 1 µg of RNA was used for cDNA synthesis, using Random Primers and 
SuperScript® II Reverse Transcriptase (Invitrogen). Quantitative real-time PCR (qRT-PCR) 
was performed using a TaqMan Mix (Applied Biosystems) and the following 
TaqManprobes (Applied Biosystems):  MMP1 (Assay Hs00899658_m1), MMP7 (Assay 
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Hs01042796_m1) and MMP-10 (Hs00233987_m1). Relative MMP-10 expression was 
normalized to levels of GAPDH (Human GAPDH Endogenous Control (FAM™ Dye / MGB 
Probe, Non-Primer Limited), Applied Biosystems). The reactions were carried out with 0.5 
µL of cDNA templates in a total volume of 10 µL. Each reaction was performed in triplicate, 
and the PCR performed in a 7500 Real Time PCR System (Applied Biosystems). 
 
 
11. Preparation of conditioned media 
 
The conditioned media collected from non-infected and infected cells were centrifuged at 
3824 g for 3 min and filtered through 0.2 µm pore size filter (Advantec). To measure the 
MMP-10 activity, conditioned media were concentrated using a Speed-Vac system. For 
protein analysis with SDS-PAGE, conditioned media were concentrated using Amicon® 
ultra-0.5 centrifugal filter devices, 10 kDa cutoff (Millipore), prepared in Laemmli 4x, and 
7.5 µL were separated by SDS-PAGE.  
 
 
12. MMP-10 activity assay 
 
The secreted active MMP-10 present in the conditioned medium, concentrated with the 
Spedd-Vac system, was measured using the fluorimetric assay SensoLyte® 520 MMP-
10 Assay Kit (AnaSpec) according to the manufacturer’s instructions. 50µL of each 
conditioned media sample were used. MMP-10 activity was measured in 96-well 
microplates. Recombinant MMP-10 (AnaSpec) was used to perform a standard curve of 
concentrations, and a fluorigenic FAM/QXLTM 520 FRET peptide was used as a 
substrate for MMP-10. Fluorescence (490 nm excitation and 520 nm emission) was 
recorded on a fluorimeter Synergy Mx (Biotek). 
 
13. Immunocitochemistry and confocal microscopy 
 
  Cell monolayers were grown on glass coverslips, fixed in ice-cold methanol or in 4% 
paraformaldehyde (actin staining),  incubated 30 minutes in 5% BSA and immunostained 
with anti-E-cadherin, anti-p120-catenin (both BD Biosciences Bioscience), anti-α-catenin, 
anti-β-catenin (both Sigma), or anti-CagA (Santa Cruz), for 1 hour or with FITC-
conjugated phalloidin (Sigma) for 15 minutes. Goat anti-mouse, anti rabbit Alexa488, or 
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anti-rabbit-Alexa594 conjugated (Molecular Probes) were used as secondary antibodies, 
and incubated for 45 minutes. Coverslips were washed in PBS and mounted with 
Vectashield with DAPI (Vector Laboratories). A Leica DMRE2, a Zeiss Imager Z1 
fluorescence microscope, or a SP2-SE-AOBS laser-scanning confocal microscope 
(Leica) was used. Confocal images were deconvolved with Huygens    Pro3.2 (SVI, The 
Netherlands). 
 
 
14. Transduction of the AGS cell line with human E-cadherin cDNA 
 
Plasmids containing human E-cadherin cDNA were constructed as previously described 
(Suriano et al., 2003b) and were stably transduced using a pLenti6/V5 expression vector 
(Invitrogen), according to manufacturer’s instructions. 
293FT cell line, the lentivirus producer cell line, was maintained in DMEM medium 
(Gibco) at 37ºC, 5% CO2. After reaching the appropriate confluence the expression 
vector plus the ViraPowerTM packaging mix were added in order to produce viral particles 
that were harvested after 24 hours. Posteriorly, these lentivirus were added to AGS 
cells and maintained for 24 hours. 5 µg/ml of blasticidin were added to the culture 
medium for clonal selection. Several clones were isolated, using cloning rings and 
splitting the cells surrounded by them, after which they were then transferred to new 
cell culture flasks. These clones were then characterized for the expression of E- 
cadherin by western blot and immunofluorescence. 
 
 
15. Aggregation assay 
 
AGS and AGSEcad cells were trypsinized, resuspended as single-cells, and 2x105 cells 
in suspension were added to 96-well agar-coated plates (Bacto Agar). As control for E-
cadherin-mediated aggregation, AGSEcad cells were incubated with an anti-E-cadherin 
antibody (MB2) (kindly provided by Professor Marc Bracke, Ghent University Hospital, 
Ghent, Belgium). Cells were then incubated for 48 hours at 37ºC in a 5% CO2 
atmosphere. The ability of cells to aggregate or to persist as a single-cell suspension 
was evaluated microscopically and photographed. 
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16. Statistical analysis 
 
Data analysis were performed with Student’s t-test and expressed as mean values of at 
least three independent experiments ± standard errors, unless otherwise stated. The 
comparison between MMP-10 expression and the cagA status of the H. pylori clinical 
isolates was performed using the non-parametric Mann-Whitney test. For that, a variable 
that represents the average of the assays for each strain was created, and strains were 
divided into cagA-positive and cagA-negative groups. Differences were considered 
significant at P values less than 0.05.
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Part I.1. Analysis of the effects of H. pylori in host gastric epithelial cell 
invasion 
 
The infection by H. pylori induces several well established alterations in the host cells, 
such as the induction of pro-inflammatory cytokines, enhancement of reactive oxygen and 
nitrogen species, and structural alterations in the organization of the cytoskeleton 
associated with increased motility and migration, that are named as “hummingbird 
phenotype” (Segal et al., 1999, Churin et al., 2001, Naumann et al., 2004). However, one 
of the less explored phenotypes that may be associated with the bacterial infection is host 
cell invasion. Invasive cells have the ability to degrade components of the extracellular 
matrix, usually by an up-regulation of MMPs, and to increase motility, that allows 
movement through the stromal tissue. The invasive phenotype must be regarded not only 
as general stromal tissue destruction, but also as a consequence of a complex signaling 
network that can also result in other cellular processes such as growth factor processing, 
cytokine release, and signaling transduction. 
 
 
1.1. Role of H. pylori and bacterial virulence factors in host cell invasion  
 
As a first approach to evaluate the effects of H. pylori on epithelial cell invasion, AGS 
cells, derived from a gastric carcinoma and commonly used in H. pylori related studies, 
were used.  
Since the presence of virulence factors such as CagA, the cag PAI, and the VacA toxin 
are associated with most severe clinical outcomes related with H. pylori infection 
(Crabtree et al., 1991a, Blaser et al., 1995, Peek et al., 1995, Figueiredo et al., 2002), 
and since cell invasion may reflect cellular process that ultimately can lead to more 
severe disease, the role of these virulence factors in cell invasion was also evaluated.   
To try to understand this issue, a Matrigel invasion assay was used. In this assay, cells 
with invasive capacity are able to degrade an artificial matrix, Matrigel, which mimics the 
extracellular matrix. The cells that overcome that barrier can then be stained and 
counted. This assay was performed by incubating AGS cells alone, as a control, or with 
the H. pylori strains 26695, 60190, or G27, on Matrigel-coated filters for a period of 24 
hours. In comparison with non-infected cells, H. pylori infected AGS cells showed a 
significant increase in the number of invasive cells through the Matrigel-coated filters 
(Figure 10A).  
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To study the role of H. pylori virulence factors in the invasive phenotype, similar 
experiments were performed using the wild type strain 60190, and its mutants for cagA 
(60190∆cagA), cagE (60190∆cagE), and vacA (60190∆vacA). The co-culture of AGS 
cells with H. pylori wild type strain 60190 and the respective mutant strains that lack 
CagA or have impaired the T4SS (cagE mutant) showed that the number of invasive cells 
in the presence of these mutants was significantly lower than that observed in presence 
of the wild type strain (Figure 10B). Results also showed that the presence of the T4SS is 
more critical to the induction of the invasive phenotype than the presence of CagA, 
indicating that other virulence factors injected by the T4SS may also be involved in the 
process. The VacA virulence factor is not involved in the induction of the phenotype, 
since a strain that lacks this virulence factor induces similar levels of invasion compared 
to the wild type strain. 
A B
 
 
Figure 10 – H. pylori stimulate AGS cell invasion in a T4SS dependent manner. Invasion assays on Matrigel 
coated filters for 24 h. (A) AGS cells infected with H. pylori strains 26695, 60190, and G27. (B) AGS infected 
with H. pylori wild type strain 60190, and its isogenic mutants 60190∆cagA, 60190∆cagE and 60190∆vacA. 
Data on graph represents the mean value +/- SE and are representative of three independent experiments. *, 
significantly different from non-infected cells;**, significantly different from cells infected with wild type H. 
pylori strain. 
 
 
1.2. Role of the c-Met in H. pylori-mediated cell invasion  
 
Once established that H. pylori is able to induce an invasive phenotype in the host gastric 
cells, the focus of the research was directed to the molecular mechanisms behind this 
phenotype. In the cancer context, the RTK c-Met was shown to be a regulator of epithelial 
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cell invasion (Hasegawa et al., 1995). Furthermore, this receptor was also shown to be 
activated by H. pylori infection leading to alterations in host cell motility (Churin et al., 
2003). Therefore, the next experiments were performed to study the involvement of c-Met 
receptor in H. pylori-mediated invasive phenotype. For that, the chemical inhibitor NK4, an 
antagonist of the natural ligand of c-Met, the hepatocyte growth factor (HGF), as well as a 
siRNA targeting c-Met were used. AGS cells treated or not with NK4 or siRNA, and 
infected or not with H. pylori, were tested for the invasive capacities in Matrigel-coated 
filters. 
As depicted in the graphs of the Figure 11, both treatments with NK4 and with siRNA 
directed to c-Met resulted in a significant decrease in the number of invasive cells in the 
infected conditions. These results clearly point to a role of the c-Met receptor in the 
induction of invasion mediated by H. pylori. 
 
Figure 11 – c-Met has a role in H. pylori-mediated cell invasion. Non-treated AGS cells or treated with (A)  
NK4, a chemical inhibitors of c-Met, or (B) with a Non-silencing siRNA or an siRNA directed to c-Met,  were 
co-cultured with H. pylori for 24 hours at a MOI of 100 on Matrigel coated filters. Data on graph represents 
the mean value +/- SE and are representative of three independent experiments. *, significantly different from 
non-infected cells;**, significantly different from cells infected with wild type H. pylori strain. 
 
 
1.3. Role of the c-Met downstream targets in H. pylori-mediated cell invasion 
 
Results so far showed that H. pylori strains with a functional T4SS induce an increase in 
host cell invasion through the c-Met receptor. The next step was to identity the signaling 
molecules downstream c-Met that are implicated in H. pylori-mediated cell invasive 
phenotype. 
To address this issue a siRNA-based strategy was used. AGS cells were transiently 
transfected with siRNA abrogating the expression of the c-Met adaptors c-Cbl, Nck, Gab1, 
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and Shc. Efficient knockdown was achieved and was maximal 48 hours after transfection 
(Figure 12). Invasion assays were performed 24 hours after transfection, by incubating 
AGS cells with H. pylori strain 26695 on Matrigel filters for an additional 24 hours period.  
Only AGS cells transfected with siRNA to Nck showed a significant decrease in the 
number of invasive cells after H. pylori infection when compared with non-silenced control 
cells (Figure 12A). These findings demonstrate that Nck plays a role in H. pylori-mediated 
cell invasive phenotype.  
Using a similar strategy, the involvement of the c-Met downstream targets c-Src, FAK, 
PLC-γ, and Shp-2 in H. pylori-mediated invasion was analyzed. Efficient knockdown was 
achieved and was maximal 48 hours after transfection (Figure 12C). Only the silencing of 
c-Src and PLC-γ resulted in a significant decrease in the number of invasive cells in the 
presence of H. pylori, in comparison with non-silenced AGS cells (Figure 12B), showing 
that c-Src and PLC-γ are involved in H. pylori-mediated cell invasion. The silencing of 
FAK also resulted in a decrease in the number of invasive cells in the presence of the 
bacteria. However, this difference was not statistically significant (Figure 12B). 
Nevertheless, we can not exclude a potential role for this kinase in the induction of cell 
invasion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12 (Next page Figure) c-Met downstream targets involved in H. pylori-mediated cell invasion. AGS 
cells or AGS cells transfected with siRNAs directed to (A) c-Cbl, Gab1, Nck, and Shc, or (B) c-Src, FAK,  
PLC- γ, and Shp-2, infected or not with H. pylori strain 26695, at a MOI of 100, were incubated for 24 hours 
on Matrigel filters and assessed for invasion. Data correspond to the mean value +/- SE and are 
representative of three independent experiments.*, significantly different from untreated cells; **, significantly 
different from AGS cells non-transfected with siRNA and infected with H. pylori 26695. (C) The efficiency of 
the siRNA transfection was assessed by western blot. AGS cells (-), AGS tranfected with a No-silencing 
siRNA (NS) or with siRNA directed to c-Cbl, Gab1, Nck, Shc, c-Src, FAK, PLC- γ, and Shp-2. Staining for α-
tubulin was used as loading control.  
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1.4. The role of H. pylori  and of c-Met in Nck, c-Src and PLC-γ activation 
 
After demonstrating that Nck, PLC-γ, and c-Src are involved in H. pylori-mediated cell 
invasion, it was next evaluated if H. pylori activates these molecules and whether this 
occurs downstream c-Met receptor activation.  
To experimentally address this issue, Non-silenced and c-Met silenced AGS cells were 
evaluated in the presence or absence of H. pylori, for the activation statues of Nck, PLC-γ, 
and c-Src. Phosphorylation of Nck and PLC-γ was analyzed by immunoprecipitation with a 
general phospho-tyrosine antibody followed by western blot, and phosphorylation of c-Src 
was evaluated using a phospho-specific antibody for the activating Tyrosine 416. The 
three proteins were phosphorylated in the presence of H. pylori in Non-silenced cells 
whereas no phosphorylation could be observed in c-Met silenced cells (Figure 13). These 
results strongly suggest that activation of Nck, PLC-γ, and c-Src by H. pylori is mediated 
by the c-Met receptor.  
 
 
 
Figure 13. H. pylori induces Nck, PLC-γ, and c-Src activation in a c-Met dependent manner. AGS cells or 
AGS cells transfected with c-Met siRNA, infected or not with H. pylori strain 26695, with a MOI of 100, for 1 
hour were analyzed. (A-B) cell lysates were immunoprecitated with an antibody against tyrosine-
phosphorylated residues (IP: PY-20) and immunostained with (A) anti-Nck or (B) anti-PLC-γ antibodies. (C) 
cell lysates were immunostained with an anti-phospho Tyr 416-Src antibody, and after stripping the same 
membrane was immunostained for α-tubulin as loading control  
 
 
Overall, results presented in this Part I.1 of the Results show that H. pylori strains with a 
competent T4SS induce host gastric cell invasion through extracellular matrix 
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components via c-Met receptor-dependent Nck, PLC-γ, and c-Src activation.
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Part I.2. Analysis of the effects of H. pylori in modulation of matrix 
metalloproteinase 10 (MMP-10)  
 
Matrix metalloproteinases are a class of enzymes involved in turnover and remodeling of 
the extracellular matrix components and also important for cell invasion, processing 
growth factors and shedding of membrane bound proteins (Parks et al., 2004, 
Chakraborti et al., 2003). Since it was demonstrated in Part I.1 that H. pylori induces host 
cell invasion, and there are previous descriptions that the bacteria can regulate certain 
MMPs both at the level of gene expression and by proteolytic activity control (Gooz et al., 
2003, Bebb et al., 2003, Krueger et al., 2006, Oliveira et al., 2006), MMP expression 
induced by H. pylori was next addressed.   
 
 
2.1. Up-regulation of MMPs by H. pylori  
 
The starting point of the next studies were the results of a genome-wide cDNA microarray 
performed by our Group (data not shown) in order to characterize changes in the gene 
expression profile of gastric epithelial AGS cells in response to H. pylori strain 60190. In 
this expression array, several MMPs were found to be up-regulated by H. pylori , namely 
MMP-1, MMP-7 and MMP-10 (Table 3). 
 
Table 3: List of up-regulated MMPs after H. pylori infection 
 
Matrix Metalloproteinase Fold increase 
MMP-1 6.6 
MMP-7 8.6 
MMP-10 14.6 
 
A series of experiments in order to validate the results of the microarray was performed. 
AGS cells were infected for 24 hours with an H. pylori strain different from the one used in 
the array (H. pylori 26695), and the RNA isolated after infection. The mRNA levels of 
MMP-1, MMP-7, and MMP-10 were analyzed by qRT- PCR and compared with non-
infected controls. The qRT-PCR results confirmed the array results for MMP-1, MMP-7, 
and MMP-10, with an up-regulation of the enzymes after H. pylori infection (Figure 14A,B). 
From the MMPs studied, MMP-10 was the one with a more pronounced increase in the 
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mRNA levels after infection with H. pylori, showing a 40-fold increase in expression in 
comparison with non-infected cells (Figure 14C).  
 
 
 
 
Figure 14. H. pylori increases in MMP mRNA expression of MMP-1, MMP-7, and MMP-10. AGS cells were 
infected with H. pylori strain 26695 for 24 hours at a MOI of 100. (A) MMP-1, (B) MMP-7, and (C) MMP-10 
expression was analyzed by qRT-PCR. MMPs expression levels were normalized to GAPDH expression and 
results are presented as fold difference relative to uninfected cells. Data on graphs represents the mean value 
+/- SE and are representative of, at least, three independent experiments. *, significantly different from non-
infected cells. 
 
 
2.2. Analysis of the effect of H. pylori in MMP-10 protein secretion and activity 
 
Since MMP-10 showed the more pronounced increase in mRNA levels in the 
presence of H. pylori, and because the regulation of this metalloproteinase in the 
context of H. pylori infection had never been explored, attention was focused on this 
particular MMP. 
To assess whether the increase in MMP-10 mRNA after infection is accompanied by an 
increase in protein secretion, the conditioned medium of AGS cells infected for 24 hours 
was collected and concentrated, and the levels of secreted MMP-10 were analyzed by 
western blot. H. pylori significantly enhanced the secretion of MMP-10 into the medium. 
(Figure 15A). Of note, no MMP-10 secretion was observed in uninfected AGS cells. 
To address the enzymatic activity of secreted MMP-10, conditioned media of infected and 
non-infected AGS cells were analyzed using a fluorimetric assay. In this experiment, 
levels of active MMP-10 were calculated as a measure of cleavage of an enzyme 
substrate (FRET peptide with a specific sequence known to be cleaved by the active 
MMP-10), by changes in fluorescence emission. Compared with non-infected cells, cells 
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infected with H. pylori showed a significant increase in emitted fluorescence, reflecting an 
increase in MMP-10 enzymatic activity (Figure 15B). 
 
Figure 15. H. pylori increases MMP-10 protein secretion and activity. AGS cells were infected with H. pylori 
strain 26695 for 24 hours at a MOI of 100. (A) Secreted MMP-10 was analyzed in conditioned media by 
western-blot and graphs represents the densitometry analysis of the blots. (B) MMP-10 activity in conditioned 
media was analyzed by FRET. Data on graphs represents the mean value +/- SE and are representative of 
three independent experiments. *, significantly different from non-infected cells. 
 
 
2.3. Role of bacterial virulence in H. pylori-induced MMP-10 expression 
 
To define the contribution of the CagA and of the T4SS virulence factors in H. pylori-
mediated increase in MMP-10 mRNA, AGS cells were co-cultured for 24 hours with H. 
pylori strain 84183 and its cagA (84183∆cagA) and T4SS (84183∆cagE) mutants. The 
analysis of the mRNA levels of MMP-10 by qRT- PCR showed that infection with wild type 
strain 84183 induces an increase in the expression of MMP-10 comparable to the one 
induced by H. pylori 26695 (Figure 16). In contrast, infection with the 84183∆cagA and 
84183∆cagE mutants, lacking cagA and a functional T4SS, respectively, led to the 
expression of significantly less amounts of MMP-10 mRNA (Figure 16). These results 
show that the increase in MMP-10 expression induced by H. pylori is dependent on the 
presence of a functional T4SS. Since the T4SS is needed for CagA translocation into the 
host cell, and because the cagA mutant also induced low MMP-10 expression, it is likely 
that H. pylori-mediated up-regulation of MMP-10 is CagA-dependent (Figure 16). 
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Figure 16. H. pylori-mediated MMP-10 expression is CagA dependent. AGS cells were infected with H. pylori 
for 24 hours at a MOI of 100 with wild-type strain 84183 and its cagE (84183∆cagE) and cagA (84183∆cagA) 
mutants. MMP-10 expression was analyzed by qRT-PCR. MMP-10 expression levels were normalized to 
GAPDH expression and results are presented as fold differences relative to uninfected cells. Data correspond 
to the mean values +/- SE and are representative of three independent experiments. *, significantly different 
from uninfected cells; **, significantly different from cells infected with wild-type H. pylori 84183. 
 
 
To confirm these results, AGS cells were infected for 24 hours with a panel of clinical 
isolates of H. pylori, with known cagA status, as well as with the non-pathogenic and cagA 
negative strain Tx30a. In general, H. pylori cagA-positive strains led to a more pronounced 
increase in MMP-10 expression after infection than did cagA-negative strains (Figure 17). 
The main exception was strain CI-50 that, although cagA-positive, was not able to 
significantly up-regulate MMP-10 (Figure 17). It is possible that this strain has an impaired 
T4SS and is not able to translocate CagA into the host cells. Curiously, Tx30a was the 
strain that among all cagA-negative strains induced a more elevated level of MMP-10, 
which was still, much less than those induced by cagA-positive strains (Figure 17). These 
results point to an important role of CagA in MMP-10 up-regulation mediated by H. pylor
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Figure 17. MMP-10 expression is higher in cells infected with H. pylori cagA-positive than with cagA-negative 
strains. AGS cells were infected for 24 hours at a MOI of 100 with a panel of H. pylori isolates with known 
cagA status. MMP-10 expression was analyzed by qRT-PCR. MMP-10 expression levels were normalized to 
GAPDH expression and results are presented as fold differences relative to uninfected cells. Data correspond 
to the mean values +/- SE and are representative of three independent experiments. *, significantly different 
from cagA negative strains. 
 
 
2.4. MMP-10 is involved in H. pylori-mediated cell invasion 
 
As one of the main functions of the MMPs is the turnover and remodeling of the 
extracellular matrix (Parks et al., 2004), and since it was previously reported that H. pylori 
cag-positive strains induce gastric cell invasion in a context of increased MMP expression 
and activity (Oliveira et al., 2006, Sokolova et al., 2012), it was determined whether MMP-
10 is involved in cell invasion mediated by H. pylori. AGS cells were transiently 
transfected with a siRNA abrogating MMP-10 expression, and the efficiency of the 
knockdown was accessed by qRT-PCR. Invasion assays were performed 24 hours after 
transfection, by incubating AGS cells with H. pylori on Matrigel filters for an additional 24 
hours. Silencing of MMP-10 inhibited H. pylori-induced MMP-10 expression in AGS cells 
(Figure 18A), and signifincantly inhibited cell invasion in response to H. pylori infection 
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(Figure 18B). These findings demonstrate that MMP-10 plays a role in H. pylori-mediated 
cell invasion. 
 
 
 
Figure 18. MMP-10 is involved in H. pylori-mediated cell invasion. (A) AGS cells were treated with a 
Non-silencing siRNA or a siRNA directed to MMP-10, and co-cultured with H. pylori for 48 hours. The 
efficiency of the knockdown was evaluated by qRT-PCR. (B) AGS cells treated with a Non-silencing or a 
siRNA directed to MMP-10, were co-cultured with H. pylori for 24 hours at a MOI of 100 on Matrigel coated 
filters. Data on graph represents the mean value +/- SE and are representative of three independent 
experiments. *, significantly different from non-infected cells;**, significantly different from cells infected with H. 
pylori 60190. 
 
 
2.5. Role of c-Met and EGFR in H. pylori-induced MMP-10 expression 
 
It has been reported that MMPs may be up-regulated by growth factors that activate 
RTKs (McCawley et al., 2001, Egeblad et al., 2002). c-Met and EGFR are two RTKs 
known to be activated during H. pylori infection (Wallasch et al., 2002, Churin et al., 2003, 
Oliveira et al., 2006). Additionally, EGFR was shown to be implicated in MMP-10 up-
regulation in squamous cell carcinoma of head and neck (Wilkins-Port et al., 2007). 
Therefore, the next experiments were performed to address whether c-Met and EGFR 
are implicated in H. pylori-mediated MMP-10 expression.  
First, it was tested whether stimulation of AGS cells with HGF and EGF, the natural 
ligands of c-Met and EGFR respectively, induced differences in MMP-10 expression. 
AGS cells were treated with HGF at 250 ng/mL and EGF at 50 ng/mL for 24 hours. The 
RNA was isolated from those cells and MMP-10 expression was analyzed by qRT- PCR. 
Both HGF and EGF enhanced MMP-10 expression, with EGF inducing a more 
pronounced increase (Figure 19A,B). These experiments showed that MMP-10 can be 
up-regulated in AGS cells via c-Met and EGFR. Next the role of these two RTKs in the 
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induction of MMP-10 during infection was addressed. To achieve this aim, AGS cells 
were treated with a Non-silencing siRNA or with siRNA directed to c-Met, and with a 
chemical inhibitor of EGFR, AG-1478, or with DMSO alone, and infected with H. pylori or 
left untreated for 24 hours. The downregulation of c-Met and EGFR abrogated H. pylori-
mediated MMP-10 expression (Figure 19C,D). These findings indicate that the increase in 
MMP-10 expression induced by H. pylori is mediated by the activation of c-Met and 
EGFR. 
 
 
 
Figure 19. H. pylori increases MMP-10 expression via EGFR and c-Met. AGS cells were treated with HGF at 
250 ng/mL (A) and EGF at 50 ng/mL (B) for 24 hours. (C-D) AGS cells were infected with H. pylori strain 
26695 for 24 hours at a MOI of 100, after the transient tranfection with a Non-silencing siRNA (NS) or an 
siRNA directed to c-Met (si c-Met) (C), or after treatment with the EGFR chemical inhibitor AG-1478 at a final 
concentration of 5µM (iEGFR), or with DMSO, 1 hour before the infection (D). (A-D) MMP-10 expression was 
analyzed by qRT-PCR. MMP-10 expression levels were normalized to GAPDH expression and results are 
presented as fold differences relative to uninfected cells (A-B), cells treated with a Non-silencing siRNA (C) or 
with DMSO (D). Data correspond to the mean values +/- SE and are representative of three independent 
experiments. *, significantly different from uninfected cells; **, significantly different from non-silenced cells or 
cells treated with DMSO infected with wild type H. pylori strain.  
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2.6. Role of c-Met and EGFR downstream targets in H. pylori-induced MMP-10 
expression 
 
 In order to have a more clear picture of the molecules involved in c-Met and EGFR 
signaling that lead to MMP-10 up-regulation in H. pylori infection, and because in Part I.1 
several c-Met downstream targets that also function downstream EGFR were found to be 
important for H. pylori-induced cell invasion, the involvement of Nck, PLC-γ, and c-Src in 
H. pylori-induced MMP-10 expression was addressed.  
To fulfill this aim, the expression of Nck, PLC-γ, and c-Src in AGS cells was 
downregulated using siRNAs, and cells were infected for 24 hours with H. pylori. As a 
control, AGS cells were transfected with a Non-silencing siRNA. Since the silencing of c-
Src was difficult to achieve, the chemical inhibitor PP2 directed to the Src family kinases 
was also used. Cells were treated one hour before infection with PP2 or DMSO and then 
infected for 24 hours. RNA was isolated after this period and analyzed by qRT-PCR. As 
expected, MMP-10 expression increased in AGS cells infected with H. pylori, but this 
increase was attenuated in cells silenced for Nck (Figure 20A). Similarly H. pylori-induced 
MMP-10 expression was decreased in cells silenced for c-Src or in which c-Src activity 
was inhibited with PP2 (Figure 20C,D). In contrast, the silencing of PLC-γ had no effect in 
H. pylori-mediated MMP-10 expression (Figure 20B). These results point to a role for Nck 
and c-Src in the regulation of MMP-10 during infection. 
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Figure 20. Nck and c-Src, but not PLC-γ, are involved in H. pylori-mediated MMP-10 expression (A-C) AGS 
cells alone or transiently transfected with a Non-silencing siRNA (NS) or with siRNAs directed to Nck, PLC-γ 
and c-Src, or (D) after a treatment for 1hour with the Src family kinases chemical inhibitor PP2 (iSrc), or 
DMSO, were infected with H. pylori strain 26695 for 24 hours at a MOI of 100. MMP-10 expression was 
analyzed by qRT-PCR. MMP-10 expression levels were normalized to GAPDH expression and results are 
presented as fold differences relative to cells treated with a Non-silencing siRNA (A-C) or with DMSO (D). 
Data correspond to the mean values +/- SE and are representative of three independent experiments. *, 
significantly different from uninfected cells; **, significantly different from non-silenced cells or cells trated with 
DMSO infected with a wild type H. pylori strain.   
 
 
2.7. Analysis of the participation of ERK1/2, JNK and p38 signaling pathways 
in H. pylori-mediated MMP-10 expression 
 
Because ERK, JNK, and p38 pathways are involved both in the induction of different 
MMPs (Ridley et al., 1997, Reunanen et al., 1998) and in H. pylori-driven signaling 
(Naumann et al., 1999, Wessler et al., 2000), and as they can function downstream c-Met 
and EGFR (Terakado et al., 2011, Brusevold et al., 2012, Tsai et al., 2012), it was next 
determined if these pathways were involved in H. pylori-mediated MMP-10 expression. 
For this purpose, the effect of chemical inhibitors of ERK1/2 (U-0126), JNK (SP600125), 
and p38 (SB203580) on MMP-10 expression after infection was evaluated. AGS cells 
were treated with the inhibitors or with the vehicle (DMSO) alone, 1 hour before infection. 
Cells were then infected with H. pylori 26695 for 24 hours in the presence of the inhibitors, 
and MMP-10 expression was measured by qRT-PCR. Infection with H. pylori in the 
presence of DMSO did not affect MMP-10 expression stimulated by the bacteria alone 
(Figure 21). The treatment with the ERK1/2 inhibitor resulted in complete abrogation of 
MMP-10 expression and treatment with the JNK inhibitor led to a significant decrease of 
MMP-10 expression after H. pylori infection (Figure 21A). On the contrary, the inhibition of 
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p38 resulted in enhanced expression of MMP-10 after infection (Figure 21B). Taken 
together, these results suggest that MMP-10 expression induced by H. pylori is partially 
mediated by JNK and ERK1/2 pathways, and that p38 may have an inhibitory role in this 
process. 
 
 
 
Figure 21. H. pylori increases MMP-10 expression through ERK and JNK pathways. AGS cells were treated 
1 hour before the infection with DMSO or with chemical inhibitors of ERK1/2 (U-0126, 25 µM; iERK) (A), JNK 
(SP600125, 20 µM; iJNK) (A), and p38 (SB203580, 20 µM; ip38) (B). (A-B) After treatment AGS cells were 
infected with H. pylori 26695 for 24 hours at a MOI of 100 (Hp). MMP-10 expression was evaluated by qRT-
PCR. MMP-10 expression levels were normalized to GAPDH expression and results are presented as fold 
differences relative to uninfected cells treated with DMSO. Data correspond to the mean values ± SE and are 
representative of three independent experiments. *, significantly different from uninfected cells; **, 
significantly different from cells treated with DMSO infected with a wild type H. pylori strain. 
 
 
2.8. Analysis of MMP-10 modulation by cytokines produced by H. pylori 
infection 
 
Several cytokines are able to modulate MMP secretion in pathological contexts such 
as chronic inflammatory diseases (Zenmyo et al., 1996). Since the infection with H. 
pylori induces chronic gastritis and it is known that pro-inflammatory cytokines are 
produced in response to H. pylori infection, it was next evaluated whether these 
cytokines play a role in the modulation of MMP-10 expression. 
A panel of pro- and anti-inflammatory cytokines available in the laboratory was used. 
AGS cells were treated for 24 hours with recombinant IL-1β, TNF-α, TGF-β, and IL-10, 
at a final concentration of 10 ng/mL, with IL-8 at 8 ng/mL, and with INF-γ at 100U/mL. 
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After this period, RNA was isolated and MMP-10 expression was analyzed by qRT-PCR. 
The graph on Figure 22 shows that from the panel of cytokines tested, only IL-1β was 
able to induce a significant increase in MMP-10 expression. This suggests that not only H. 
pylori, but also IL-1β that is produced in the gastric mucosa in response to the infection 
may contribute to MMP-10 modulation. 
 
 
Figure 22. IL-1β treatment increase MMP-10 expression.   AGS cells were treated with IL-1β, TNF-α, TGF-β 
and IL-10 at a final concentration of 10 ng/mL and, with IL-8 at 8 ng/mL and INF-γ at 100U/mL for 24 hours. 
MMP-10 expression was evaluated by qRT-PCR. MMP-10 expression levels were normalized to GAPDH 
expression and results are presented as fold differences relative to untrated cells. Data on graphs represents 
the mean value +/- SE and are representative of three independent experiments, except for IL-10 and IL-8 
with two independent experiments. *, significantly different from non-treated cells. 
 
 
2.9. Role of MMP-10 in MMP-1 activation in H. pylori infection 
 
Several MMPs are activated via proteolytic cleavage by other MMPs (Mannello et al.). 
MMP-10 can activate other MMPs, namely MMP-1 (Nakamura et al., 1998, Windsor et 
al., 1993), a metalloproteinase that is up-regulated by H. pylori, and is involved in gastric 
tissue degradation and remodeling (Krueger et al., 2006, Pillinger et al., 2007, Sokolova 
et al., 2012). Indeed, in our model system, MMP-1 was also found to be up-regulated in 
AGS cells by H. pylori infection (Figure 23). 
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Therefore, and to study whether MMP-10 has a role in MMP-1 activation during H. pylori 
infection, AGS cells were transiently transfected with a siRNA directed to MMP-10 or with 
a Non-silencing siRNA, and infected for 24 hours with H. pylori strain 26695. After the 
infection period, the conditioned media were collected and concentrated, and the levels 
of secreted MMP-1 were analyzed by western-blot. As expected, H. pylori infection led to 
an increase in the levels of secreted MMP-1 (Figure 23). Interestingly, the silencing of 
MMP-10 resulted in a decrease in the secreted form of MMP-1 (Figure 23). These results 
suggest that MMP-10 may function as a pro-MMP-1 activator in the context of H. pylori 
infection. 
 
Figure 23. MMP-10 mediates MMP-1 activation during H. pylori infection. AGS cells transiently transfected 
with Non-silencing siRNA (NS) or with siRNA directed to MMP-10 (si MMP-10) were infected with H. pylori 
strain 26695 for 24 hours at a MOI of 100. (A) Secreted MMP-1 in conditioned media was analyzed by 
western-blot. (B) Data on graphs, corresponding to the quantification of the blots, represents the mean value 
± SE, and are representative of three independent experiments. *, significantly different from uninfected cells.
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Part II.1. Analysis of the effects of E-cadherin in H. pylori-mediated cell 
invasion and signaling  
 
The E-cadherin-catenin complex is a major component of the adherens junctions and 
functions has an invasion suppressor. The function of E-cadherin is frequently 
compromised in gastric carcinoma, a condition strongly associated with H. pylori infection. 
Results from the Part I of the Results together with published data, showed that H. pylori 
activates the c-Met receptor leading to a motogenic response and to invasion of host 
cells (Churin et al., 2003). Therefore, in Part II of the Results it was investigated whether 
E-cadherin has a role in H. pylori-induced c-Met phosphorylation-dependent cell invasion. 
 
 
1.1. H. pylori-mediated invasive phenotype in cells with intact adherens 
junctions  
 
The human gastric carcinoma cells AGS, IPA220, and NCI-N87 were confronted with H. 
pylori on Matrigel invasion assays. It was observed that, in contrast to AGS cells, which 
acquired an invasive phenotype in response to H. pylori, IPA220 and NCI-N87 cells were 
significantly less responsive to H. pylori (Figure 24). From the panel of gastric cell lines 
tested, IPA220 and NCI-N87 cells have, to the best of our knowledge, intact E-
cadherin/catenin complexes, whereas AGS cells harbour an E-cadherin mutation leading 
to a truncated form of the protein that is not expressed. These results point to a role of the 
E-cadherin/catenin complex in the inhibition of H. pylori-mediated invasion. 
A B
 
 
Figure 24. The E-cadherin/catenin complex suppresses H. pylori-mediated cell invasive phenotype. (A) 
Invasion assays of AGS, IPA220 and NCI-N87 cells infected or not for 24 hours with H. pylori on Matrigel-
coated filters. Graphics represent the mean value of invasion ± SD and are representative of three 
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independent experiments. *, significantly different from uninfected cells. (B) E-cadherin staining of IPA220 and 
NCI-N87 cells. Nuclei were counterstained with DAPI. Scale bar represents 100 µm. 
 
 
1.2. Generation and characterization of an AGSEcad cell line  
 
To investigate the role of E-cadherin in H. pylori-mediated invasive phenotype, AGS cells 
that do not express this adhesion molecule were transduced with wild-type E-cadherin. In 
this way it was possible to compare the role of H. pylori infection in two cell lines with the 
same genetic background and that only differ in E-cadherin expression. AGS were stably 
transduced with the human CDH1 gene using a lentivirus transduction system. For clone 
selection, transduced cells were grown in medium with blasticidin. Only clones with a 
homogeneous expression of E-cadherin at the cell membrane were selected. To exclude 
clonal dependency, all experiments reported were performed with two distinct clones 
(clones 1a and 4b). 
E-cadherin expression was confirmed by western blot and immunofluorescence (Figure 
25). Immunocytochemistry of the E-cadherin-transduced AGS cells (AGSEcad) showed 
E-cadherin, β-, α-, and p120-catenins mostly located at the cell membrane in a honey-
comb-like pattern (Figure 25B), suggesting that E-cadherin recruits β-, α-, and p120-
catenin to this site to form an adhesion complex. 
To elucidate the functionality of the E-cadherin/catenin complex in the AGSEcad cells, it 
was performed an aggregation assay, a standard method that evaluates the ability of cells 
to aggregate in an E-cadherin-dependent manner. AGS cells that do not express E-
cadherin are not able to aggregate, remaining as single cells after 48 hours of incubation 
(Figure 26). In contrast, AGSEcad cells form small aggregates, suggesting the presence 
of a functional E-cadherin/catenin complex. The fact that these cells are no longer able to 
aggregate in the presence of the MB2 antibody that inhibits E-cadherin-homophilic 
interactions and consequently cell-cell adhesion, confirms that the E-cadherin/catenin 
complex of AGSEcad cells is functional.  
These set of experiments demonstrate that in AGS transduced with E-cadherin, β-, α-, 
and p120-catenins are recruited to the membrane, where they assemble a functional 
adhesion complex. 
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Figure 25 - Characterization of AGS cells stably expressing E-cadherin. (A) E-cadherin expression was 
evaluated in AGS and AGSEcad cell lines by western blot for E-cadherin and α-tubulin immunostaining was 
used as loading control. (B) Immunoflurescence for the adherens junctions components E-cadherin, β-, α- or 
p120-catenin of AGS and AGSEcad cells. Nuclei were counterstained with DAPI.  
 
 
 
 
 
Figure 26 – Slow aggregation assay in AGS and AGSEcad cell lines. Aggregation assay of AGS, 
AGSEcad, and AGSEcad cells cultured with an anti-E-cadherin antibody (AGSEcad+MB2). Cells were 
plated isolated on top of agar and evaluated after 48h. Figures are representative of three independent 
experiments. 
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1.3. Role of E-cadherin in H. pylori-mediated cell invasion  
 
Giving that AGSEcad cells have a functional adherens junctions complex, it was next 
investigated whether E-cadherin was sufficient to inhibit H. pylori-mediated invasive 
phenotype. 
AGS, AGSEcad, and NCI-N87 cells were infected with H. pylori strains 26695 and 60190, 
and used in Matrigel invasion assays. After infection, AGSEcad cells displayed 
significantly lower levels of invasion than AGS cells (Figure 27). Similar results were 
obtained in infected NCI-N87 cells that endogenously express E-cadherin, suggesting that 
E-cadherin expression is sufficient to suppress H. pylori-mediated invasive phenotype. 
 
 
Figure 27. E-cadherin counteracts H. pylori-mediated cell invasive phenotype.  AGS, AGSEcad, and NCI-N87 
cells infected or not for 24 hours with H. pylori strain 26695 or 60190 on Matrigel-coated filters. Graphics 
represent the mean value of invasion +/-  SD and are representative of three independent experiments. *, 
significantly different from uninfected cells; **, significantly different from AGS cells infected with H. pylori. 
 
 
1.4. Role of E-cadherin in H. pylori-mediated c-Met and p120-catenin tyrosine 
phosphorylation  
 
Since the cell motogenic response and invasion induced by H. pylori in AGS cells require 
c-Met phosphorylation (Churin et al., 2003, Oliveira et al., 2006), the effect of E-cadherin 
on the phosphorylation status of c-Met was investigated. In addition and because p120-
catenin tyrosine phosphorylation is modulated by E-cadherin (Ozawa et al., 2001), the 
phosphorylation status of p120-catenin was also investigated. 
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Lysates of H. pylori-infected AGS and AGSEcad cells were immunoprecipitated with an 
antibody recognizing tyrosine-phosphorylated residues, and immunoblotted with anti-c-
Met and anti-p120-catenin antibodies (Figure 28).  
The expression of c-Met and of p120-catenin was not altered by H. pylori in any of the cell 
lines. In AGS cells, H. pylori increased the phosphorylation level of c-Met and of p120-
catenin. In contrast, in AGSEcad cells H. pylori decreased the phosphorylation levels of 
both proteins. These results were further confirmed in the NCI-N87 cell line, where 
tyrosine phosphorylation levels of c-Met and p120-catenin decreased after infection 
(Figure 28). Overall, these results suggest that E-cadherin suppresses H. pylori-mediated 
phosphorylation of c-Met and of p120-catenin.  
 
 
Figure 28. E-cadherin counteracts H. pylori-mediated c-Met and p120-catenin tyrosine phosphorylation. 
Western blot analysis of AGS, AGSEcad and NCI-N87 cells infected with H. pylori for 1 hour. Total cell lysates 
were immunoprecipitated with an antibody against tyrosine-phosphorylated residues (PY-20) and 
immunostained with anti-c-Met or anti-p120-catenin antibodies. In parallel, total cell lysates were 
immunostained with the same antibodies to control differences of expression. α-tubulin immunostaining was 
used as loading control. Graphics represent the variation in c-Met and p120-catenin tyrosine phosphorylation 
in comparison to the endogenous phosphorylation levels of uninfected cells. Data correspond to the mean 
value +/- SD and are representative of three independent experiments. *, significantly different from 
uninfected cells. 
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1.5. Effect of H. pylori on the localization of elements of E-cadherin-catenin 
complex  
 
Using confocal microscopy, the localization of the elements of the E-cadherin/catenin 
complex after H. pylori infection was analysed. One hour after infection with H. pylori, 
there was an increase in the intensity of membrane staining of E-cadherin and of p120-
catenin (Figure 29), and in the nuclear levels of β-catenin (data not shown). No 
differences regarding α-catenin were observed. 
 
 
Figure 29. H. pylori affects the localization of elements of the E-cadherin/catenin complex. AGSEcad 
monolayers were infected with H. pylori for 1 or 6 hours. After fixation, monolayers were stained with 
antibodies specific for E-cadherin, p120- or α-catenins (green). Nuclei were counterstained with DAPI (red). 
Scale bar represents 40 µm. Images are representative of three independent experiments.  
 
 
Since CagA localizes to the inner surface of the plasma membrane after injection (Segal 
et al., 1999, Asahi et al., 2003), and the membrane staining of E-cadherin and p120-
catenin increased after infection (Figure 29), the putative co-localization between CagA 
and these E-cadherin/catenin complex elements was investigated.  
Analysis of the xz and yz confocal sections suggest that after 1 hour of infection of 
AGSEcad cells, CagA partially co-localizes with E-cadherin and with p120-catenin 
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(arrowheads). Immunofluorescent signal corresponding to CagA was also visualized in 
areas negative for p120-catenin and E-cadherin (Figure 30). Specificity of the 
immunostaining was confirmed with non-immunizing IgGs of the same isotype. 
 
 
 
Figure 30. CagA, E-cadherin and p120-catenin co-localization during infection. AGSEcad monolayers 
infected with H. pylori for 1 hour were double immunostained for E-cadherin (green) and CagA (red) or p120-
catenin (green) and CagA (red). Immunostainings were also performed using a CagA isotype antibody as 
control. xz or yz sections for both channels or for each channel apart can be visualized in more detail below 
each panel. Arrowheads indicate areas of co-localization. Images were obtained with a confocal microscope 
and are representative of two independent experiments. Scale bar represents 10 µm. 
 
 
1.6. Analysis of H. pylori CagA interactions with E-cadherin and with p120-
catenin 
 
Since H. pylori CagA interacts and co-localizes with elements of the E-cadherin/catenin 
complex, the role of H. pylori virulence protein CagA in this interaction was investigated. 
Lysates of H. pylori-infected AGSEcad cells were immunoprecipitated with anti-E-
cadherin or anti-p120 catenin antibodies, and immunoblotted with an anti-CagA antibody. 
It was observed that CagA co-immunoprecipitated with E-cadherin and, interestingly, it 
was also observed that CagA co-immunoprecipitated with p120-catenin (Figure 31A). 
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Immunoprecipitation with non-immunizing IgGs of the same isotype confirmed the 
specificity of such interactions. Likewise, in NCI-N87 cells CagA imunoprecipitated with E-
cadherin and also with p120-catenin (Figure 31A). Furthermore, in both AGSEcad and 
NCI-N87 cells, in the presence of bacteria the binding between E-cadherin and p120-
catenin was enhanced (Figure 31B,C). No differences were observed regarding the β-
catenin/α-catenin interaction. Thus, our results indicate that after infection, H. pylori CagA 
binds to elements of the E-cadherin/catenin complex. 
 
 
 
 
Figure 31. H. pylori CagA interacts with E-cadherin, with p120-catenin, and with c-Met. (A) AGSEcad and 
NCI-N87 cells were infected with H. pylori for 1 hour. Cell lysates were immunoprecipitated with anti-E-
cadherin, anti-p120-catenin or anti-c-Met antibodies, and used for Western blot to be immunostained with an  
anti-CagA antibody. Immunoprecipitation was also performed with the same isotype control IgGs. 
Immunoblots were restained for E-cadherin or p120-catenin as loading controls. (B) AGSEcad cells were 
infected with H. pylori for 1 hour. Cell lysates were immunoprecipitated with anti-E-cadherin, anti-p120-catenin 
or anti-β-catenin antibodies, and used for Western blot to be immunostained with anti-p120-catenin, anti-E-
cadherin, and anti-α-catenin antibodies. Immunoblots were restained for p120- or β-catenins, as loading 
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controls. (C) NCI-N87 cells were infected with H. pylori for 1 hour. Cell lysates were immunoprecipitated with 
anti-E-cadherin or anti-p120-catenin antibodies, and used for Western blot to be immunostained with the 
same antibodies. Immunoblot was restained for E-cadherin as loading control. Graphics represent the 
variation in protein co-immunoprecipitation in comparison to the endogenous levels of uninfected cells. Data 
correspond to the mean value +/- SD and are representative of three independent experiments. *, significantly 
different from uninfected cells. 
 
 
Since CagA targets the c-Met receptor, inducing its phosphorylation (Churin et al., 2003, 
Oliveira et al., 2006), and activating downstream effector molecules, it was next examined 
whether the interactions between CagA and E-cadherin, and CagA and p120-catenin 
occurred downstream c-Met.  
Co-immunoprecipitation studies on H. pylori-infected AGSEcad cells confirmed that CagA 
interacts with c-Met (Figure 31A) as previously described (Churin et al., 2003). 
Interestingly, interactions established between c-Met and E-cadherin, and between c-Met 
and p120-catenin were enhanced after infection with H. pylori 26695 and 60190 (Figure 
32A). In agreement with these observations, in H. pylori-infected NCI-N87 cells, increased 
binding of c-Met and E-cadherin and of c-Met and p120-catenin was also observed 
(Figure 32A). When cells were infected with a cagA mutant strain (60190CagA-), there 
was a decrease in c-Met/E-cadherin but not in c-Met/p120-catenin interactions (Figure 
32B), suggesting that CagA plays a role in the formation of the c-Met/E-cadherin 
interaction. 
Studies with siRNA targeting c-Met did not affect the expression of p120-catenin and, as 
expected, abolished the interactions between c-Met and p120-catenin (Figure 32C) and 
between c-Met and E-cadherin (data not shown). Noteworthy, silencing of c-Met 
abolished the interactions between CagA and p120-catenin and also between CagA and 
E-cadherin (Figure 32D). These results suggest that interactions established between 
CagA and E-cadherin and between CagA and p120-catenin are c-Met dependent. 
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Figure 32. The interaction established between CagA, E-cadherin, and p120-catenin is mediated by c-Met. (A) 
AGSEcad and NCI-N87 cells were infected with H. pylori for 1 hour and cell lysates were immunoprecipitated 
with anti-E-cadherin or anti-p120-catenin antibodies and used for Western blot to be immunostained with an 
anti-c-Met antibody. Anti-c-Met and anti- α-tubulin antibodies were used as loading controls. (B) AGSEcad 
cells were infected with H. pylori strain 60190 and with its cagA mutant (60190CagA-) for 1 hour. Cell lysates 
were immunoprecipitated with anti-E-cadherin or anti-p120-catenin antibodies and used for Western blot to be 
immunostained with an anti-c-Met antibody. Anti-c-Met and anti-α-tubulin antibodies were used as loading 
controls. (C) AGSEcad cells were transiently transfected with siRNA directed to c-Met. The effect of 
transfection on c-Met, p120-catenin and α-tubulin expression was evaluated by Western blot with specific 
antibodies. (D) AGSEcad and NCI-N87 cells transfected or not with c-Met siRNA were infected with H. pylori 
for 1 hour. Cell lysates were immunoprecipitated with anti-p120-catenin and anti-E-cadherin antibodies and 
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used on Western blot to be immunostained with anti-c-Met, and anti-CagA antibodies. Data correspond to the 
mean value +/- SD and are representative of three independent experiments. *, significantly different from 
uninfected cells. 
 
 
Altogether, the results presented in Part II of the Results evidence that H. pylori alters the 
localization of elements of the E-cadherin/catenin complex, leading to formation of a 
multiproteic complex composed by CagA, c-Met, E-cadherin, and p120-catenin. The 
formation of this complex impairs c-Met and p120-catenin tyrosine phosphorylation and 
suppresses the cell invasive phenotype induced by H. pylori. 
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H. pylori induces alterations in several host cell signaling transduction pathways, which 
results in alterations of the normal cell behavior. The host cell invasive phenotype induced 
by H. pylori is a not well studied issue, and the clarification of its molecular mechanisms 
as well as the consequences to the cell and tissue homeostasis is of great importance. 
The insights that a study in this area can bring may be of great importance to understand 
the pathological conditions associated with H. pylori infection. 
 
 
Part I. Analysis of the effects of H. pylori in host gastric epithelial cell invasion and 
in modulation of matrix metalloproteinase 10 (MMP-10) 
  
In Part I.1 of the Results, it was demonstrated that H. pylori infection induces host cell 
invasion that is dependent on the presence of a functional bacterial T4SS and is mediated 
by the c-Met receptor and its downstream targets Nck, PLC-γ, and c-Src. 
Giving the fact that H. pylori virulence factors differentially interfere with signaling 
pathways in the host gastric epithelial cells, the role of CagA, of the T4SS, and of VacA 
in the induction of host cell invasion was studied. The experiments with different H. 
pylori strains clearly showed that maximal stimulation of cell invasion was achieved 
only when the bacteria have a functional T4SS. The presence of the T4SS could induce 
cell invasion either by the establishment of close contact with the host cell membrane, or 
by functioning as a translocator of an effector molecule. CagA is translocated by the T4SS 
(Odenbreit et al., 2000) and, after injection into the host cell is able to modulate cellular 
functions by interacting intracellularly with the c-Met receptor and triggering 
morphological changes and motility similar to those induced by HGF (Segal et al., 1999, 
Churin et al., 2003, Al-Ghoul et al., 2004). The observation that the number of invading 
cells after infection with a cagA mutant is lower than that observed with the wild type 
strain, suggests that CagA is important for stimulation of the invasive phenotype. These 
observations are in accordance with data showing that kidney canine cells transfected 
with cagA display an invasive phenotype (Bagnoli et al., 2005). The fact that the T4SS is 
more critical than CagA for the induction of cell invasion suggests that additional effector 
molecule(s) might be translocated into the host cell via the T4SS. This is in accordance 
with previous published works showing that H. pylori can activate a number of signaling 
pathways in a T4SS-dependent, but CagA-independent manner (Crabtree et al., 1995, 
Naumann et al., 1999, El-Etr et al., 2004). Additionally, it has also been shown that the 
T4SS is responsible for delivery of soluble compounds of peptidoglycan into the host 
cells (Viala et al., 2004). In contrast to what was observed for the CagA and the T4SS 
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mutants, the VacA mutant induced similar levels of invasion to those of the wild-type 
strain, indicating that VacA is not involved in H. pylori-mediated cell invasion. 
The c-Met receptor has been previously associated with invasion of cancer cells 
(Weidner et al., 1990, Giordano et al., 1992, Trusolino et al., 2001). Furthermore, c-Met 
was also demonstrated to be a target of H. pylori CagA that is able to induce 
phosphorylation of the receptor, enhancing the cell motogenic response (Churin et al., 
2003). Due to these facts, the c-Met function in bacteria-mediated cell invasion was 
studied. The confirmation of the involvement of c-Met was demonstrated by treating the 
cells with the NK4 inhibitor or by transfecting the cells with siRNA directed to c-Met. In 
these conditions, H. pylori was not able to stimulate cell invasion, thus confirming the 
importance of c-Met on this cell phenotype.  
The c-Met receptor is activated by H. pylori in a ligand-independent manner, resulting in 
host cell invasion. This fact is particularly relevant as a similar situation is described in 
gastric carcinoma patients where c-Met mutations (Chen et al., 2001) or overexpression 
(Inoue et al., 2004), result in the receptor activation in a ligand independent way. 
Interesting enough is also the fact that, in gastric carcinoma patients, the presence of c-
Met has a significant association with poor prognosis and peritoneal dissemination 
(Toiyama et al., 2012). It is also known that c-Met has a pro-metastatic and pro-motility 
activity mediated by reactive oxygen species (Ferraro et al., 2006, Jagadeeswaran et al., 
2007). This fact should not be underestimated in the H. pylori infection context where 
there is an enhancement in the production of reactive oxygen and nitrogen species 
(Ding et al., 2007, Elfvin et al., 2007, Katsurahara et al., 2009).  
Upon binding of HGF, c-Met undergoes conformational changes leading to 
phosphorylation of specific tyrosine residues at the receptor intracellular domains, which 
act as docking sites for adaptor proteins and signal transducers. Once established that 
c-Met was involved in H. pylori-mediated cell invasion, the understanding of its 
downstream molecular mechanisms was the next step taken. Using a siRNA based 
strategy, a panel of c-Met adaptor molecules such as c-Cbl, Gab1, Nck, and Shc (Pelicci 
et al., 1995, Kochhar et al., 1996, Weidner et al., 1996, Garcia-Guzman et al., 2000), 
and other known downstream targets such as FAK, PLCγ, Shp-2, and c-Src (Okano et 
al., 1993, Rahimi et al., 1998, Beviglia et al., 1999, Kodama et al., 2000) were studied. 
The silencing of Nck, PLC-γ, and c-Src impaired H. pylori-mediated cell invasion in a 
significant manner. PLC-γ was previously reported to be activated after H. pylori infection 
(Churin et al., 2003, Franke et al., 2008). The involvement of this enzyme in the induction 
of host cell invasion by H. pylori is in agreement with previous results showing its 
involvement in the motogenic response induced by the bacteria (Churin et al., 2003), a 
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condition required for a cell to become invasive. In this line, and in a non-infectious 
context, there are descriptions showing that PLC-γ is also linked to cytoskeletal 
alterations needed to cell motility (Wells et al., 1999, Jones et al., 2005).  
In this Part I.1 of Results, and for the first time, a role for Nck in the context of H. pylori 
infection was described. In another infection model, it has been shown that the EPEC 
virulence factor Tir is able to interact with Nck, inducing actin pedestal formation 
necessary for bacteria internalization into the host cell (Gruenheid et al., 2001). In a non-
infectious context, it has also been described that Nck functions downstream the RTK 
PDGFR (Rivera et al., 2006, Ruusala et al., 2008, Abella et al., 2010). Nck is involved in 
cytoskeletal re-organization, cell motility (Rohatgi et al., 2001; Zhou et al., 2003; Rivera et 
al., 2004; Rivera et al., 2009), and in invadopodia formation (Stylli et al., 2009, Oser et al.). 
All these cellular processes are important for cell invasion, which is in accordance with 
the results obtained in the case of H. pylori infection. 
c-Src kinase is involved in the induction of cellular alterations by H. pylori, working as a 
CagA kinase (Selbach et al., 2002). In addition, c-Src is involved in the process of cancer 
invasion in non-gastric models (Chiang et al., 2005, Herynk et al., 2007, Lawler et al., 
2009). c-Src appears to mediate cancer invasion via c-Met activation (Herynk et al., 2007), 
or by stimulation with inflammatory cytokines (Lin et al., 2007). The discovery of the 
involvement of c-Src in H. pylori-mediated cell invasion is, therefore, not surprising. 
The downregulation of FAK also resulted in decreased cell invasion, though not in a 
significant manner. However, a role for FAK kinase in the induction of an invasive 
phenotype by the bacteria can not be excluded. The involvement of FAK in alterations 
induced by H. pylori has been previously described (Pai et al., 1999, Tsutsumi et al., 2006, 
Tabassam et al., 2008, Tabassam et al., 2011, Tegtmeyer et al., 2011). Additionally, it 
has been shown that FAK can function downstream of c-Met, mediating alterations in cell 
motility and invasion in other systems (Chen et al., 2006, Hui et al., 2009).  
The observations that Nck, PLC-γ, and c-Src are activated downstream of c-Met are in 
accordance with previous reports (Okano et al., 1993, Rahimi et al., 1998, Beviglia et al., 
1999, Kodama et al., 2000, Kochhar et al., 1996). Data in the literature, together with the 
findings obtained in this Part I.1 of the Results, point to the importance of RTK-mediated 
signaling in host cell alterations induced by H. pylori. 
 
Cell invasion has a proteolytic component in which metalloproteinases are key enzymes. 
MMPs are able to degrade components of the extracellular matrix, process cytokines and 
growth factors, and cleave cell surface receptors that act as signal transducers in 
invasion pathways  (Egeblad et al., 2002).  
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In the context of  H. pylori infection, it was already known that the presence of bacteria 
enhance the production and activation of MMPs in epithelial cells, contributing to gastric 
tissue damage (Bebb et al., 2003, Crawford et al., 2003, Gooz et al., 2003, Wroblewski et 
al., 2003, Krueger et al., 2006). The molecular mechanisms triggered by H. pylori leading 
to up-regulation of MMPs have however not been fully explored. 
In Part I.2 of the Results of this thesis, it was also validated that H. pylori leads to an 
increase in the expression of MMP-1, MMP-7, and MMP-10 in the AGS cell infection 
model system. These results confirmed the reports showing that H. pylori infection up-
regulates MMP-1 (Kitadai et al., 2003, Krueger et al., 2006, Pillinger et al., 2007) and 
MMP-7 (Bebb et al., 2003, Crawford et al., 2003, Gooz et al., 2003, Wroblewski et al., 
2003, Krueger et al., 2006). MMP-10 has gained attention during the last years due to its 
association with a broad spectrum of pathological conditions, such as cancer and 
inflammatory and cardiovascular diseases (Gill et al., 2004, P et al., 2001, Mathew et al., 
2002, Thorns et al., 2003, Bodey et al., 2000, Saghizadeh et al., 2001, Ogata et al., 2005). 
Increased expression of MMP-10 has been described in gastric carcinoma tissue (Aung 
et al., 2006, Lee et al., 2009). Furthermore, cDNA microarray studies to investigate 
changes in gene expression in hypergastrinemic transgenic (INS-GAS) mice stomachs 
infected with H. felis (Takaishi et al., 2007), and in a mouse gastric epithelial progenitor 
cell line infected with H. pylori (Giannakis et al., 2008), have suggested that Helicobacter 
up-regulates MMP-10. In this thesis, and for the first time, the role of H. pylori infection on 
the modulation of MMP-10 expression, as well as the regulation of this process in human 
gastric epithelial cells, was explored.  
It was demonstrated that infection with pathogenic H. pylori strains, such as 26695 and 
84183, increase MMP-10 mRNA, protein secretion and activity. The experiments showed 
that H. pylori is able to increase MMP-10 mRNA levels as high as 40-fold compared with 
non-infected conditions. These expression levels are much higher than the ones reported 
in an expression array comparing infected and non-infected cells (Krueger et al., 2006), 
and this difference may be due to the use of a different strain and a different MOI. 
That MMP-10 up-regulation is associated with CagA-positive strains was demonstrated 
by results obtained with infection of AGS cells with a H. pylori cagA-mutant. These results 
were further validated using a panel of H. pylori clinical isolates with known cagA status. 
Infection with strains that are more virulent such as CagA-positive strains, results in more 
severe disease, such as atrophic gastritis, peptic ulcer disease, and gastric carcinoma 
(Crabtree et al., 1991b, Figueiredo et al., 2002, Blaser et al., 1995, Peek et al., 1995). 
One can speculate that H. pylori CagA-positive strains lead to high levels of MMP-10 
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expression and protein secretion, leading to aberrant signaling, making the individuals 
infected with such strains at higher risk of disease. 
In a study where normal versus gastric carcinoma tissues were analyzed with a SAGE 
approach, and where MMP-10 was identified as a cancer associated protein, 15 out of 20 
serum samples of gastritis patients did not present MMP-10 expression. In that study, 
however, the H. pylori status was not determined (Aung et al., 2006). This may be an 
indication that MMP-10 does not have a role in gastritis associated with H. pylori 
colonization, but may be associated with more severe disease.  
A role for MMP-10 in cell invasion in H. pylori infection context was also demonstrated for 
the first time. Cells with abrogation of MMP-10 expression and infected with H. pylori were 
significantly less invasive than non-silenced infected cells. Previous reports in non-
infectious contexts showed that MMP-10 expression is associated with increase invasion 
of carcinoma cells (Frederick et al., 2008, Deraz et al., 2011). 
The results that c-Met and EGFR are associated with H. pylori-mediated MMP-10 
expression are novel findings. It has been shown that MMPs may be up-regulated by 
growth factors that activate RTKs (McCawley et al., 2001, Egeblad et al., 2002). c-Met 
and EGFR are RTKs previously reported to be targeted by H. pylori (Wallasch et al., 
2002, Churin et al., 2003). In fact, c-Met is one of the CagA targets (Churin et al., 2003, 
Oliveira et al., 2006, Oliveira et al., 2009), in keeping with our results that CagA-positive 
strains are significantly better inducers of MMP-10 than CagA-negative strains. 
The EGFR was previously shown to be involved in MMP-10 up-regulation in squamous 
cell carcinoma of head and neck (Wilkins-Port et al., 2007). Moreover, and in the context 
of H. pylori infection, EGF family members were shown to be involved in the stimulation 
of other MMPs, such as MMP-7, (Wroblewski et al., 2003). On the other hand, H. pylori-
mediated MMP up-regulation results in an increase of HB-EGF processing, a ligand of 
EGFR, and thus leads to an increase in the receptor activation (Wallasch et al., 2002, Yin 
et al., 2010). Although apparently contradicting, these data may point to a feedback 
regulation mechanism mediated by MMPs during H. pylori infection. The fact that two 
RTKs are involved in the same cellular process may be an indication that they cooperate 
and compensate the absence of the other. This hypothesis is in accordance with previous 
descriptions of cross-talk between c-Met and EGFR (Jo et al., 2000, Nath et al., 2001, Xu 
et al., 2007, Mueller et al., 2008).  
Of the molecules involved in H. pylori-mediated cell invasion described in Part I.1 of the 
Results, Nck, PLC-γ, and c-Src, all described to function downstream c-Met and EGFR  
(Okano et al., 1993, Chang et al., 1995, Kochhar et al., 1996, Rahimi et al., 1998, 
Kassis et al., 1999, Hake et al., 2008), only Nck and c-Src were shown to be involved 
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in MMP-10 modulation after infection. Giving that Nck is an adaptor protein of the RTKs 
studied, it may function in the early stages of signaling transduction. The role of c-Src is 
not surprising since this is a kinase of CagA, a virulence factor that is essential to MMP-
10 increased expression. Whether the phosphorylation of CagA is necessary to MMP-10 
up-regulation will be an interesting issue to address. Indeed, in a previous report the 
inhibition of CagA phosphorylation using a c-Src chemical inhibitor resulted in a decrease 
of H. pylori-mediated MMP-9 secretion  (Nam et al., 2011).  
Our Group has previously shown that H. pylori T4SS-competent and CagA-positive 
strains induce AGS cell invasion via c-Met receptor activation and increased activities of 
MMP-2 and MMP-9 (Oliveira et al., 2006). It is plausible that phosphorylation of tyrosine 
residues at the c-Met receptor intracellular domains mediated by CagA results in the 
phosphorylation and binding of adaptor proteins and activation of signal transducers, 
including Nck and c-Src, eventually leading to MMP-10 expression and cell invasion. 
Our Group has previously observed that the increase in the proteolytic activities of MMP-
2 and MMP-9 upon H. pylori infection, significantly decreased after silencing c-Met 
expression, suggesting that c-Met is involved in the activation of these MMPs (Oliveira et 
al., 2006). Adding to this observation, it has been shown that MMP-10 cleaves and 
activates pro-MMP-9 (Nakamura et al., 1998). Whether c-Met-mediated MMP-10 
expression plays a role in pro-MMP-9 activation in the context of H. pylori infection will be 
an interesting topic of further studies.  
It was demonstrated that the ERK1/2 and JNK signaling pathways are involved in H. 
pylori-induced MMP-10 expression. These observations, together with the finding that 
EGFR is involved in H. pylori stimulation of MMP-10 are also consistent with previous 
reports of H. pylori-mediated ERK activation via transactivation of the EGFR (Keates et 
al., 2001, Keates et al., 2005). The involvement ERK1/2, JNK, and p38 signal 
transduction pathways in MMP regulation has been previously described (Reunanen et 
al., 1998, Ridley et al., 1997), including in the context of H. pylori infection (Crawford et 
al., 2003, Krueger et al., 2006, Pillinger et al., 2007, Nam et al., 2011). In contrast to ERK 
and JNK, our results showed that inhibition of p38 signaling significantly stimulated MMP-
10 expression. Curiously, the finding that inhibition of p38 enhanced MMP-10 expression 
was also reported in head and neck cancer (Deraz et al., 2011). Our results with H. pylori 
infection are similar to those obtained by Pillinger et al. using the same AGS cell line, and 
which detected a significantly enhancing effect of the p38 inhibitor SB203580 on MMP-1 
expression (Pillinger et al., 2007). Similar findings were also obtained in AGS cells by 
Nam et al. in which p38 inhibitor slightly activated MMP-9 secretion (Nam et al., 2011). 
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A panel of cytokines associated to H. pylori infection, including IL-1β, TNF-α, INF-γ, TGF-
β, IL-10, and IL-8 (Romero-Adrian et al., 2010), were evaluated in the modulation of 
MMP-10 expression. Of these, only IL-1β was able to induce an overexpression of MMP-
10. This is particularly interesting giving the previously described role of IL-1β during H. 
pylori infection in increasing gastric cell secretion of MMP-3 (Gooz et al., 2003), a MMP of 
the same sub-family of MMP-10.  
The results obtained here suggest a role for MMP-10 during H. pylori infection in the 
activation of MMP-1. However, that is probably not the only mechanism of MMP-1 
activation, since the silencing of MMP-10 was not sufficient to abrogate active MMP-1 
present in conditioned medium. This is particularly interesting because MMPs are 
regulated at several levels, both transcriptional and post-transcriptional. One of the post-
transcriptional regulatory events is the activation of the pro-enzyme to an active form, 
which is probably what occurs in MMP-1 regulation by MMP-10. While previous works 
that described an association between MMP-1 up-regulation and H. pylori infection have 
focused on the transcriptional regulation (Krueger et al., 2006, Pillinger et al., 2007, 
Sokolova et al., 2012), this is the first study describing a post-transcriptional process 
leading to MMP-1 activation. The fact that MMP-10 may function as activator of other 
MMPs, makes this metalloproteinase a special player in the amplification of the general 
MMP response during H. pylori infection.  
The studies associating the up-regulation of MMPs to infection with H. pylori usually 
describe the final result of MMP activation as effectors of invasion and migration. 
However, MMPs are also molecular regulators able to modulate a plethora of chemokines, 
reactive oxygen species, and growth factors that, in turn, act in the induction of several 
pathological processes (Parks et al., 2004). Future studies addressing the role of MMPs 
during H. pylori infection not only as modulators of tissue damage, but also as modulators 
of other pathological processes, should be of critical importance. The increase in 
production of MMPs associated to infection with H. pylori virulent strains may account for 
gastric tissue damage and for the ability of host epithelial cells to invade surrounding 
tissues. This may also suggest a role for the bacterium in later stages of gastric 
carcinogenesis.  
In conclusion, these results show that MMP-10 expression is induced in gastric epithelial 
cells by CagA-positive H. pylori strains via the c-Met and EGF receptors, in a process that 
involves Nck and Src, and also the ERK and JNK pathways. Our results also 
demonstrate that MMP-10 is involved in H. pylori-mediated gastric cell invasion (Figure 
33). In the future, it will be interesting to address whether targeting MMPs in the context 
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of H. pylori infection, either by direct inhibitors or by targeting the signaling pathways that 
up-regulate MMP expression, will improve the outcome of the infection.  
 
 
 
Figure 33. H. pylori-mediated cell invasion and MMP-10 up-regulation. H. pylori CagA-positive strains induce 
gastric cell invasion via c-Met-mediated PLC-γ, Nck, and c-Src activation. MMP-10 is up-regulated by H. 
pylori cagA-positive strains via the c-Met and EGFR, in a process that involves Nck and c-Src, and also ERK 
and JNK pathways. MMP-10 is also an important molecule for cell invasion induced by H. pylori. Green 
arrows refer to findings reported in this thesis regarding H. pylori-mediated cell invasion, and dark blue arrows 
refer to results regarding MMP-10 up-regulation.  
 
 
 
Part II. Analysis of the effects of E-cadherin in H. pylori-mediated cell invasion and 
signaling  
 
In Part II of the Results, it was demonstrated that H. pylori alters the E-cadherin/catenin 
complex, leading to the formation of a multiproteic complex composed of CagA, c-Met, E-
cadherin, and p120-catenin. Due to the establishment of this complex, H. pylori-induced 
c-Met and p120-catenin phosphorylation as well as H. pylori-induced cell invasive 
phenotype were abrogated. 
In cell lines containing an intact E-cadherin/catenin complex, H. pylori induced lower 
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levels or no invasion in comparison with AGS cells. Using two clones from an E-cadherin 
stably transduced cell line (AGSEcad), in which a functional E-cadherin/catenin complex 
was established, it was shown that E-cadherin was sufficient to suppress the invasive 
phenotype induced by H. pylori.  
Induction of AGS cell invasion by H. pylori involves c-Met tyrosine phosphorylation 
(Oliveira et al., 2006). In contrast, H. pylori decreases the phosphorylation levels of c-Met 
in cells with a stable E-cadherin/catenin complex. Also, depending on the E-cadherin 
status, infection with H. pylori differently affects the tyrosine phosphorylation of p120-
catenin. In cells lacking E-cadherin expression, H. pylori induced p120-catenin 
phosphorylation, whereas in cells expressing E-cadherin H. pylori led to reduced p120-
catenin phosphorylation. Taken together, these data point to a role of E-cadherin in the 
suppression of H. pylori-induced c-Met and p120-catenin phosphorylation and, 
consequently, in the suppression of the cell invasive phenotype. 
 As already mentioned, c-Met is a receptor tyrosine kinase with a well-documented 
participation in cell invasion. p120-catenin interacts with the cytoplasmic juxtamembrane 
domain of E-cadherin (Yap et al., 1998), which, in conjunction with the phosphorylation 
status of p120-catenin, plays an important role in the stabilization of E-cadherin (Reynolds 
et al., 2004a, Yanagisawa et al., 2006). Phosphorylation of p120-catenin promotes its 
dissociation from E-cadherin and its translocation to the cytoplasm or nucleus where it 
participates in many signaling events (van Hengel et al., 1999). Endogenous p120-
catenin is described to promote migration and invasiveness of E-cadherin-deficient cells 
(Yanagisawa et al., 2006). In agreement with these findings are the ones performed in 
experimental models, where re-establishment of E-cadherin function in E-cadherin-
deficient cell lines reversed the invasive phenotype, pointing to E-cadherin role in 
suppression of cell invasion (Frixen et al., 1991, Vleminckx et al., 1991, Suriano et al., 
2003a).  
The phosphorylation statuses of c-Met and of p120-catenin are regulated by kinases and 
phosphatases such as c-Src, Fer, Shp-2, and PTP1B (Reynolds et al., 1989, Kim et al., 
1995, Balsamo et al., 1996, Ukropec et al., 2000). Because differences in cell invasion 
are associated with differences in c-Met and p120-catenin phosphorylation, a potential 
role for these kinases and phosphatases in the process of invasion is an interesting issue 
to explore. 
In both AGSEcad and NCI-N87 cells, E-cadherin expression levels were not altered by H. 
pylori, which is in accordance with previously published data in in vitro models (Conlin et 
al., 2004, Bebb et al., 2006). Although there is one description of an association between 
H. pylori infection and downregulation of E-cadherin expression (Terres et al., 1998), the 
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findings presented in Part II of the Results of this thesis are also in accordance with those 
of the majority of the studies using gastric biopsy specimens that show no association 
between the two events (Bebb et al., 2006, Zullo et al., 2004, Shun et al., 2001, Chan et 
al., 2003b). In line with the observations of others, it was observed that H. pylori infection 
also did not affect the expression levels of p120-, β-, or α-catenins (Bebb et al., 2006, 
Krueger et al., 2007). Although no differences were observed in the expression of these 
molecules, H. pylori infection led to increased intensity in membrane staining of E-
cadherin and of p120-catenin. These were also the experimental evidences from the 
immunoprecipitation studies, showing enhanced E-cadherin/p120-catenin binding after 
infection, suggesting that H. pylori alters the organization of the E-cadherin/catenin 
complex. 
After injection into the host cell cytoplasm the CagA T4SS effector localizes to the inner 
surface of the plasma membrane (Higashi et al., 2005). The confocal immunostainings 
pointed to co-localization of CagA and E-cadherin, and, most interestingly, to co-
localization of CagA and p120-catenin at the cell membrane. The immunoprecipitation 
assays using in vitro infection revealed that CagA indeed physically interacts with E-
cadherin, with c-Met, and with p120-catenin. The finding that CagA interacts with E-
cadherin is in agreement with the work of Murata-Kamiya et al. who reported that in 
CagA-transfected cells, CagA interacts with E-cadherin, destabilizing the E-cadherin/β-
catenin binding (Murata-Kamiya et al., 2007). The findings reported in this thesis also 
confirm previous observations of the interaction between CagA and c-Met (Churin et al., 
2003), and add novelty to the field of study by showing interaction between CagA and 
p120-catenin. 
Another interesting observation in this study was that after H. pylori infection, c-Met/E-
cadherin, and c-Met/p120-catenin interactions were enhanced. Taken together with the 
CagA interactions results, these observations suggest that CagA, E-cadherin, p120-
catenin, and c-Met interact with each other possibly forming a multiproteic complex. 
Furthermore, experiments with siRNA targeting c-Met revealed that, in the absence of c-
Met, CagA was no longer able to interact with E-cadherin or with p120-catenin, 
suggesting that interactions of CagA with the two elements of the E-cadherin/catenin 
complex occur via c-Met. 
The hypothesis formulated taking these results into consideration is that after infection, 
injected CagA interacts with c-Met and this complex now interacts with the E-
cadherin/catenin complex, leading to the formation of a multiproteic complex (Figure 34). 
This model is supported by the co-immunoprecipitations and siRNA results and might 
explain the reorganization of the E-cadherin/catenin complex observed by 
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immunocytochemistry. Further studies should be performed to elucidate how these four 
molecules interact within the multiproteic complex. There is now increasing evidence that 
E-cadherin participates in and regulates several signaling pathways via its extracellular 
domain (McLachlan et al., 2007). The extracellular domain of E-cadherin establishes not 
only homophilic, but also heterophilic interactions with tyrosine kinase receptors such as 
c-Met (Hiscox et al., 1999, Mateus et al., 2007, Reshetnikova et al., 2007). It is possible 
that the c-Met/E-cadherin interaction is established via their extracellular domain and that 
H. pylori CagA interacts with both E-cadherin and p120-catenin via c-Met.  
 
 
 
Figure 34. H. pylori and host cell invasion. (A) In cells with an intact E-cadherin/catenin complex H. pylori 
infection leads to enhanced c-Met/E-cadherin, c-Met/p120-catenin, and E-cadherin/p120-catenin interactions. 
In these cells, CagA binds to c-Met and this complex now interacts with the E-cadherin/catenin complex, 
suppressing H. pylori-mediated c-Met and p120-catenin phosphorylation and cell invasive phenotype (B) In E-
cadherin negative cells, H. pylori CagA leads to an increase in the phosphorylation levels of both p120-
catenin and c-Met. The activation of c-Met and its downstream targets Nck, c-Src, and PLC-γ results in host 
cell invasion.  
 
 
Disruption of the adherens junctions by H. pylori has been shown in several reports using 
cell line models (Conlin et al., 2004, Weydig et al., 2007, Schirrmeister et al., 2009, Hoy et 
al., 2010). These alterations may involve E-cadherin shedding via ADAM-10 induction by 
H. pylori or via the secreted bacterial protease HtrA (Schirrmeister et al., 2009, Hoy et al., 
2010). Furthermore, it has been shown that H. pylori induces translocation of E-cadherin 
from the cell membrane to intracellular location (Conlin et al., 2004, Weydig et al., 2007, 
Schirrmeister et al., 2009). In both cases, E-cadherin alterations induced by H. pylori 
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result in phenotypic changes such as cell scattering and elongation, increased cell 
migration and invasion. The apparent discrepancies between these observations and the 
results obtained in this thesis may derive from differences in infection time and cell lines 
used. Here, the phosphorylation and co-immunoprecipitation assays were performed 1 
hour after infection, a short-term infection time, and it is possible that longer infection 
periods result in different phenotypes. Nevertheless, the invasion assays were performed 
after 24 hours of infection, and corroborate the results obtained after 1 hour infection, 
showing that the potential inactivation of the c-Met due to its interaction with E-cadherin 
suppresses the invasive phenotype induced by the bacteria.  
It should also be noted that when one is addressing the issue of H. pylori infection in cell-
cell junction dysfunction two main aspects should be taken into consideration. First, a lot 
of studies have been performed in cell line models, often non-human and non-gastric, 
and frequently cancer-derived and with impaired cell-cell junctions. For example, the AGS 
and the MKN45 cell lines harbor mutations in the E-cadherin gene (Yokozaki, 2000). 
Also, genetic alterations in components of the Wnt signaling pathway are common in cell 
lines such as MKN7, MKN28 and HT29 (Yokozaki, 2000, Hsi et al., 1999). In addition, in 
host cell lines and bacteria co-culture models, infections cannot easily be maintained for 
long time periods, making these models more close to acute that to chronic infections. 
Second, results obtained in cell lines do not match those observed in the gastric mucosa 
of H. pylori-infected patients. In particular, gastric biopsy specimens of patients with and 
without H. pylori infection do not show any relationship between the infection and 
changes in the expression or distribution of E-cadherin, β-catenin, or p120-catenin. This 
does not mean that the phenomena observed in vitro do not occur in vivo, but may be 
explained if H. pylori-induced alterations in the adherens junctions are fast and transient 
and, therefore, not observable in fixed gastric tissues. Another possible explanation is 
that alterations in adherens junctions induced by H. pylori only occur in a subset of cells. 
These cells may then be selected as having growth advantages or increased resistance 
to apoptosis, therefore rendering them more susceptible to accumulation of DNA lesions 
which may lead to malignant transformation. 
 
 
 
Concluding remarks  
 
It is possible to make an analogy between what occurs during infection with H. pylori and 
the exploitation of the natural resources by the human being. In order to obtain cheap 
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food and raw materials to overcome its needs, Man can damage its ecosystem in an 
irreversible way, which can compromise the future viability of the species in the habitat. 
In a similar way, H. pylori infection, since it is chronic and acquired during childhood 
persisting through the host’s lifetime, may induce, in the long term, such a pressure in 
the ecosystem that compromises either the viability of the gastric tissue, or bacterial 
survival. Since we are talking about an ecosystem, it is important to stress that changes 
in one particular process may affect all the other processes of the system in a way that 
sometimes may not be very clear. Therefore, any particular molecular process should be 
understood as being part of something bigger, and the final phenotype observed may be 
understood as the interplay of several variables.  
It is known that host, bacterium, and environmental factors account for the differences in 
the clinical outcome of H. pylori infection. Although it is known that only a small 
proportion of infected individuals develop gastric carcinoma, the exact mechanisms 
underlying disease development mediated by H. pylori infection remain unraveled. The 
interaction between H. pylori and gastric epithelial cells leads to activation of host 
signaling pathways, modification of cellular functions, and induction of cell phenotypes 
important for carcinogenesis. 
Results in this thesis suggest that in cells with intact adherens junctions H. pylori leads 
to formation of a multiproteic complex composed of CagA, c-Met, E-cadherin, and p120-
catenin which impairs c-Met and p120-catenin tyrosine phosphorylation and suppresses 
cell invasion induced by H. pylori. In contrast, in the absence of E-cadherin, H. pylori 
infection associates with an increased ability of the cells to invade. It is arguable whether 
the invasive phenotype observed in the Matrigel in vitro cell model overlaps with tumor 
cell invasion, as observed during tumor progression in vivo. The latter is the result of a 
multistage process involving other events in addition to E-cadherin impairment; in fact it 
is arguable whether H. pylori would play a role in tumor invasion, because often, H. 
pylori is not present in full-blown gastric carcinoma. Instead, H. pylori infection might 
play an important role in selecting for survival gastric epithelial cells harboring E-
cadherin inactivation (genetic or epigenetic) that would otherwise undergo apoptosis 
before actual tumor progression occurs. In fact, recent data showed that cells lacking a 
functional E-cadherin have increased survival when compared to E-cadherin wild-type 
cells (Ferreira et al., 2012). In other words, E-cadherin inactivation is an initiator event, 
whereas H. pylori infection works as a tumor promoter. As such, H. pylori infection would 
increase the likelihood of E-cadherin-deficient cell lineage survival and further 
accumulation of oncogenic events in a process that, in the early phase, becomes H. 
pylori independent.
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H. pylori is a gram-negative bacterium that infects more than half of the human 
population, causing chronic superficial gastritis, that can progress to more severe 
diseases, including gastric carcinoma. 
H. pylori induces alterations in host cell signaling pathways that result in alterations of the 
normal cell behavior. One of the less explored phenotypes associated with H. pylori 
infection is cell invasion, a phenotype which involves a multitude of processes including 
cell migration and extracellular matrix degradation by MMPs (Matrix Metalloproteinases). 
The general aim of the work presented in this thesis was to evaluate the role of H. pylori 
infection in the induction of gastric epithelial cell invasion. The initial approach consisted 
on the evaluation of the invasive capacity through extracellular matrix components of the 
non-invasive human gastric cancer cell line AGS after infection with H. pylori. The role of 
the bacterial virulence factors CagA, T4SS (Type 4 Secretion System), and VacA was 
also evaluated. After establishing that the c-Met receptor was important for H. pylori-
mediated AGS cell invasion, the role of the downstream targets of c-Met was also 
elucidated. Results showed that H. pylori strains with a competent T4SS induce host 
gastric cell invasion through extracellular matrix components via c-Met receptor-
dependent Nck, PLC-γ, and c-Src activation. 
Based on the aforementioned results pointing to a role of H. pylori in inducing 
extracellular matrix degradation by host cells, and since MMPs are important for 
extracellular matrix degradation, the next aim was to evaluate the role of H. pylori in MMP 
expression. Studies started with the validation of a panel of MMPs shown to be up-
regulated in a cDNA expression microarray performed by our Group. After confirmation 
that H. pylori increased the expression of MMP-1, MMP-7, and MMP-10, a more detailed 
investigation on the effect of H. pylori on MMP-10 modulation was performed. 
Quantitative real-time polymerase chain reaction, western blot, enzymatic activity, and 
invasion assays were used in uninfected and H. pylori-infected cells. The role of the H. 
pylori virulence factors CagA and T4SS was addressed using bacterial mutants and a 
panel of H. pylori clinical isolates with known cagA status. The involvement of specific 
host cell signaling pathways and of receptor tyrosine kinases in modulation of MMP-10 
expression by H. pylori was evaluated in experiments with siRNA gene silencing and with 
chemical inhibitors. Results obtained in Part I.2 of the Results of the thesis showed that 
MMP-10 expression is induced in gastric epithelial cells by CagA-positive H. pylori strains 
via the c-Met and EGF receptors, in a process that involves Nck and c-Src and also the 
ERK and JNK pathways, as well as it involvement in H. pylori-mediated cell invasion.  
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Since the E-cadherin-catenin complex functions as an invasion suppressor, the next aim 
was to evaluate whether the complex had a role in H. pylori-mediated cell invasion and 
signaling. For that, gastric cell lines with intact E-cadherin-catenin complex were used. 
Also, and for the purpose of comparison with previous data obtained in the AGS 
background, an AGS cell line with a wild-type E-cadherin was established. For the 
characterization of the structure and function of the adherens junctions, 
immunofluorescence, confocal microscopy and aggregation assays were used. The 
phosphorylation and interactions between proteins of the adherens junctions were 
evaluated by co-immunoprecipitation and western blot. The invasion capacity of the 
different cell lines was assessed with Matrigel assays. Results presented in this part of 
the thesis evidence that H. pylori infection leads to formation of a multiproteic complex 
composed by CagA, c-Met, E-cadherin, and p120-catenin. This complex impairs H. pylori-
mediated c-Met and p120-catenin tyrosine phosphorylation and suppresses the invasive 
phenotype induced by H. pylori. 
 
Altogether, these results suggest that the interaction between H. pylori and gastric 
epithelial cells leads to activation of host signaling pathways, modification of cellular 
functions, and induction of cell phenotypes which underlie disease, namely gastric 
carcinoma. The elucidation of H. pylori-host interactions may provide further insights on 
H. pylori pathogenesis and on the mechanisms relevant to gastric disease development. 
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H. pylori é uma bactéria gram-negativa que infecta mais de metade da população 
humana, causando gastrite superficial crónica que pode progredir para doenças mais 
graves, incluindo o carcinoma gástrico. 
H. pylori induz alterações nas vias de sinalização da célula do hospedeiro que resultam 
em alterações no comportamento normal da célula. Um dos fenótipos menos 
explorados associados com a infecção por H. pylori é a invasão celular, um fenótipo, 
que envolve uma multiplicidade de processos, incluindo a migração celular e a 
degradação da matriz extracelular por MMPs (Metaloproteases da Matriz). O objectivo 
geral do trabalho apresentado nesta tese foi o de avaliar o papel da infecção por H. 
pylori na indução de invasão das células epiteliais gástricas. A abordagem inicial 
consistiu na avaliação da capacidade invasiva através de componentes da matriz 
extracelular de células AGS, uma linha celular gástrica humana não-invasiva,  após a 
infecção com H. pylori. O papel do fatores de virulência bacterianos CagA, T4SS 
(Sistema de Secreção Tipo 4) e VacA também foi avaliado. Depois de estabelecer que 
o receptor c-Met era importante para invasão celular das células AGS, mediada por H. 
pylori, o papel dos alvos a jusante do c-Met foi estudado. Os resultados mostraram que 
as estirpes de H. pylori com um T4SS competente induzem invasão de células 
gástricas do hospedeiro através dos componentes da matriz extracelular, por uma via 
dependente da activação de c-Met, Nck, PLC-γ, e c-Src. 
Com base nos resultados acima, que apontam para um papel de H. pylori na indução 
de degradação da matriz extracelular das células do hospedeiro, e uma vez que as 
MMPs são importantes para a degradação da matriz extracelular, o objectivo seguinte 
foi o de avaliar o papel de H. pylori na expressão de MMPs. O estudo começou com a 
validação de um painel de MMPs sobre-expressas num microarray de expressão de 
cDNA realizado pelo Grupo. Após a confirmação de que a infecção por H. pylori 
aumentou a expressão das MMP-1, MMP-7 e MMP-10, foi investigado mais 
detalhadamente o efeito de H. pylori na modulação da MMP-10. Em células não 
infectadas e infectadas por H. pylori foram feitos ensaios de real-time-PCR, western 
blot, ensaios de actividade enzimática e invasão. O papel dos factores de virulência 
CagA e T4SS de H. pylori foi estudado utilizando estirpes mutantes e um painel de 
isolados clínicos de H. pylori, com o status do cagA conhecido. O envolvimento de vias 
de sinalização celular do hospedeiro e de receptores tirosina-cinase na modulação da 
expressão de MMP-10 por H. pylori foi avaliado em experiências com siRNA e com 
inibidores químicos. Os resultados obtidos na Parte I.2 dos Resultados mostraram que 
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a expressão de MMP-10 é induzida em células epiteliais gástricas por estirpes de H. 
pylori CagA-positivas, através dos receptores c-Met e EGFR, num processo que 
envolve as proteínas Nck e c-Src e também as vias de sinalização ERK e JNK, bem 
como o seu envolvimento na invasão celular mediada por H. pylori. 
Uma vez que o complexo E-caderina-cateninas funciona como supressor de invasão, o 
objectivo seguinte foi o de avaliar o papel do complexo na invasão e sinalização 
celulares mediada por H. pylori. Para isso, foram utilizados linhas celulares gástricas 
com o complexo E-caderina-cateninas intacto. Além disso, e para efeitos de 
comparação com os dados anteriores obtidos com as células AGS, foi estabelecida 
uma linha celular AGS com expressão de E-caderina de tipo selvagem. Para a 
caracterização da estrutura e função das junções de adesão foi utilizada 
imunofluorescência, microscopia confocal e ensaios de agregação. A fosforilação e as 
interacções entre proteínas das junções de adesão foram avaliados por co-
imunoprecipitação e western blot. A capacidade de invasão das diferentes linhas 
celulares foi avaliada com ensaios de Matrigel. Os resultados apresentados nesta parte 
da tese mostraram que a infecção por H. pylori leva à formação de um complexo 
multiproteico composto por CagA, c-Met, E-caderina e catenina p120 . Este complexo 
impede a fosforilação de residuos tirosina no c-Met e catenina p120 mediada por H. 
pylori e suprime o fenótipo invasivo induzido pela bacteria. 
 
No seu conjunto, estes resultados sugerem que a interacção entre H. pylori e  as 
células epiteliais gástricas conduz à activação de vias de sinalização do hospedeiro, à 
modificação de funções, e à indução de fenótipos celulares que poderão estar 
subjacentes ao desenvolvimento de doença, nomeadamente de carcinoma gástrico. A 
elucidação das interações H. pylori-hospedeiro pode fornecer informações sobre a 
patogénese de H. pylori, e sobre possíveis mecanismos relevantes para o 
desenvolvimento de doenças gástricas associadas à infecção. 
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ABSTRACT 
Helicobacter pylori colonizes the human stomach inducing chronic gastritis, that in 
some cases evolves to more severe diseases, such as peptic ulcer disease and gastric 
carcinoma. 
H. pylori infection leads to up-regulation of the expression and activity of several 
matrixmetalloproteinases (MMPs), both in gastric cell lines and in the gastric mucosa. 
The aim of this study was to analyze the mechanisms leading to up-regulation of MMP-
10 in gastric epithelial cells induced by H. pylori. 
Infection of AGS cells with H. pylori led to an increase in MMP-10 mRNA, protein 
secretion, and activity. H. pylori strains that were mutant for cagA or for cagE (lacking 
the ability to translocate CagA) failed to increase MMP-10 expression. These results 
were confirmed in cocultures of cells performed with a panel of H. pylori clinical isolates 
with known cagA status. 
Treatment of AGS cells with HGF or EGF led to an increase in MMP-10 expression. 
Inhibition of c-Met, EGFR, and their common downstream targets Nck, and c-Src, with 
siRNAs or with chemical inhibitors abrogated H. pylori-induced MMP-10 expression, 
suggesting their involvement in MMP-10 up-regulation induced by the infection. 
Specific inhibitors of ERK1/2 and JNK abolished or significantly decreased H. pylori-
induced MMP-10 expression, whereas an inhibitor of p38 enhanced MMP-10 
expression. Inhibition of MMP-10 expression led to a decrease in gastric cell invasion 
mediated by H. pylori infection. 
In conclusion, MMP-10 expression is stimulated by H. pylori strains containing CagA, in 
a process that involves c-Met and EGFR and their downstream targets Nck, and c-Src, 
via the ERK1/2 and JNK pathways. Induction of MMP-10 is also implicated in H. pylori-
mediated cell invasion. 
 
Keywords: Helicobacter pylori, MMP-10, CagA 
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INTRODUCTION 
 
H. pylori are gram negative bacteria that infect the stomach of half of the world’s 
population. Infection is associated with chronic gastritis (54), which in the majority of 
the cases remains for the lifetime of the host. However, some individuals may develop 
more severe disease such as peptic ulcer disease, gastric mucosa-associated 
lymphoid tissue (MALT) lymphoma, and gastric carcinoma (54, 67). The differences in 
clinical outcomes associated with H. pylori infection are likely the result of the interplay 
between host, environmental, and bacterial virulence factors. 
About 60% of H. pylori strains contain a cag pathogenicity island (PAI) that encodes 
components of a type IV secretion system (T4SS). It has been shown that individuals 
infected with H. pylori cag PAI-positive strains have more severe gastric inflammation, 
and are more likely to develop peptic ulcer disease, and gastric carcinoma than 
individuals infected with cag PAI-negative strains (5, 13, 17, 21, 55). This is likely to 
occur since H. pylori cag PAI-positive are more interactive with the host cells than are 
cag PAI-negative strains, and induce stress response kinases such as ERK 1/2, JNK, 
and p38, and transcription factor NF-kB and AP-1 activation (29, 45, 76). As a 
consequence, H. pylori leads to increased expression of inflammatory cytokines such 
as IL-8, IL-1β, or TNF-α, cytoskeleton rearrangements, and cell motogenic and 
invasive phenotypes (11, 12, 44, 49), which may ultimately result in tissue damage in 
the gastric mucosa. 
Matrix metalloproteinases (MMPs) are a family of zinc-dependent enzymes that 
degrade components of the extracellular matrix and have an central role in tissue 
remodeling and cell invasion (8). Additionally, MMPs cleave non-matrix targets 
including cell surface receptors, cytokines, cell-cell adhesion molecules, and other 
proteinases (65). MMPs participate in processes, such as cell proliferation, 
differentiation, adhesion, migration, angiogenesis, apoptosis, and inflammation, both in 
physiological and in pathological settings (8, 35). 
The interaction between H. pylori and the gastric mucosa induces a variety of MMPs, 
including MMP-1, MMP-2, MMP-3, MMP-7, and MMP-9, directly or indirectly via 
induction of cytokine synthesis (4, 22, 33, 49, 57, 73). 
cDNA microarray studies to investigate changes in gene expression in 
hypergastrinemic transgenic (INS-GAS) mice stomachs infected with H. felis (68), and 
in a mouse gastric epithelial progenitor cell line infected with a chronic atrophic 
gastritis-derived H. pylori strain (19), have suggested that Helicobacter up-regulates 
MMP-10. However, the modulation of MMP-10 by H. pylori has never been explored. 
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In addition, MMP-10 is overexpressed in several epithelial-derived cancers (6, 20, 38, 
52, 71) and has been considered as marker of poor prognosis in gastric carcinoma 
patients (2, 36). 
Here, we report that H. pylori stimulates the expression, protein secretion, and activity 
of MMP-10 in AGS cells, in a process dependent on the presence of CagA, and 
mediated by the receptor tyrosine kinases c-Met and EGFR, and its downstream 
targets Nck, c-Src, ERK1/2, and JNK. We further demonstrate that MMP-10 is involved 
in H. pylori-mediated gastric cell invasion. 
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MATERIALS AND METHODS 
 
Cell culture and reagents 
AGS cells derived from a human gastric carcinoma (ATCC, Rockville, MD), were 
maintained in RPMI 1640 (Gibco; Grand Island, NY, USA) with 10% fetal bovine serum 
(Hyclone; Cramlington, UK), 200 µg/ml streptomycin, and 200 IU/ml penicillin (Gibco) at 
37ºC, under a humidified atmosphere containing 5% CO2.  
 
Bacterial strains and growth conditions  
Bacteria were grown in tryptic soy agar supplemented with 5% sheep blood (BD 
Bioscience; Heidelberg, Germany) and incubated 48 hours at 37ºC under a 
microaerophilic atmosphere. H. pylori strains 26695 (ATCC 700392), Tx30a (ATCC 
51932), 84183 and its cagA (84183∆cagA) and cagE (84183∆cagE) mutants (a kind 
gift from Prof. John Atherton), were used. A panel of H. pylori isolates with known 
cagA-status was also used. The presence of cagA was determined by PCR-reverse 
hybridization as previously described (74). 
 
Infection of gastric cells  
80% confluent cell monolayers were washed in PBS and incubated in antibiotic-free 
medium. For infection, H. pylori was added to cells at a multiplicity of infection (MOI) of 
100. Cultures were maintained at 37ºC under a 5% CO2 atmosphere for 24 hours. 
After infection, conditioned medium was collected, and the cells were lysed for RNA 
isolation. 
 
Quantification of mRNA by Real-Time PCR 
Total RNA was extracted using TriPure Isolation Reagent (Roche; Mannheim, 
Germany). One µg of RNA was used for cDNA synthesis, using Random Primers and 
SuperScript® II Reverse Transcriptase (Invitrogen; Carlsbad, CA, USA). Real-time PCR 
was performed using a TaqMan Mix (Applied Biosystems; Branchburg, NJ, USA) and 
the MMP-10 TaqMan probe (Hs00233987_m1, Applied Biosystems). Relative MMP-10 
expression was normalized to levels of GAPDH (Human GAPDH Endogenous Control 
(FAM™ Dye / MGB Probe, Non-Primer Limited), Applied Biosystems). PCR was 
performed in a 7500 Real Time PCR System (Applied Biosystems). 
 
Preparation of Conditioned Medium 
Conditioned medium was collected, centrifuged at 3824 g for 3 min and filtered through 
0.2 µm pore size filters (Advantec). To measure MMP-10 activity, conditioned medium 
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was concentrated using a Speed-Vac system. For SDS-PAGE, conditioned medium 
was concentrated using Amicon® ultra-0.5 centrifugal filter devices, 10 kDa cutoff 
(Millipore; Billerica, MA, USA).  
 
Preparation of cell lysates  
Cells were lysed in Catenin lysis buffer (1% Triton X-100, 1% NP-40 in PBS, pH 7.4) 
with proteases and phosphatases inhibitors (3mM sodium vanadate, 20mM NaF, 1mM 
phenylmethylsulfonyl fluoride, 10 µg/ml aprotinin, and 10µg/ml leupeptin). 25 µg of 
protein were used for analysis of total lysates. Proteins were separated by SDS-PAGE.  
 
Immunoblot analysis  
Proteins were transferred onto Hybond nitrocellulose membranes (GE Healthcare; 
Little Chalfont, Buckinghamshire, UK), blocked with 5% non-fat milk in PBS +0.1% 
Twen-20 (PBS-T) and incubated overnight at 4ºC with primary antibody. It was used an 
anti MMP-10 antibody (Santa Cruz Biotechnology: Santa Cruz, CA, USA), and a HRP-
conjugated donkey anti-goat (Santa Cruz Biotechnology). Subsequently LuminataTM 
Forte Western HRP Substract (Millipore) detection was performed.  
 
MMP-10 activity 
MMP-10 activity in conditioned medium was assessed using the fluorimetric assay 
SensoLyte® 520 MMP-10 Assay Kit (AnaSpec; Fremont, CA, USA), according to the 
manufacturer’s instructions. Recombinant MMP-10 (AnaSpec) was used to do a 
standard curve of concentrations and a fluorigenic FAM/QXLTM 520 FRET peptide was 
used as a substrate.  
 
Cell treatment 
Pharmacological inhibitors U-0126, SB203580, SP600125, and AG-1478 were 
obtained from Cayman Chemicals (Ann Arbor, MI, USA), and PP2 from Calbiochem 
(Gibbstown, NJ, USA). The concentrations of inhibitors used were 25 µM for U-0126, 
20 µM for SB203580 and SP600125 and 5µM for PP2 and AG-1478. Cells were 
treated one hour before the infection, and the inhibitor was not removed during the 
experiment. HGF at 250 ng/mL (Immunotools; Friesoythe, Germany) and EGF at 50 
ng/mL (Sigma; Steinheim, Germany) were used to treat the cells for 24hours. 
 
Small interference RNA (siRNA) transfection  
50% confluent monolayers were washed and incubated in serum- and antibiotic-free 
medium. siRNAs targeting c-Met, Nck, PLC-γ, c-Src, MMP-10, and Non-silencing 
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siRNA were obtained from Qiagen. Transfection was performed using Lipofectamine 
2000 (Invitrogen). Silencing efficiencies of siRNAs were evaluated, 48 hours after 
transfection, by western blot for all siRNAs, except for MMP-10, which was evaluated 
by Real-time PCR. 
 
Invasion assays  
Matrigel-coated 24-well invasion inserts of 8 µm pore-size filters (BD Biosciences) were 
incubated one hour at 37ºC with antibiotic-free medium. After this period, 5x104 cells, in 
the presence or absence of H. pylori at a MOI of 100, were incubated 24 hours at 37ºC. 
Filters were washed with PBS and fixed in 4% paraformaldehyde. Non-invading cells 
were stained and mounted in Vectashield with DAPI (Vector Laboratories; Burlingame, 
CA, USA). Invasive cells were scored in 20 microscopic fields (20X objective). 
 
Statistical analysis  
Data were analyzed with Student’s t-test and expressed as mean values of at least 
three independent experiments ± standard errors. The comparison between MMP-10 
expression and the cagA status of the H. pylori strains was performed using the non-
parametric Mann-Whitney test. For that, a variable that represents the average of the 
assays for each strain was created, and strains were divided into cagA-positive and 
cagA-negative groups. Differences were considered significant at p values lower than 
0.05. 
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RESULTS 
 
H. pylori increases MMP-10 expression and activity 
Increased expression of several MMPs has been reported in the context of H. pylori 
infection and in gastric carcinoma (2, 19, 33, 68). Specifically, the modulation of MMP-
10 by H. pylori has never been explored in depth in human gastric epithelial cells. 
Therefore, we assessed the role of H. pylori infection in MMP-10 expression and 
activity. For that, AGS gastric cells were cultured in the presence or absence of H. 
pylori strain 26695 at a MOI of 100. After 24 hours of infection, RNA was isolated and 
MMP-10 mRNA levels were analyzed by quantitative real-time PCR (qRT-PCR). As 
shown in Figure 1A, H. pylori induced a 40-fold increase in MMP-10 mRNA levels 
compared to uninfected cells, which display very low levels of MMP-10 (p < 0.001). 
Next, we tested whether the observed increase in MMP-10 mRNA expression was 
accompanied by an increase in MMP-10 secretion. For that, conditioned media of H. 
pylori-infected and uninfected AGS cells were collected and concentrated 2x, and the 
levels of secreted MMP-10 were detected by western blot. The results showed that H. 
pylori induced not only increased MMP-10 mRNA expression, but also induced 
secretion of MMP-10 (Figure 1B). No MMP-10 secretion was detected in AGS control 
cells. To further elucidate the activity of the secreted MMP-10, conditioned media of 
infected and uninfected AGS cells were analyzed using a fluorimetric activity assay. As 
it can be seen in Figure 1C, the MMP-10 secreted by AGS cells upon H. pylori infection 
was active. 
 
H. pylori-mediated MMP-10 expression is CagA dependent 
To define the relative contribution of the CagA and of the T4SS virulence factors to H. 
pylori-mediated increase in MMP-10 expression, AGS cells were infected for 24 hours 
with H. pylori strain 84183 and its cagA (84183∆cagA) and T4SS (84183∆cagE) 
mutants.  
The analysis of MMP-10 mRNA levels by qRT-PCR showed that infection with H. pylori 
wild type 84183 and 26695 strains induce similar expression levels (Figures 1 A and 
2A). In contrast, infection with the 84183∆cagA and 84183∆cagE mutants, lacking 
cagA and a functional T4SS, respectively, lead to the expression of significantly less 
amounts of MMP-10 (Figure 2A). These results show that the increase in MMP-10 
mRNA induced by H. pylori is CagA-dependent. 
To confirm these results in strains which have not been manipulated, we used H. pylori 
clinical isolates which have been submitted to low number of passages in the 
laboratory and for which the cagA status was known. AGS cells were infected with H. 
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pylori isolates and, in parallel, with the non-pathogenic strain Tx30a. After 24 hours of 
infection, the MMP-10 mRNA levels were quantified by qRT-PCR. Infection with cagA-
positive strains led to a more pronounced increase in MMP-10 expression than did 
cagA-negative strains (Figure 2B). The main exception was strain CI-50 that although 
cagA-positive was not able to significantly up-regulate MMP-10 (Figure 2B). It is 
possible that this strain has an impaired T4SS and is not able to translocate CagA into 
the host cells. Curiously, Tx30a was the strain that among all cagA-negative strains 
induced a higher level of MMP-10, which was still much lower than the levels of MMP-
10 induced by cagA-positive strains. Overall, these results point to an important role of 
CagA in MMP-10 up-regulation mediated by H. pylori. 
 
H. pylori increases MMP-10 expression via c-Met and EGFR 
It has been reported that MMPs may be up-regulated by growth factors that activate 
RTKs (16, 39). In fact, EGFR has been implicated in MMP-10 up-regulation in 
squamous cell carcinoma of head and neck (77). Interestingly, H. pylori infection has 
also been shown to activate EGFR and c-Met (11, 49, 75). Therefore, we addressed 
whether these two RTKs were implicated in H. pylori-mediated MMP-10 expression. 
First, we tested whether stimulation of AGS cells with HGF and EGF, the natural 
ligands of c-Met and EGFR respectively, altered MMP-10 expression. AGS cells were 
treated with HGF and EGF for 24 hours. The MMP-10 expression was analyzed by 
qRT- PCR. Both HGF and EGF enhanced MMP-10 expression, with EGF inducing a 
more pronounced increase (Figure 3A and 3B), demonstrating that MMP-10 can be up-
regulated via c-Met and EGFR in AGS cells. Next, the role of c-Met and EGFR in the 
induction of MMP-10 during infection was addressed.  
For that, AGS cells were knocked-down for c-Met by siRNA and for EGFR by the 
chemical inhibitor AG-1478, and infected or not with H. pylori for 24 hours. The 
downregulation of c-Met or EGFR abrogated H. pylori-mediated MMP-10 expression 
(Figure 3C and 3D). These findings indicate that the increase in MMP-10 expression 
induced by H. pylori is mediated by the activation of c-Met and EGFR. 
 
c-Src and Nck, but not PLC-γ, are involved in H. pylori-induced MMP-10 
expression 
To further dissect the molecular mechanisms involved in c-Met and EGFR signaling 
that lead to MMP-10 up-regulation by H. pylori, we chose common c-Met and EGFR 
downstream targets described to be important for H. pylori-mediated signaling. To fulfill 
this aim, the expression of Nck, PLC-γ, and c-Src in AGS cells was downregulated 
using siRNAs. Efficient knockdown was achieved and was maximal 48 hours after 
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transfection. As control, AGS cells were transfected with a Non-silencing siRNA. Since 
the silencing of Src was difficult to achieve, the chemical inhibitor PP2 directed to the 
Src family kinases was also used. Cells were treated one hour before infection with 
PP2 or DMSO and then infected for 24 hours. RNA was isolated after this period and 
analyzed by qRT-PCR. As expected, MMP-10 expression increased in AGS cells 
infected with H. pylori, but this increase was attenuated in cells silenced for Nck (Figure 
4A). Similarly H. pylori-mediated MMP-10 expression was decreased in cells silenced 
for Src or in which Src activity was inhibited with PP2 (Figure 4C and 4D). In contrast, 
the silencing of PLC-γ had no effect in H. pylori-mediated MMP-10 expression (Figure 
4B). These results point to a role for Nck and Src in the regulation of MMP-10 during 
infection. 
 
H. pylori increases MMP-10 expression through ERK and JNK, but not p38 
pathways 
Because ERK, JNK, and p38 pathways are involved in the induction of different MMPs 
(59, 60) and in H. pylori-driven signaling (45, 76), and because they can function 
downstream c-Met and EGFR receptors (7, 70, 72), we next determined their 
involvement in H. pylori-mediated MMP-10 expression. For this purpose, AGS cells 
were treated with chemical inhibitors of ERK1/2 (U-0126), JNK (SP600125), and p38 
(SB203580), or with the vehicle (DMSO) alone, 1 hour before infection. Cells were then 
infected with H. pylori 26695 in the presence of the inhibitors for 24 hours, and MMP-10 
expression were measured by qRT-PCR. Infection with H. pylori in the presence of 
DMSO did not affect MMP-10 expression stimulated by the bacteria alone (Figure 5A, 
5B and 1A). The treatment with the ERK1/2 inhibitor resulted in complete abrogation of 
MMP-10 expression, whereas treatment with the JNK inhibitor led to a significant 
decrease of MMP-10 expression after H. pylori infection (Figure 5A). In contrast, the 
inhibition of p38 resulted in enhanced expression of MMP-10 after infection (Figure 5 
B). Taken together, these results suggest that MMP-10 expression induced by H. pylori 
is partially mediated by JNK and ERK1/2 pathways, and that p38 may have an 
inhibitory role in this process. 
 
MMP-10 promotes cell invasion mediated in H. pylori infection  
As one of the main functions of MMPs is the turnover and remodeling of the 
extracellular matrix (53), and since it was previously reported that H. pylori cag-positive 
strains induce gastric cell invasion in a context of increased MMP expression and 
activity (49, 64), we next determined whether MMP-10 is involved in cell invasion 
mediated by H. pylori. AGS cells were transiently transfected with a siRNA abrogating 
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MMP-10 expression, and the efficiency of the knockdown was accessed by qRT-PCR. 
Invasion assays were performed 24 hours after transfection, by incubating AGS cells 
with H. pylori on Matrigel filters for an additional 24 hours. Silencing of MMP-10 
inhibited H. pylori-induced MMP-10 expression in AGS cells (Figure 6A), and 
significantly inhibited cell invasion in response to H. pylori infection (Figure 6B). These 
findings demonstrate that MMP-10 plays a role in H. pylori-mediated cell invasion. 
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DISCUSSION 
 
Persistent infection of the gastric mucosa with H. pylori and concomitant chronic 
inflammation underlies the association between this pathogen and peptic ulceration 
and gastric neoplasia. Despite the mechanisms through which H. pylori promotes ulcer 
and carcinoma have not been fully elucidated, the capability of this infectious organism 
to stimulate gastric epithelial cell secretion of MMPs, with possible induction of mucosal 
tissue damage by degradation of extracellular matrix components and by modulation of 
cytokine and chemokine activity, may partly explain the association. 
Our data indicates that H. pylori infection of gastric epithelial cells stimulates the 
expression and secretion of MMP-10. MMP-10, also known as stromelysin-2, has been 
associated with a broad spectrum of pathological conditions, including inflammatory 
diseases and cancer (6, 20, 38, 47, 52, 62, 71). MMP-10 is up-regulated in lung, head 
and neck, esophagus, brain, and liver cancers (6, 20, 38, 52, 71). This MMP has been 
recently detected as one of the highly expressed genes in gastric carcinoma 
specimens compared with normal tissues by serial analysis of gene expression (SAGE) 
data analysis (2), and high levels of MMP-10 were found in serum samples from 
patients with gastric carcinoma (65/69, 94.2%). In these patients, MMP-10 has been 
considered as a marker of poor prognosis (2, 36). Nevertheless, and although MMP-10 
expression has been associated with Helicobacter infections in cDNA expression 
microarrays (19, 33, 68), this is the first study in which MMP-10 regulation is addressed 
in the context of H. pylori infection. 
Our data also indicates that up-regulation of MMP-10 expression by H. pylori is 
dependent on infection with CagA-positive strains. The CagA protein is a T4SS effector 
that is translocated into the host cells, where it can be phosphorylated by Src and Abl 
family kinases (46, 63, 69). Both the phosphorylated and the non-phosphorylated forms 
of CagA are able to activate multiple signaling pathways in the host cell, leading to cell 
proliferation, cytoskeletal rearrangements, and disruption of cell-cell junctions (1, 63). 
Consistent with the functional activities of CagA, infection with H. pylori strains that are 
CagA-positive results in more severe disease, including peptic ulcer disease and 
gastric carcinoma (5, 13, 17, 55). 
Our results that c-Met and EGFR are associated with H. pylori-mediated MMP-10 
expression are novel findings. It has been shown that MMPs may be up-regulated by 
growth factors that activate RTKs (16, 39). c-Met and EGFR are RTKs previously 
reported to be targeted by H. pylori (11, 75). In fact, c-Met is one of the CagA targets 
(11, 49, 50), in keeping with our results that Cag-A positive strains are significantly 
better inducers of MMP-10 than CagA-negative strains. 
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The EGFR was previously shown to be involved in MMP-10 up-regulation in squamous 
cell carcinoma of head and neck (78). Moreover, and in the context of H. pylori 
infection, EGF family members were shown to be involved in the stimulation of other 
MMPs, such as MMP-7, (79). On the other hand, H. pylori-mediated MMP up-
regulation results in an increase of HB-EGF processing, a ligand of EGFR, and thus 
leads to an increase in the receptor activation (75, 81). Although apparently 
contradicting, these data may point to a feedback regulation mechanism mediated by 
MMPs during H. pylori infection. The fact that two RTKs are involved in the same 
cellular process may be an indication that they cooperate and compensate the absence 
of the other. This hypothesis is in accordance with previous descriptions of cross-talk 
between c-Met and EGFR (27, 40, 43, 80). 
Nck, PLC-γ, and Src are all described to function downstream c-Met and EGFR (9, 24, 
28, 32, 48, 58). Of these, only Nck and Src were shown to be involved in MMP-10 
modulation by H. pylori. Nck is important for cytoskeletal re-organization, cell motility, 
and formation of invadopodia (51, 61, 66). In an infection context, Nck interacts with the 
enteropathogenic Escherichia coli virulence factor Tir, leading to actin pedestal 
formation necessary for bacteria internalization into the host cell (23). Here, we 
describe for the first time a role for Nck in the context of H. pylori infection. 
The non-receptor tyrosine Src kinase is linked to cell invasion and proteolysis in 
several cancer models (10, 26, 34), and in some cases this occurs via c-Met activation 
(26), or by stimulation with cytokines (37). Src is also one of the kinases of CagA (63), 
which we found to be important in H. pylori-mediated MMP-10 expression. Whether the 
phosphorylation of CagA is necessary for MMP-10 up-regulation will be an interesting 
issue to address. Indeed, in a previous report the inhibition of CagA phosphorylation 
using a chemical inhibitor of Src resulted in a decrease of H. pylori-mediated MMP-9 
secretion (42). 
We have demonstrated that the ERK1/2 and JNK signaling pathways are involved in H. 
pylori-induced MMP-10 expression. These observations, together with the finding that 
EGFR is involved in H. pylori stimulation of MMP-10 are also consistent with previous 
reports of H. pylori-mediated ERK activation via transactivation of the EGFR (30, 31). 
The involvement ERK1/2, JNK, and p38 signal transduction pathways in MMP 
regulation has been previously described (59, 60), including in the context of H. pylori 
infection (14, 33, 42, 56). In contrast to ERK and JNK, our results showed that 
inhibition of p38 signaling significantly stimulated MMP-10 expression. Curiously, the 
finding that inhibition of p38 enhanced MMP-10 expression was also reported in head 
and neck cancer (15). Our results with H. pylori infection are similar to those obtained 
by Pillinger et al. using the same AGS cell line, and which detected a significantly 
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enhancing effect of the p38 inhibitor SB203580 on MMP-1 expression (55). Similar 
findings were also obtained in AGS cells by Nam et al. in which p38 inhibitor slightly 
activated MMP-9 secretion (42). 
The results we have obtained point to MMP-10 as a player in gastric cell invasion 
mediated by H. pylori. Indeed, MMPs play an important role in the degradation of 
extracellular matrix, which is an important component of cellular invasion. We have 
previously shown that H. pylori T4SS-competent and CagA-positive strains induce AGS 
cell invasion via c-Met receptor activation and increased activities of MMP-2 and MMP-
9 (49). c-Met has a well-documented participation in cell invasion (3, 18, 25). It is 
plausible that phosphorylation of tyrosine residues at the c-Met receptor intracellular 
domains mediated by CagA results in the phosphorylation and binding of adaptor 
proteins and activation of signal transducers, including Nck and Src, eventually leading 
to MMP-10 expression and cell invasion. 
We have previously observed that the increase in the proteolytic activities of MMP-2 
and MMP-9 upon H. pylori infection, significantly decreased after silencing c-Met 
expression, suggesting that c-Met is involved in the activation of these MMPs (49). 
Adding to this observation, it has been shown that MMP-10 cleaves and activates pro-
MMP-9 (41). Whether c-Met-mediated MMP-10 expression plays a role in pro-MMP-9 
activation in the context of H. pylori infection will be an interesting topic of further 
studies.  
In conclusion, our results show that MMP-10 expression is induced in gastric epithelial 
cells by CagA-positive H. pylori strains via the c-Met and EGF receptors, in a process 
that involves Nck and Src, and also the ERK and JNK pathways. Our results also 
demonstrate that MMP-10 is involved in H. pylori-mediated gastric cell invasion. In the 
future, it will be interesting to address whether targeting MMPs in the context of H. 
pylori infection, either by direct inhibitors or by targeting the signaling pathways that up-
regulate MMP expression, will improve the outcome of the infection. 
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FIGURE LEGENDS 
 
Figure 1. H. pylori increases MMP-10 mRNA expression, protein secretion, and 
activity. AGS cells were infected with H. pylori strain 26695 for 24 hours at a MOI of 
100. (A) MMP-10 expression was analyzed by qRT-PCR. MMP-10 expression levels 
were normalized to GAPDH expression and results are presented as fold differences 
relative to uninfected cells (B) Secreted MMP-10 was analyzed in the conditioned 
medium by western-blot. (C) MMP-10 activity in conditioned medium was analyzed by 
FRET. Data correspond to the mean values ± standard errors and are representative 
of, at least, three independent experiments. *, significantly different from uninfected 
cells. 
 
Figure 2. H. pylori-mediated MMP-10 expression is CagA dependent. AGS cells 
were infected with H. pylori for 24 hours at a MOI of 100 and MMP-10 expression was 
analyzed by qRT-PCR. MMP-10 expression levels were normalized to GAPDH 
expression and results are presented as fold differences relative to uninfected cells. (A) 
Infection with H. pylori wild-type strain 84183 and its cagA (84183∆cagA) and cagE 
(84183∆cagE) mutants. (B) Infection with a panel of H. pylori isolates with known cagA 
status. Data correspond to the mean values ± standard errors and are representative of 
three independent experiments. *, significantly different from uninfected cells; **, 
significantly different from cells infected with wild-type H. pylori 84183. 
 
Figure 3. H. pylori increases MMP-10 via c-Met and EGFR. AGS cells were treated 
with HGF at 150 or 250 ng/mL (A) and EGF at 50 or 150 ng/mL (B) for 24 hours. (C-D) 
AGS cells were infected with H. pylori strain 26695 for 24 hours at a MOI of 100, after 
the transient tranfection with a Non-silencing siRNA (NS) or an siRNA directed to c-Met 
(si c-Met) (C), or after treatment with the EGFR chemical inhibitor AG-1478 at a final 
concentration of 5µM (iEGFR), or with dimethyl sulfoxide vehicle (DMSO), 1 hour 
before the infection (D). (A-D) MMP-10 expression was analyzed by qRT-PCR. MMP-
10 expression levels were normalized to GAPDH expression and results are presented 
as fold differences relative to uninfected cells (A-B), cells treated with a Non-silencing 
siRNA (C) or with DMSO (D). Data correspond to the mean values ± standard errors 
and are representative of three independent experiments. *, significantly different from 
uninfected cells; **, significantly different from cells infected with H. pylori 26695. 
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Figure 4. c-Src and Nck, but not PLC-γ, are involved in H. pylori-induced MMP-10 
expression. (A-C) AGS cells alone or transiently transfected with a Non-silencing 
siRNA (NS) or with siRNAs directed to Nck, PLC-γ and Src, or (D) after a treatment for 
1 hour with the Src family kinases chemical inhibitor PP2 (iSrc), or DMSO, were 
infected with H. pylori strain 26695 for 24 hours at a MOI of 100. MMP-10 expression 
was analyzed by qRT-PCR. MMP-10 expression levels were normalized to GAPDH 
expression and results are presented as fold differences relative to cells treated with a 
Non-silencing siRNA (A-C) or with DMSO (D). Data correspond to the mean values ± 
standard errors and are representative of three independent experiments. *, 
significantly different from uninfected cells; **, significantly different from non-silenced 
cells or cells trated with DMSO.   
 
Figure 5. H. pylori increases MMP-10 expression through ERK and JNK, but not 
p38 pathways. AGS cells were treated 1 hour before the infection with dimethyl 
sulfoxide vehicle (DMSO) or with chemical inhibitors of ERK1/2 (U-0126, 25 µM; iERK) 
(A), JNK (SP600125, 20 µM; iJNK) (A), and p38 (SB203580, 20 µM; ip38) (B). (A-B) 
After treatment AGS cells were infected with H. pylori 26695 for 24 hours at a MOI of 
100. MMP-10 expression was evaluated by qRT-PCR. MMP-10 expression levels were 
normalized to GAPDH expression and results are presented as fold differences relative 
to uninfected cells treated with DMSO. Data correspond to the mean values ± standard 
errors and are representative of three independent experiments. *, significantly different 
from uninfected cells; **, significantly different from cells infected with H. pylori 26695. 
 
Figure 6. MMP-10 is involved in H. pylori-mediated cell invasion. (A) AGS cells 
were treated with a Non-silencing siRNA or a siRNA directed to MMP-10, and co-
cultured with H. pylori for 48 hours. The efficiency of the knockdown was evaluated by 
qRT-PCR. (B) AGS cells treated with a Non-silencing siRNA or an siRNA directed to 
MMP-10, were co-cultured with H. pylori for 24 hours at a MOI of 100 on Matrigel 
coated filters. Data correspond to the mean values ± standard errors and are 
representative of three independent experiments. *, significantly different from 
uninfected cells; **, significantly different from cells infected with H. pylori 60190.  
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CagA Associates with c-Met, E-Cadherin, and p120-
Catenin in a Multiproteic Complex That Suppresses
Helicobacter pylori–Induced Cell-Invasive Phenotype
Maria Jose Oliveira,1,a Angela Margarida Costa,1,2,a Ana Catarina Costa,1,2 Rui Manuel Ferreira,1 Paula Sampaio,3
Jose Carlos Machado,1,2 Raquel Seruca,1,2 Marc Mareel,4 and Ceu Figueiredo1,2
1Institute of Molecular Pathology and Immunology of the University of Porto, 2Department of Pathology, Medical Faculty of Porto, and 3Institute
of Molecular and Cellular Biology, Porto, Portugal; and 4Laboratory of Experimental Cancer, Ghent University Hospital, Ghent, Belgium
Background. Helicobacter pylori induces an invasive phenotype in gastric epithelial cells through a mechanism
that requires the type IV secretion system and the phosphorylation of c-Met. The E-cadherin–catenin complex is
a major component of the adherens junctions and functions as an invasion suppressor. We investigated whether
E-cadherin has a role in H. pylori–induced, c-Met phosphorylation-dependent cell-invasive phenotype.
Methods. AGS cells that lack E-cadherin and that are invasive to H. pylori stimulation were transduced with
E-cadherin and infected with H. pylori. NCI-N87 cells, which endogenously express E-cadherin, were also used
for infection experiments.
Results. E-cadherin was sufficient to suppress not only H. pylori–mediated cell-invasive phenotype but also c-
Met and p120-catenin tyrosine phosphorylation. H. pylori infection led to increased interactions between E-cadherin
and p120-catenin, c-Met and E-cadherin, and c-Met and p120-catenin. Using in vitro infection assays, we showed
that H. pylori CagA interacts with E-cadherin, p120-catenin, and c-Met. Finally, using small interfering RNA, we
showed that interactions between CagA and E-cadherin and between CagA and p120-catenin were established
through c-Met.
Conclusions. We suggest that H. pylori alters the E-cadherin–catenin complex, leading to formation of a
multiproteic complex composed of CagA, c-Met, E-cadherin, and p120-catenin. This complex abrogates c-Met
and p120-catenin tyrosine phosphorylation and suppresses the cell-invasive phenotype induced by H. pylori.
Helicobacter pylori colonizes the stomach of more than
one-half of the human population and is a risk factor
for gastric carcinoma development [1–3]. In the past
2 decades, many studies have been performed in an
attempt to identify H. pylori virulence factors, to eval-
uate their biological effect, and to clarify their contri-
bution to infection and disease [4–6].
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The cag pathogenicity island (cagPAI) is one of the
best characterized H. pylori virulence factors. Studies
have demonstrated that individuals infected with H.
pylori cagPAI–positive strains present increased inflam-
mation and have a higher risk of developing peptic ulcer
disease and gastric carcinoma, compared with individ-
uals infected with cagPAI-negative strains [3, 7]. The
cagPAI is a cluster of ∼30 genes that encode compo-
nents of a type IV secretion system (T4SS). Once at-
tached to the host cell, cagPAI-positive strains inject
CagA into the host cytoplasm via the T4SS [8]. Inside
the host cell, CagA localizes to the inner surface of the
plasma membrane [9] and targets cell-cell junctions,
namely the tight and the adherens junctions [10, 11].
CagA is also described to target the tyrosine kinase c-
Met receptor, leading to its activation and induction of
a motogenic phenotype [12].
The E-cadherin–catenin complex is a major com-
ponent of adherens junctions, functioning as a cell-cell
adhesion complex, a regulator of signaling pathways,
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and a bacterial cell receptor [13, 14]. E-cadherin molecules
establish homophilic interactions through their extracellular
domains to form adhesive complexes. The extracellular domain
of E-cadherin also participates in heterophilic interactions with
other proteins, such as the epidermal growth factor receptor
[15, 16], the c-Met receptor [17, 18], and the internalin A
surface receptor of Listeria monocytogenes [13]. The cytoplasmic
domain of E-cadherin interacts directly with b- and p120-ca-
tenins via separate interaction domains, and these molecules
physically interact or regulate the actin cytoskeleton [19]. E-
cadherin loss of function by mutation or promoter hypermeth-
ylation is a common feature of many cancers, including diffuse-
type gastric carcinomas [20, 21]. H. pylori infection has been
associated with E-cadherin gene promoter methylation [22, 23]
and affects the functionality of the E-cadherin–catenin complex
[11, 24].
We previously reported that H. pylori strains containing a
functional T4SS induce an invasive phenotype of gastric cells
through a c-Met–receptor dependent signaling pathway [25].
In the present study, we revealed that E-cadherin is sufficient
to suppress H. pylori–induced cell-invasive phenotype. Our in
vitro infection assays confirm that CagA interacts with E-cad-
herin, and for the first time to our knowledge, we revealed that
CagA also interacts with p120-catenin. Furthermore, we re-
vealed that CagA, c-Met, E-cadherin, and p120-catenin form
in a multiproteic complex.
MATERIALS AND METHODS
Cell culture and complementary DNA (cDNA) transduction.
AGS, NCI-N87 (American Type Culture Collection [ATCC]),
and IPA220 cells derived from human gastric carcinomas were
maintained in RPMI 1640 (Invitrogen) with 10% fetal bovine
serum, 2.5 mg/mL fungizone (Bristol-Myers Squibb), 200 mg/
mL streptomycin, and 200 IU/mL penicillin at 37C under 5%
carbon dioxide. Cells were stably transduced using a pLenti6/
V5 construct containing E-cadherin cDNA, as described else-
where [26]. For clonal selection, 5 mg/mL of blasticidin was
added to the medium.
Immunocytochemistry and confocal microscopy. Con-
fluent monolayers were grown on glass coverslips, fixed in ice-
cold methanol, incubated in 5% bovine serum albumin (Sigma-
Aldrich), and immunostained with mouse monoclonal anti–
E-cadherin, anti–a-catenin, or anti–p120-catenin antibodies
(BD Biosciences–Transduction Laboratories) or with rabbit
polyclonal anti–b-catenin (Sigma-Aldrich) or anti-CagA (Santa
Cruz Biotechnology) antibodies. Rabbit anti-mouse or swine
anti-rabbit–fluorescein isothiocyanate conjugate (Amersham)
and goat anti–mouse-Alexa488 or anti–rabbit-Alexa594 con-
jugate were used as secondary antibodies (Molecular Probes).
A Leica DMRE2 fluorescence microscope or a SP2-SE-AOBS
laser-scanning confocal microscope (Leica Microsystems) were
used. Confocal images were deconvolved with Huygens Pro3.2
(SVI).
Aggregation assays. Cells were trypsinized, resuspended as
single cells, and added to 96-well agar-coated plates. As control
for E-cadherin–mediated aggregation, AGSEcad cells were in-
cubated for 48 h with an anti–E-cadherin antibody (MB2). The
ability of cells to aggregate or persist as a single-cell suspension
was evaluated microscopically.
Bacterial strains and growth conditions. Bacteria were
grown in tryptic soy agar supplemented with 5% sheep blood
(BioMe´rieux) and were incubated for 48 h at 37C under a mi-
croaerophilic atmosphere. Experiments were performed with
H. pylori strain 26695 (ATCC 700392; cag PAI+), 60190 (ATCC
49503; cag PAI+), or an insertion mutant for cagA (60190
CagA).
Infection of gastric cells. Eighty percent confluent mon-
olayers were washed in phosphate-buffered saline and were
incubated in serum and antibiotic-free medium (Invitrogen).
H. pylori was added at a multiplicity of infection of 100. Cul-
tures were maintained at 37C under a 5% carbon dioxide
atmosphere.
Invasion assays. Twenty-four–well Matrigel-coated inva-
sion inserts of 8 mm pore-size filters (BD Biosciences) were
incubated for 1 h at 37C with antibiotic-free medium. After
rehydration, cells were incubated for 24 h at 37C on45 10
top of the filters, in the presence or absence of H. pylori. Fil-
ters were washed, fixed in 4% paraformaldehyde, and mount-
ed in Vectashield with 4′-6-diamidino-2-phenylindole (Vector
Laboratories). Invasive cells were scored in at least 25 micro-
scopic fields (20 objective).
Preparation of cell lysates and immunoprecipitation. Cells
were lysed in 20 mmol/L Tris-hydrochloride (pH, 7.5), 150
mmol/L sodium chloride, 1% Triton X-100, 1% NP-40, 3
mmol/L sodium vanadate, 20 mmol/L sodium fluoride, 1
mmol/L phenylmethylsulphonyl fluoride, 10 mg/mL aprotinin,
and 10 mg/mL leupeptin. Seven hundred fifty micrograms of
proteins were incubated overnight at 4C with mouse mono-
clonal antiphosphotyrosine, anti–E-cadherin, anti–p120-ca-
tenin, or anti–c-Met antibodies. Immunoprecipitated com-
plexes were incubated for 1 h with protein G-sepharose beads
(Amersham), which were washed and pre-incubated in 1%
bovine serum albumin solution. Proteins were separated by
sodium dodecyl sulfate polyacrylamide gel electrophoresis.
Immunoblot analysis. Proteins were transferred onto Hy-
bond nitrocellulose membranes (Amersham), blocked with 4%
bovine serum albumin (phosphorylated proteins) or 5% nonfat
milk in phosphate-buffered saline plus 0.5% Tween-20 (overall
protein), and incubated for 1 h with mouse monoclonal anti–
E-cadherin, anti–p120-catenin, anti-CagA, or rabbit polyclonal
anti–c-Met antibodies (Santa Cruz Biotechnology). Goat anti-
rabbit (Santa Cruz Biotechnology) or rabbit anti-mouse (Amer-
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Figure 1. The E-cadherin–catenin complex suppresses Helicobacter pylori–mediated cell-invasive phenotype. A, Invasion assays of AGS, IPA220,
and NCI-N87 cells infected or not infected for 24 h with H. pylori on Matrigel-coated filters. Graphics represent the mean value of invasion
deviation and are representative of 3 independent experiments. B, E-cadherin staining of IPA220 and NCI-N87 cells. Nuclei were counterstainedstandard
with 4′-6-diamidino-2-phenylindole. Scale bar represents 100 mm. C, Western blot for E-cadherin of AGS cells and of AGS cells stably transduced
with human E-cadherin (AGSEcad). a-Tubulin immunostaining was used as loading control. *Significantly different from uninfected cells.
sham) HRP-conjugated secondary antibodies were used; sub-
sequently, ECL detection (Amersham) was performed.
Small interference RNA (siRNA) transfer. siRNA targeting
c-Met, previously tested for knockdown efficiency, were from
Qiagen. Nonsilencing siRNA duplexes were used as negative
control. Fifty percent confluent monolayers were washed and
incubated in serum- and antibiotic-free medium and were tran-
siently transfected with 80 nmol/L or 100 nmol/L of siRNA for
AGSEcad and NCI-N87, respectively, with use of Lipofectamine
2000 (Invitrogen).
Statistical analysis. Data were analyzed using Student’s t
test and were expressed as mean values of at least 3 independent
deviations. Differences were consid-experiments standard
ered to be statistically significant at .P ! .05
RESULTS
Cells expressing a functional E-cadherin–catenin complex are
not responsive to H. pylori–induced cell invasion. We pre-
viously reported that H. pylori induces an invasive phenotype
of AGS cells into extracellular matrix components through a
mechanism that requires the T4SS and the phosphorylation of
the c-Met receptor [25]. Because the E-cadherin–catenin com-
plex functions as an invasion suppressor [27, 28], we investi-
gated whether the complex has a role in H. pylori–mediated
cell-invasive phenotype. For that, the human gastric carcinoma
cells AGS, IPA220, and NCI-N87 were confronted with H. pylori
on Matrigel invasion assays. We observed that, in contrast to
AGS cells, which acquired an invasive phenotype in response
to H. pylori, cell lines IPA220 and NCI-N87 were significantly
less responsive to H. pylori (figure 1A). From the panel of gastric
cell lines tested, IPA220 and NCI-N87 cells have an intact E-
cadherin–catenin complex (figure 1B), whereas AGS cells har-
bor an E-cadherin mutation, leading to a truncated form of
the protein that is not expressed (C.O., personal communi-
cation) (figures 1C and 2A). These results point to a role of
the E-cadherin–catenin complex in the inhibition of H. py-
lori–mediated invasion.
AGS cells expressing E-cadherin assemble a functional E-
cadherin–catenin complex. To investigate the role of E-cad-
herin in H. pylori–mediated invasive phenotype, we stably
transduced AGS cells with E-cadherin. Before transduction, we
confirmed by Western blot and immunocytochemistry that
AGS cells do not express E-cadherin (figures 1C and 2A). AGS
were stably transduced using a lentivirus transduction system
with human E-cadherin cDNA. For clone selection, transduced
cells were grown in medium with blasticidin, and each clone
 at U
niversidade do Porto on O
ctober 9, 2012
http://jid.oxfordjournals.org/
D
ow
nloaded from
 
748 • JID 2009:200 (1 September) • Oliveira et al
Figure 2. AGS cells stably expressing E-cadherin assemble a functional
E-cadherin–catenin complex. A, E-cadherin (cad) or b-, a-, or p120-catenin
(ctn) of AGS and AGSEcad cells. Nuclei were counterstained with 4′-6-
diamidino-2-phenylindole. Scale bar represents 50 mm. B, Aggregation
assay of AGS, AGSEcad, and AGSEcad cells cultured with an anti–E-
cadherin antibody (AGSEcad+MB2). Scale bar represents 100 mm. Figures
are representative of 3 independent experiments.
was characterized by Western blot and immunocytochemistry
for E-cadherin expression (figures 1C and 2A). Only clones
with a homogeneous expression of E-cadherin at the cell
membrane were selected. To exclude clonal dependency, all
experiments reported were performed with 2 distinct clones
(clones 1a and 4b). Immunocytochemistry of the E-cadherin–
transduced AGS cells (AGSEcad) showed E-cadherin and b-,
a-, and p120-catenins mostly located at the cell membrane in
a honeycomb-like pattern (figure 2A), which suggests that E-
cadherin recruits b-, a-, and p120-catenin to this site to form
an adhesion complex.
To elucidate the functionality of the E-cadherin–catenin
complex, we performed an aggregation assay that evaluates the
ability of cells to aggregate in an E-cadherin–dependent man-
ner. Our results provide evidence that AGS cells that do not
express E-cadherin are not able to aggregate but remain as single
cells (figure 2B). In contrast, AGSEcad cells form small aggre-
gates, suggesting the presence of a functional E-cadherin–ca-
tenin complex. The fact that these cells are no longer able to
aggregate in the presence of an antibody inhibiting E-cadherin–
mediated cell-cell adhesion confirms that the E-cadherin–ca-
tenin complex of AGSEcad cells is functional. These experi-
ments demonstrate that, in AGS transduced with E-cadherin,
b-, a-, and p120-catenins are recruited to the membrane, where
they assemble a functional adhesion complex.
E-cadherin counteracts H. pylori–mediated cell-invasive
phenotype and H. pylori–mediated c-Met and p120-catenin
tyrosine phosphorylation. To investigate whether E-cadherin
was sufficient to inhibit H. pylori-mediated invasive phenotype,
AGS, AGSEcad, and NCI-N87 cells were infected with H. pylori
strains 26695 and 60190 and were used in Matrigel invasion
assays. After infection, AGSEcad cells display significantly lower
levels of invasion than do AGS cells (figure 3A). Similar results
were obtained in infected NCI-N87 cells that endogenously
express E-cadherin, suggesting that E-cadherin expression is
sufficient to suppress H. pylori–mediated invasive phenotype.
Because the invasive phenotype induced by H. pylori in AGS
cells requires c-Met phosphorylation [25], we investigated the
effect of E-cadherin on the phosphorylation status of this re-
ceptor on infection. In addition, because p120-catenin tyrosine
phosphorylation is modulated by E-cadherin [29], we also in-
vestigated the phosphorylation status of p120-catenin. There-
fore, lysates of H. pylori–infected AGS and AGSEcad cells were
immunoprecipitated with an antibody recognizing tyrosine-
phosphorylated residues and were immunoblotted with anti–
c-Met and anti–p120-catenin antibodies (figure 3B). The ex-
pression of c-Met and of p120-catenin is not altered by H.
pylori in any of the cell lines. In AGS cells, H. pylori increases
the phosphorylation level of c-Met and p120-catenin. In con-
trast, in AGSEcad cells, H. pylori decreases the phosphorylation
levels of both proteins. These results were further confirmed
in the NCI-N87 cell line, where tyrosine phosphorylation levels
of c-Met and p120-catenin decreased after infection (figure 3B).
Overall, these results suggest that E-cadherin suppresses H. py-
lori–mediated phosphorylation of c-Met and of p120-catenin.
H. pylori affects the localization of elements of the E-cad-
herin–catenin complex. Using confocal microscopy, we also
analyzed the localization of the elements of the E-cadherin–
catenin complex after infection. One hour after infection with
H. pylori, we observed an increase in the intensity of membrane
staining of E-cadherin and of p120-catenin (figure 4A) and in
the nuclear levels of b-catenin (data not shown). No differences
in a-catenin were observed.
Because CagA localizes to the inner surface of the plasma
membrane after injection [9] and the membrane staining of
E-cadherin and p120-catenin increased after infection (figure
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Figure 3. E-cadherin counteracts Helicobacter pylori–mediated cell-invasive phenotype, c-Met, and p120-catenin tyrosine phosphorylation. A, AGS,
AGSEcad, and NCI-N87 cells infected or not infected for 24 h with H. pylori strain 26695 or 60190 on Matrigel-coated filters. Graphics represent the
mean value of deviation and are representative of 3 independent experiments. B, Western blot analysis of AGS, AGSEcad, andinvasion standard
NCI-N87 cells infected with H. pylori for 1 h. Total cell lysates were immunoprecipitated with an antibody against tyrosine-phosphorylated residues
(IP:PY-20) and immunostained with anti–c-Met (WB:c-Met) or anti-p120-catenin (WB:p120ctn) antibodies. In parallel, total cell lysates were immunostained
with the same antibodies to control differences of expression. a-tubulin immunostaining was used as loading control. Graphics represent the variation
in c-Met and p120-catenin tyrosine phosphorylation in comparison with the endogenous phosphorylation levels of uninfected cells. Data correspond
to the mean deviation and are representative of 3 independent experiments. *Significantly different from uninfected cells; **Sig-values standard
nificantly different from infected AGS cells.
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Figure 4. Helicobacter pylori affects the localization of elements of
the E-cadherin–catenin complex. A, AGSEcad monolayers were infected
with H. pylori for 1 or 6 h. After fixation, monolayers were stained with
antibodies specific for E-cadherin (Ecad) or p120- or a-catenins (ctn;
green). Nuclei were counterstained with 4′-6-diamidino-2-phenylindole
(red). Scale bar represents 40 mm. Images are representative of 3 in-
dependent experiments. B, AGSEcad monolayers infected with H. pylori
for 1 h were double immunostained for Ecad (green) and CagA (red) or
p120ctn (green) and CagA (red). Immunostainings were also performed
using a CagA isotype antibody as control. Xz or yz sections for both
channels or for each channel apart are shown in more detail below each
panel. Arrowheads indicate areas of colocalization. Images were obtained
with a confocal microscope and are representative of 2 independent
experiments. Scale bar represents 10 mm.
4A), we investigated putative colocalization between CagA and
these E-cadherin–catenin complex elements. Analysis of the xz
and yz confocal sections suggest that, after 1 h of infection of
AGSEcad cells, CagA partially colocalizes with E-cadherin and
with p120-catenin. An immunofluorescent signal correspond-
ing to CagA was also visualized in areas negative for p120-
catenin and E-cadherin (figure 4B). Specificity of the immu-
nostaining was confirmed with nonimmunizing immunoglob-
ulin G (IgG) of the same isotype.
H. pylori CagA interacts with E-cadherin and with p120-
catenin. Because H. pylori CagA interacts and colocalizes with
elements of the E-cadherin–catenin complex, we investigated
the role of H. pylori virulence protein CagA in this interaction.
Therefore, lysates of H. pylori–infected AGSEcad cells were im-
munoprecipitated with anti–E-cadherin or anti-p120 catenin
antibodies and were immunoblotted with an anti-CagA anti-
body. We observed that CagA co-immunoprecipitates with E-
cadherin, and of interest, we also observed that CagA co-im-
munoprecipitates with p120-catenin (figure 5A). Immuno-
precipitation with nonimmunizing IgGs of the same isotype
confirmed the specificity of such interactions. Likewise, in
NCI-N87 cells, CagA co-imunoprecipitates with E-cadherin
and also with p120-catenin (figure 5A). Furthermore, in the
presence of bacteria in both AGSEcad and NCI-N87 cells, the
binding between E-cadherin and p120-catenin is enhanced (fig-
ure 5B and 5C). No differences were observed in the interaction
between b-catenin and a-catenin. Thus far, our results indicate
that, after infection, H. pylori CagA binds to elements of the
E-cadherin–catenin complex.
The interactions established between CagA and E-cadherin
and between CagA and p120-catenin are mediated by c-Met.
Because CagA targets the c-Met receptor, inducing its phos-
phorylation and activating downstream effector molecules [12],
we examined whether the interactions between CagA and E-
cadherin and between CagA and p120-catenin occurred down-
stream c-Met. Co-immunoprecipitation studies of H. pylori–
infected AGSEcad cells confirmed that CagA interacts with c-
Met (figure 5A), as described elsewhere [12]. Of interest, in-
teractions established between c-Met and E-cadherin and be-
tween c-Met and p120-catenin are enhanced after infection with
H. pylori 26695 and 60190 (figure 6A and 6B). In agreement
with these observations, in H. pylori–infected NCI-N87 cells,
increased binding of c-Met and E-cadherin and of c-Met and
p120-catenin was also observed (figure 6A). When we infected
cells with a cagA mutant strain (60190CagA), there was a
decrease in interactions between c-Met and E-cadherin but not
in interactions between c-Met and p120-catenin (figure 6B);
this suggests that CagA plays a role in the formation of the
interaction between c-Met and E-cadherin.
Studies with siRNA targeting c-Met did not affect the ex-
pression of p120-catenin and, as expected, abolished the in-
teractions between c-Met and p120-catenin (figure 6C and 6D)
and those between c-Met and E-cadherin (data not shown). Of
note, silencing of c-Met abolished the interactions between
CagA and p120-catenin and also between CagA and E-cadherin
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Figure 5. Helicobacter pylori CagA interacts with E-cadherin (Ecad), p120-catenin (ctn), and c-Met. A, AGSEcad and NCI-N87 cells were infected
with H. pylori for 1 h. Cell lysates were immunoprecipitated with anti-Ecad, anti-p120ctn or anti-c-Met antibodies and were used for Western blot
(WB) to be immunostained with an anti-CagA antibody. Immunoprecipitation (IP) was also performed with the same isotype control immunoglobulin
G. Immunoblots were restained for Ecad or p120ctn as loading controls. B, AGSEcad cells were infected with H. pylori for 1 h. Cell lysates were
immunoprecipitated with anti-Ecad, anti-p120ctn, or anti-b-ctn antibodies and were used for WB to be immunostained with anti-p120ctn, anti-Ecad,
and anti-actn antibodies. Immunoblots were restained for p120- or b-ctns as loading controls. C, NCI-N87 cells were infected with H. pylori for 1 h.
Cell lysates were immunoprecipitated with anti-Ecad or anti-p120ctn antibodies and were used for WB to be immunostained with the same antibodies.
Immunoblot was restained for Ecad as loading control. Graphics represent the variation in protein co-IP in comparison with the endogenous levels of
uninfected cells. Data correspond to the mean deviation and are representative of 3 independent experiments. *Significantly differentvalues standard
from uninfected cells.
(figure 6D). These results suggest that interactions established
between CagA and E-cadherin and between CagA and p120-
catenin are c-Met dependent.
Altogether, our results evidence that H. pylori alters the lo-
calization of elements of the E-cadherin–catenin complex, lead-
ing to formation of a multiproteic complex composed by CagA,
c-Met, E-cadherin, and p120-catenin. The formation of this
complex impairs c-Met and p120-catenin tyrosine phospho-
rylation and suppresses the invasive phenotype induced by H.
pylori.
DISCUSSION
In the present study, we demonstrated that E-cadherin is suf-
ficient to suppress H. pylori–mediated cell invasion. We pre-
viously showed that H. pylori induces an invasive phenotype
of AGS cells into extracellular matrix components [25]. In cell
lines containing an intact E-cadherin–catenin complex, H. py-
lori induced lower levels or no invasion. By using 2 clones from
an E-cadherin stably transduced cell line (AGSEcad), in which
a functional E-cadherin–catenin complex was established, we
have shown that E-cadherin is sufficient to suppress the invasive
phenotype induced by H. pylori.
Induction of AGS-invasive phenotype by H. pylori involves
c-Met tyrosine phosphorylation, as we described elsewhere [25].
In contrast, in E-cadherin–catenin functional cell lines, H. pylori
decreased the phosphorylation levels of c-Met. Also, depending
on the E-cadherin status, infection with H. pylori has different
affects on the tyrosine phosphorylation of p120-catenin. In cells
 at U
niversidade do Porto on O
ctober 9, 2012
http://jid.oxfordjournals.org/
D
ow
nloaded from
 
Figure 6. The interaction established between CagA, E-cadherin (Ecad), and p120-catenin (ctn) is mediated by c-Met. A, AGSEcad and NCI-N87
cells were infected with Helicobacter pylori for 1 h, and cell lysates were immunoprecipitated with anti-Ecad or anti-p120ctn antibodies and used for
Western blot (WB) to be immunostained with an anti–c-Met antibody. a-Tubulin was used as a loading control. Graphics represent the variation in
protein co-immunoprecipitation (IP) in comparison with the endogenous levels of uninfected cells. Data correspond to the mean value standard
deviation and are representative of 3 independent experiments. B, AGSEcad cells were infected with H. pylori strain 60190 and with its cagA mutant
(60190CagA-) for 1 h. Cell lysates were immunoprecipitated with anti-Ecad or anti-p120ctn antibodies and used for WB to be immunostained with
an anti–c-Met antibody. Anti–c-Met and anti–a-tubulin antibodies were used as loading controls. C, AGSEcad cells were transiently transfected with
small interfering RNA (siRNA) directed to c-Met. The effect of transfection on c-Met, p120-ctn, and a-tubulin expression was evaluated by WB with
specific antibodies. D, AGSEcad and NCI-N87 cells transfected or not transfected with c-Met siRNA were infected with H. pylori for 1 h. Cell lysates
were immunoprecipitated with anti-p120ctn and anti-Ecad antibodies and used on WB to be immunostained with anti–c-Met and anti-CagA antibodies.
Data are representative of 2 independent experiments. Lip, lipofectamine; nS, nonsilencing siRNA.
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Figure 7. Hypothetical model of Helicobacter pylori CagA, c-Met, E-cadherin (E-cad), and p120-catenin interactions. A, In E-cad–negative cells, H.
pylori CagA leads to an increase in the phosporylation levels of both c-Met and p120-catenin and to an invasive phenotype of cells. B, In cells with
an intact E-cad–catenin complex H. pylori infection leads to enhanced interactions between c-Met and E-cad, c-Met and p120-catenin, and E-cad and
p120-catenin. In these cells, CagA binds to c-Met, and this complex then interacts with the E-cad–catenin complex, suppressing H. pylori–mediated
c-Met and p120-catenin phosphorylation and cell-invasive phenotype. C, c-Met is a crucial molecule in the establishment of the multiproteic complex.
lacking E-cadherin expression, H. pylori induced p120-catenin
phosphorylation, whereas in cells expressing E-cadherin, H.
pylori led to reduced p120-catenin phosphorylation. Taken to-
gether, our data point to a role for E-cadherin in the suppres-
sion of H. pylori–induced c-Met and p120-catenin phospory-
lation and, consequently, in the suppression of the cell-invasive
phenotype.
c-Met is a receptor tyrosine kinase with a well-documented
participation in cell invasion [30–32]. Phosphorylation of ty-
rosine residues at the c-Met receptor intracellular domains re-
sults in the phosphorylation and binding of adaptor proteins
and activation of signal transducers, eventually leading to cell
invasion [32]. p120-Catenin interacts with the cytoplasmic jux-
tamembrane domain of E-cadherin [33], and this interaction
and the phosphorylation status of p120-catenin play an im-
portant role in the stabilization of E-cadherin [14, 34]. Phos-
phorylation of p120-catenin promotes its dissociation from E-
cadherin and its translocation to the cytoplasm or nucleus,
where it participates in many signaling events [35]. Endogenous
p120-catenin is described to promote migration and invasive-
ness of E-cadherin–deficient cells [34]. Our findings are in
agreement with other experimental models in which re-estab-
lishment of E-cadherin function in E-cadherin–deficient cell
lines reversed the invasive phenotype, pointing to a role for E-
cadherin as a suppressor of cell invasion [26–28]. The present
study constitutes, to our knowledge, the first experimental evi-
dence implicating E-cadherin as a suppressor of bacterial-me-
diated cell-invasive phenotype.
In our experimental model, in both AGSEcad and NCI-N87
cells, E-cadherin expression levels were not altered by H. pylori,
and this is concordant with previously published data in in
vitro models [36, 37]. Although there is one description of an
association between H. pylori infection and downregulation of
E-cadherin expression [38], our findings are also in accordance
with those of the vast majority of the studies performed using
gastric biopsy specimens that show no association between the
2 events [36, 39–41]. In line with the observations of others,
we found that H. pylori infection also did not affect the ex-
pression levels of p120-, b-, or a-catenins [36, 42]. Although
no differences were observed in the expression of these mol-
ecules, H. pylori infection led to increased intensity in mem-
brane staining of E-cadherin and of p120-catenin, as well as
increased nuclear translocation of b-catenin. These experimen-
tal results concur with results of earlier research indicating in-
creased nuclear levels of b-catenin after infection [24]. In keep-
ing with increased intensity in E-cadherin and p120-catenin
membrane staining is the experimental evidence from our im-
munoprecipitation studies, which revealed enhanced binding
of E-cadherin and p120-catenin after infection, suggesting that
H. pylori alters the organization of the E-cadherin–catenin
complex.
One of the known effectors of H. pylori T4SS is CagA. CagA
is injected into the host cell cytoplasm and localizes to the inner
surface of the plasma membrane [9]. Our confocal immuno-
stainings pointed to colocalization between CagA and E-cad-
herin and, most interestingly, to colocalization of CagA and
p120-catenin at the cell membrane. The immunoprecipitation
assays using in vitro infection revealed that CagA indeed phys-
ically interacts with E-cadherin, c-Met, and p120-catenin. The
finding that CagA interacts with E-cadherin is in agreement
with the work of Murata-Kamiya et al [11], who reported that,
in CagA-transfected cells, CagA interacts with E-cadherin, de-
stabilizing the binding of E-cadherin and b-catenin. Our find-
ings also confirm previous observations of interaction between
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CagA and c-Met [12] and add novelty to the field by showing
interaction between CagA and p120-catenin.
Another interesting observation in this study was that, after
H. pylori infection, interactions between c-Met and E-cadherin
and between c-Met and p120-catenin were enhanced. Taken
together with the CagA interactions results, these observations
suggest that CagA, E-cadherin, p120-catenin, and c-Met inter-
act with each other, possibly forming a multiproteic complex.
Furthermore, experiments with siRNA targeting c-Met revealed
that, in the absence of c-Met, CagA was no longer able to
interact with E-cadherin nor with p120-catenin, suggesting that
interactions of CagA with the 2 elements of the E-cadherin–
catenin complex occur via c-Met.
Our hypothesis is that, after infection, injected CagA inter-
acts with c-Met, and this complex then interacts with the E-
cadherin–catenin complex, leading to the formation of a multi-
proteic complex (figure 7). This model is supported by our co-
immunoprecipitation and siRNA results and might explain the
reorganization of the E-cadherin–catenin complex observed by
immunocytochemistry. Additional studies should be performed
to elucidate how these 4 molecules interact within the multi-
proteic complex. There is now increasing evidence that E-cad-
herin participates in and regulates several signaling pathways
via its extracellular domain [43]. The extracellular domain of
E-cadherin establishes not only homophilic but also hetero-
philic interactions with tyrosine kinase receptors such as c-Met
[16–18]. It may be possible that the interaction between c-Met
and E-cadherin is established via their extracelullar domain and
that H. pylori CagA interacts with both E-cadherin and p120-
catenin via c-Met.
In conclusion, we suggest that H. pylori infection leads to
formation of a multiproteic complex composed of CagA, c-
Met, E-cadherin, and p120-catenin. The formation of this com-
plex impairs c-Met and p120-catenin tyrosine phosphorylation
and suppresses the invasive phenotype induced byH. pylori.
However, in the absence of E-cadherin, H. pylori infection as-
sociates with an increased ability of the cells to invade. We do
not think that the invasive phenotype observed in our in vitro
cell model overlaps with tumor cell invasion, as observed during
tumor progression in vivo. The latter is the result of a multistage
process involving other events in addition to E-cadherin im-
pairment; in fact it is arguable whether H. pylori would play a
role in tumor invasion, because often, H. pylori is not present
in full-blown gastric carcinoma. Instead, H. pylori infection
might play an important role in selecting for survival gastric
epithelial cells harboring E-cadherin inactivation (genetic or
epigenetic) that would otherwise undergo apoptosis before ac-
tual tumor progression occurs. In other words, E-cadherin in-
activation is an initiator event, whereas H. pylori infection works
as a tumor promoter. As such, H. pylori infection would in-
crease the likelihood of E-cadherin–deficient cell lineage sur-
vival and further accumulation of oncogenic events in a process
that, in the early phase, becomes H. pylori independent.
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Abstract 
Mucosal epithelia are targeted by several microorganisms as a way of adhesion, 
internalization, and/or exploitation of the host properties to induce disease. 
Helicobacter pylori are worldwide prevalent bacteria that colonize the human stomach. 
Persistent infection of the gastric mucosa with H. pylori and concurrent chronic gastritis 
induced by the bacterium are risk factors for gastric carcinoma. The interactions at the 
H. pylori-epithelial interface are important to understand the pathogenesis of these 
bacteria and the host responses that contribute to carcinogenesis. Here, we provide an 
overview of the interactions between H. pylori and proteins of the adherens junctions 
and discuss the potential role of those interactions in gastric carcinoma development. 
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Epithelial cell-cell junctions 
Mucosal epithelia establish an interface between the external environment and the 
internal organs. They are physical and functional barriers that prevent external 
elements, like microorganisms, to reach the interstitial space and the blood stream. 
This is mainly accomplished by the existence of cell-cell junctions – tight junctions, 
adherens junctions, desmosomes, and gap junctions – which are essential components 
of epithelial integrity (57, 93). 
The tight junctions are the most apical set of cell-cell junctions that separate the apical 
and the basolateral domains of the plasma membrane, and selectively regulate the 
paracellular flux of ions and small molecules (5). They are composed of 
transmembrane proteins occludin, claudins, and junctional adhesion molecules (JAMs), 
and cytosolic proteins, zona ocludens (ZO)-1, -2, and 3, that bridge transmembrane 
proteins with the cytoskeleton (92). 
Adherens junctions are localized immediately below tight junctions and their main 
function is to maintain cell-cell adhesion. The major component of the adherens 
junctions is the transmembrane protein E-cadherin. The extracellular part of E-cadherin 
establishes homophilic interactions with E-cadherin molecules of neighboring cells, 
promoting cohesion of the epithelium. E-cadherin may also establish heterophilic 
interactions, namely with the receptor tyrosine kinases EGFR and c-Met (32, 33, 52, 
76), modulating their signaling properties. The cytoplasmic domain of E-cadherin is 
associated with β-, p120-, and α-catenins, and the latter establishes a connection 
between E-cadherin and the actin cytoskeleton. These protein-protein interactions, as 
well as the phosphorylation status of the catenins, are important in junction stabilization 
(77, 106). 
Desmosomes provide mechanical stability and intercellular communication to 
neighboring cells. They are composed by transmembrane desmoglein and desmocollin 
cadherins, which bind cytoplasmatic plakoglobin and plakophilin, which in turn bind to 
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desmoplakin. The latter anchors intermediate filaments, which establish a mechanical 
continuum across cells (40, 54, 66). Gap junctions are formed channels constituted by 
connexins, that allow intercellular passage of ions and small molecules. In addition, 
gap junctions also have a role in regulating cell morphology, establishing polarity, and 
rearrangement of the cytoskeleton (53).  
 
Adherens junctions as targets of microorganisms 
Disruption of the intercellular junctions is a strategy used by several microorganisms as 
a means of adhering to, entering cells, and/or exploiting host signaling to their 
advantage. Although the first line of defense against infectious agents in mucosal 
epithelia are tight junctions, microorganisms also explore cell-cell junctions at levels 
below the tight junctions. Indeed, E-cadherin is used as a receptor for adhesion and/or 
internalization by several microorganisms, allowing microbial persistence in the host, 
avoidance of mechanical clearance, and increased pathogenesis. 
The best example of the use of E-cadherin for adhesion and internalization is the 
Gram-positive food-borne pathogen Listeria monocytogenes. L. monocytogenes has 
the ability to induce its internalization into non-phagocytic cells and to cross the 
intestinal, placental and blood-brain barriers (11). L. monocytogenes utilizes cell wall 
surface internalins A (InlA) and B (InlB) to promote adherence and internalization into 
host cells (55). InlA specifically interacts with E-cadherin and recruits α-, β- and p120-
catenins, as well as actin, to the site of bacterial entry (47, 48). 
The Als3 adhesin of the opportunistic fungus Candida albicans mimics host cell 
cadherins and induces fungal endocytosis by adhering to N-cadherin on endothelial 
cells and E-cadherin on oral epithelial cells (73). This mechanism is important for 
hematogenously disseminated and oropharyngeal candidiasis, characterized by fungal 
invasion of host cells. 
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Streptococcus pneumoniae adheres to the epithelial cell surface in the first steps of 
nasopharyngeal carriage and colonization, and E-cadherin has been identified as a 
receptor for the pneumococcal surface adhesin A (PsaA) (3). 
E-cadherin has also been reported as a target of bacterial proteases. E-cadherin 
cleavage leads to weaker cell-cell adhesion which may allow access of the 
microorganisms to the intercellular epithelial spaces and to the tissues underlying 
epithelia. 
Enterotoxigenic Bacteroides fragilis produce a toxin named fragilysin or BFT, which 
specifically cleaves the extracellular domain of E-cadherin on intestinal and other 
polarized epithelial cells, resulting in junction disassembly (101). E-cadherin cleavage 
by BFT releases β-catenin to the cytoplasm, resulting in β-catenin nuclear localization 
and stimulation of β-catenin-TCF-dependent cell proliferation (102). This BFT-mediated 
extracellular domain cleavage of E-cadherin also induces proteolysis of intracellular E-
cadherin, in a process dependent on γ-secretase (103). 
Porphyromonas gingivalis, an etiological agent of human adult periodontitis, produces 
cysteine proteases termed gingipains, namely HRgpA, RgpB, and Kgp, which degrade 
E-cadherin. This process of disruption of the adherens junctions suggests that P. 
gingivalis can invade the underlying connective tissues via a paracellular pathway (41).  
Enterococcus faecalis are commensals of the mammalian gastrointestinal tract, which 
can cause opportunistic infections when they penetrate the gut barrier. The GelE 
metalloprotease from E. faecalis cleaves the extracellular domain of E-cadherin, and is 
implicated in the development of chronic intestinal inflammation by impairment of the 
epithelial barrier integrity. Mice that are susceptible to intestinal inflammation show 
significantly reduced levels of the extracellular domain of E-cadherin, which result from 
GelE-mediated proteolytic cleavage (83). 
The contact of C. albicans with oral and with intestinal epithelial cells induces E-
cadherin cleavage, both in the extracellular and in the intracellular domains, and γ-
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secretase is implicated in the latter cleavage event (27, 97). Interestingly, during the 
interaction of C. albicans with oral epithelial cells, E-cadherin is degraded only in 
localized areas of tissue invasion by the Sap5p secreted aspartyl-protease of the 
fungus (97). 
Staphylococcus aureus contributes to the pathogenesis of pneumonia by secreting α-
hemolysin (Hla). Hla induces injury in epithelial cells by interacting with its receptor, the 
zinc-dependent metalloprotease ADAM10. Hla upregulates ADAM10 metalloprotease 
activity in alveolar epithelial cells, resulting in cleavage of E-cadherin. E-cadherin 
cleavage is associated with disruption of epithelial barrier function, contributing to the 
pathogenesis of lethal acute lung injury (39). 
Additional mechanisms of pathogen-induced adherens junctions disruption that do not 
require E-cadherin cleavage have also been described. Clostridium botulinum 
produces the botulinum neurotoxin (BoNT), the etiological agent of botulism, which 
forms large protein complexes through associations with non-toxic components, such 
as hemagglutinin (HA). HA directly binds E-cadherin and disrupts E-cadherin-mediated 
cell-cell adhesion and the epithelial barrier, in a mechanism that does not include 
proteolysis of E-cadherin (86). 
Pseudomonas aeruginosa disrupts adherens junctions by altering the phosphorylation 
status of E-cadherin and β-catenin, which is paralleled by changes in the expression 
and distribution of these junctional proteins (96). 
 
Disruption of the adherens junctions by Helicobacter pylori 
Helicobacter pylori are spiral-shaped Gram-negative bacteria colonize the stomach of 
more than half of the world population (10, 58). H. pylori infection results in chronic 
gastritis in all infected individuals, a condition that persists during the host lifetime if the 
infection is not eradicated. Infection may also result in more severe clinical outcomes, 
such as peptic ulcer disease, mucosa-associated lymphoid tissue lymphoma, and 
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gastric carcinoma (85), and the diversity in virulence of H. pylori is an important factor 
in the infection outcome (18, 20, 50, 56, 80). 
One of the most important differences in virulence between H. pylori strains is the 
presence of the cag pathogenicity island, encoding a type IV secretion system (T4SS), 
which allows translocation of the bacterial effector CagA into the host cells (10). Inside 
the host cell, CagA may undergo tyrosine phosphorylation by host kinases (65, 81, 90), 
and both phosphorylated and non-phosphorylated CagA can activate multiple signaling 
pathways leading to cell proliferation, cytoskeletal rearrangements, and disruption of 
cell-cell junctions (2, 90). Individuals infected with CagA-positive strains have higher 
degrees of inflammation and epithelial damage in the stomach, and enhanced risk for 
peptic ulcer disease and gastric carcinoma, than those infected with CagA-negative 
strains (4, 17, 70), especially those infected with strains harboring high number of 
tyrosine phosphorylation sites in CagA (6, 7, 24). 
 
Several lines of evidence show that H. pylori interferes with cell-cell junctional 
complexes, although the importance of this phenomenon for gastric disease 
development is not fully understood. 
In the gastric mucosa, H. pylori can be found within the mucus layer, and in close 
contact with the epithelial cells, preferentially at the apical side of the intercellular 
contacts (31, 62, 91). The tropism of the bacteria for this localization may contribute to 
alterations to the structure and function of the tight junctions. Indeed, it has been 
shown that H. pylori infection of epithelial cells induces internalization of occludin and 
claudins, and increases myosin light chain phosphorylation, leading to tight junction 
relaxation and increased epithelial barrier permeability (23, 46, 100). Further, CagA 
interacts with ZO-1 and JAM-A, and recruits these proteins to the sites of bacteria 
attachment, altering the composition and function of the tight-junctional complex (2). 
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Although not so frequently described in the literature, it has also been observed that H. 
pylori reaches the intercellular spaces below the tight junctions, and even penetrates 
the epithelium towards the lamina propria in the basolateral side of the cells (62), 
showing that H. pylori is able to disrupt the adherens junctions. Interestingly, there are 
also reports demonstrating the presence of H. pylori inside the host cells, both in 
biopsies and in in vitro models (21, 22, 62, 63, 72, 84, 99). Whether this particular 
localization of H. pylori is related to use the adherens junctions as a means of 
internalization, as it has been shown for other microorganisms, remains to be 
elucidated. 
The known mechanisms underlying H. pylori-mediated adherens junctions disruption 
are diverse and directed towards different components of the complex. 
 
Helicobacter pylori and E-cadherin 
Studies have shown that H. pylori targets E-cadherin by several mechanisms. 
Promoter methylation of the CDH1 gene (encoding E-cadherin) is frequently observed 
in H. pylori-infected individuals (12, 49, 71). The importance of this epigenetic 
mechanism of gene silencing in the context of H. pylori infection is reinforced by 
studies showing that eradication of H. pylori reduces CDH1 promoter methylation levels 
(13, 49, 71). Although the molecular mechanisms through which H. pylori mediates E-
cadherin promoter methylation are not fully understood, Qian et al. have shown that 
CDH1 promoter methylation could be induced by infection with H. pylori or treatment of 
gastric cancer cell lines with interleukin-1β (IL-1β), a cytokine up-regulated in the 
context of H. pylori infection (75). This effect was inhibited by treatment with an 
interleukin-1 receptor antagonist (IL-1ra) antibody, suggesting that IL-1β may play a 
role in E-cadherin methylation (75). More recently, the same group has extended the 
study and showed that H. pylori- and IL-1β-mediated CDH1 promoter methylation, led 
to decreased E-cadherin expression and concomitant increase in DNA 
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methyltransferase activity (37). Nevertheless, other studies have failed to show a 
decrease in E-cadherin expression associated with H. pylori infection both in cell lines 
and in the gastric mucosa (8, 12, 15). Of note, no CDH1 mutations have been 
described associated to H. pylori infection. 
In addition to epigenetic silencing, H. pylori has been associated with other 
mechanisms of disturbance of E-cadherin functions, such as proteolytic cleavage of its 
extracellular domain (also known as ectodomain shedding), and protein delocalization 
from the cell membrane. 
Weidig et al. and Schirmeister et al. reported E-cadherin ectodomain shedding upon H. 
pylori infection in two different cell line models, the breast cancer MCF-7 and the 
gastric cancer NCI-N87 cells, respectively (79, 98). In both reports, ectodomain 
shedding of E-cadherin was neither dependent on H. pylori CagA nor on the presence 
of a functional T4SS. This finding is in keeping with a recent report showing that H. 
pylori-positive patients had significantly higher serum levels of soluble E-cadherin than 
uninfected controls, independently of the CagA status of the infecting strain (64). There 
is evidence that the host disintegrin metalloproteinase ADAM10 contributes to H. pylori-
induced shedding of E-cadherin in NCI-N87 cells, but since specific inhibition of 
ADAM10 led to a partial inhibition of E-cadherin shedding, it is possible that other 
proteases are also involved in this process (79). In fact, Hoy et al. have recently 
identified the high-temperature requirement A (HtrA), a serine protease from H. pylori, 
as a new secreted virulence factor which cleaves the ectodomain of the E-cadherin. E-
cadherin shedding by HtrA leads to epithelial barrier disruption and may allow H. pylori 
to access the intercellular spaces (35). HtrA-mediated E-cadherin cleavage may be a 
pathogenic mechanism of multiple Gram-negative bacteria, as is has recently been 
shown for pathogens such as enteropathogenic Escherichia coli, Shigella flexneri, and 
Campylobacter jejuni (34). 
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Studies have shown that H. pylori also induces E-cadherin translocation from the cell 
membrane to the cytoplasm (15, 79). Conlin et al. have demonstrated that H. pylori-
induced redistribution of E-cadherin to intracellular vesicles was accompanied by the 
translocation from the cytoplasm to intracellular tubular structures of IQGAP-1, a 
protein that regulates the formation of adherens junctions. The results of E-cadherin 
internalization mediated by H. pylori in the NCI-N87 gastric cell line were confirmed in 
primary gastric cells. After 48 hours of bacterial infection, the presence of a reduced 
level of E-cadherin at the cell membrane was demonstrated, mediating a reduced level 
of cell-cell adhesion. These alterations to epithelial cell adhesion molecules induced by 
H. pylori were paralleled by increased levels of Rho-GTP and cell migration (15). Using 
the human breast cancer MCF-7 cell line, Weidig et al. also reported internalization of 
E-cadherin upon H. pylori infection, simultaneously with E-cadherin cleavage (98). A 
rapid dissociation of the E-cadherin/β-catenin/p120 complex from the actin 
cytoskeleton was observed upon infection, by disruption of the interaction between E-
cadherin and α-catenin (98). 
Although E-cadherin alterations mediated by H. pylori are independent of CagA, 
physical interaction between these proteins has been described by two independent 
groups using different cell lines and methodologies (59, 69). Murata-Kamiya et al. used 
the gastric cancer cell line MKN28 transfected with CagA expression vectors, and 
showed that CagA was able to interact with E-cadherin. This led to β-catenin release 
from the adherens junctions and nuclear translocation, with transactivation of genes 
encoding intestinal specific proteins like MUC2, contributing to the development of 
intestinal metaplasia (59). This effect was independent of the CagA tyrosine 
phosphorylation status but dependent on a specific region of CagA known as the 
multimerization sequence (45). 
Using in vitro infection with live bacteria, Oliveira et al. showed that CagA interacts with 
E-cadherin, both in human gastric AGS cells transfected with wild type E-cadherin, and 
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in the NCI-N87 cell line that naturally establishes adherens junctions (69). Furthermore, 
and in parallel with CagA/E-cadherin interaction, interactions between p120 and CagA, 
and between c-Met and CagA were also observed after H. pylori infection, raising the 
possibility that the CagA/E-cadherin interaction might not be direct (69). In fact, 
silencing of c-Met in these cells abolished the interactions between CagA and E-
cadherin, and CagA and p120, suggesting that CagA interaction with elements of the 
adherens junctions is mediated by c-Met (69). The CagA, c-Met, E-cadherin, and p120 
multiproteic complex led to impairment of H. pylori-induced c-Met-mediated signaling 
and suppression of cell invasion (69). These findings are in agreement with previous 
observations in E-cadherin defective gastric cells in which H. pylori activated c-Met 
signaling (14, 68), and increased the activity of MMP2 and MMP9, leading to 
extracellular matrix degradation and subsequent cell invasion (68). 
 
Helicobacter pylori and β-catenin 
The binding of catenins to the intracellular domain of E-cadherin has a crucial role in 
the adherens junctional complex stabilization, connection to the cell cytoskeleton, and 
cell signaling. 
When not tethered at the membrane in the adherens junctions, β-catenin is 
phosphorylated by a multiproteic complex comprising the serine/threonine kinase 
glycogen synthase kinase 3β (GSK3β), and the scaffolding proteins adenomatous 
polyposis coli (APC), axin, and casein kinase 1α (Ck1α) and targeted to degradation 
via the ubiquitin/proteasome pathway (1, 29). This degradation pathway is 
counteracted when the Wnt pathway is active, resulting in β-catenin stabilization in the 
cytoplasm. Cytoplasmic stabilized β-catenin may be translocated into the nucleus 
where it forms a nuclear complex with the transcription factors of the T cell 
factor⁄lymphoid enhancer-binding factor (TCF/LEF) family, promoting the expression of 
a wide-range of genes important for carcinogenesis (9, 29, 51, 74). 
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Several studies have addressed the effect of H. pylori infection in β-catenin signaling 
and have shown that H. pylori leads to the delocalization of β-catenin from the cell 
membrane (8, 25, 26, 28, 38, 45, 59, 61, 82, 87, 88, 98). H. pylori phosphorylates and 
inactivates GSK3β (61, 82, 87, 89) and, by suppressing GSK3β activity H. pylori leads 
to inhibition of β-catenin phosphorylation and ubiquitin-dependent degradation (82). H. 
pylori-mediated GSK3β suppression occurs through activation of the 
phosphatidylinositol 3-kinase⁄protein kinase B (PI3K) ⁄ (Akt) signaling pathway via 
EGFR and c-Met receptor (60, 61, 82, 87, 89, 105). In one report however, β-catenin 
stabilization was described to occur in a phosphorylation-independent process (25). 
The canonical Wnt-signaling pathway appears to be involved in the regulation of β-
catenin in the context of H. pylori infection. In fact, it has been shown that after H. pylori 
infection there is increased synthesis of Wnt10A by the epithelial cells (43). 
Additionally, H. pylori-induced activation of β-catenin was shown to involve the 
phosphorylation of the Wnt pathway co-receptor low density lipoprotein receptor-
related protein LRP6 and proteins of the dishevelled family, namely Dvl2 and Dvl3 (28). 
Several studies report β-catenin translocation to the nucleus after H. pylori infection 
(25, 26, 28, 38, 59, 61, 82, 87, 88). There are however two studies in non-gastric cell 
lines that did not show nuclear translocation or activation of β-catenin signaling after 
infection (8, 67). β-catenin nuclear translocation induced by H. pylori leads to TCF/LEF-
dependent transcription of genes involved in carcinogenesis, including cyclin D1 (28, 
45, 59, 61, 82). This effect was shown to be CagA-dependent in the majority of studies 
(25, 38, 45, 59, 87, 88), with the exception of one study performed in a non-human, 
non-gastric cell line (82). Additional effectors of the T4SS, like peptidoglycan (60, 95), 
and other H. pylori virulence factors, such as the multifunctional toxin VacA (16, 61) 
and the outer membrane protein OipA (26, 104), may also be involved. The use of the 
Mongolian gerbil model has shown that H. pylori infection induces gastric carcinoma 
precursor lesions, with aberrant β-catenin expression, that led to transcriptional up-
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regulation of genes implicated in carcinogenesis. In this model-system, and in 
agreement with most of the cell-line models, aberrant β-catenin expression was 
associated with infection with H. pylori CagA-positive strains (25, 26). 
 
Helicobacter pylori and p120-catenin 
p120-catenin (p120) is another important component in adherens junctional complex 
stability and signaling (30). p120 binds to the juxtamembrane domain of E-cadherin 
(107), and mutations in this domain abolish E-cadherin-mediated cell-cell adhesion 
(42). In addition to E-cadherin stabilization, p120 can also interact with the transcription 
factor Kaiso (19, 78, 94). 
Two reports show that H. pylori alters the cellular localization and the phosphorylation 
status of p120, but not total p120 protein levels (44, 67). Krueger et al. showed that 
after six hours of infection of primary gastric epithelial cells, there was a recruitment of 
the non-phosphorylated p120 to perinuclear vesicles, whereas the fraction of 
phosphorylated p120 increased and could be detected in the nucleus, at the cell 
membrane, and at the leading edge of migrating cells (44). Those alterations were 
associated with elongation of cells and increased migration. Ogden et al. also showed 
nuclear translocation of p120 after H. pylori infection of MKN28 cells and of ex vivo 
mouse gastric glands. Nuclear translocation of p120 induced by H. pylori was 
associated with increased MMP-7 mRNA, and occurred by release of the MMP-7 
transcriptional repressor Kaiso. These changes were associated with reduced levels of 
p120 tyrosine phosphorylation, while total p120 remained unchanged (67). H. pylori-
mediated p120 nuclear translocation was dependent on factors of the T4SS, but 
independent of the T4SS effector CagA (67). 
 
Relevance of H. pylori-adherens junctions interactions for gastric carcinoma 
development 
14 
 
When addressing the issue of H. pylori infection in cell-cell junction dysfunction two 
main aspects should be taken into consideration. First, a lot of studies have been 
performed in cell line models, often non-human and non-gastric, and frequently cancer-
derived and with impaired cell-cell junctions. For example, the AGS and the MKN45 
cell lines harbor mutations in the E-cadherin gene (108). Also, genetic alterations in 
components of the Wnt signaling pathway are common in cell lines such as MKN7, 
MKN28 and HT29 (36, 108). In addition, in host cell lines-bacteria co-culture models, 
infections cannot easily be maintained for long time periods, making these models 
more close to acute that to chronic infections. 
Second, results obtained in cell lines do not match those observed in the gastric 
mucosa of H. pylori-infected patients. In particular, gastric biopsy specimens of patients 
with and without H. pylori infection do not show any relationship between the infection 
and changes in the expression or distribution of E-cadherin, β-catenin, or p120. This 
does not mean that it the phenomena observed in vitro do not occur in vivo, but may be 
explained if H. pylori-induced alterations in the adherens junctions are fast and 
transient and, therefore, not observable in fixed gastric tissues. Another possible 
explanation is that alterations in adherens junctions induced by H. pylori only occur in a 
subset of cells. These cells may then be selected as having growth advantages or 
increased resistance to apoptosis, therefore rendering them more susceptible to 
accumulation of DNA lesions which may lead to malignant transformation. 
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Table 1. Examples of infectious agents that target adherens junctions as a means to adhere, enter and/or exploit host cell signaling 
 
Species Virulence factor Mechanism of action Reference 
Listeria monocytogenes InlA Adhesion to E-cadherin and host cell invasion 12 
Streptococcus pneumoniae PsaA Adhesion to E-cadherin and host colonization 16 
Candida albicans Als3 Adhesion to E-cadherin and host cell invasion 15 
 Sap5p Extracellular and intracellular E-cadherin cleavage 23 
Bacteroides fragilis BFT Extracellular and intracellular E-cadherin cleavage 17, 18, 19 
Porphyromonas gingivalis HRgpA, RgpB, Kgp Extracellular E-cadherin cleavage 20 
Enterococcus faecalis GelE Extracellular E-cadherin cleavage 21 
Staphylococcus aureus Hla Extracellular E-cadherin cleavage via ADAM-10 24 
Clostridium botulinum BoNT E-cadherin, disrupting epithelial barrier 25 
Pseudomonas aeruginosa ? 
Alteration of phosphorylation status and delocalization of the adherens 
junctions proteins 
26 
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Hereditary diffuse gastric cancerE-cadherin and P-cadherin are major contributors to cell–cell adhesion in epithelial tissues, playing pivotal
roles in important morphogenetic and differentiation processes during development, and in maintaining in-
tegrity and homeostasis in adult tissues. It is now generally accepted that alterations in these two molecules
are observed during tumour progression of most carcinomas. Genetic or epigenetic alterations in E- and
P-cadherin-encoding genes (CDH1 and CDH3, respectively), or alterations in their proteins expression,
often result in tissue disorder, cellular de-differentiation, increased invasiveness of tumour cells and
ultimately in metastasis. In this review, we will discuss the major properties of E- and P-cadherin molecules,
its regulation in normal tissue, and their alterations and role in cancer, with a speciﬁc focus on gastric and
breast cancer models.
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Cadherin superfamily is mainly composed by 1) classical
cadherins, which are the major components of cell–cell adhesive
junctions; 2) non-classical cadherins, which include desmosomal
cadherins; and 3) protocadherins, which are implicated in neuronal
plasticity [1,2]. E- and P‐cadherins belong to the subfamily of classical/
type I cadherins that comprises only four members: the non-neuronal
epithelial (E-) and placental (P-) cadherins, and the neuronal neural
(N-) and retinal (R-) cadherins [3].
The epithelial-calcium dependent cell–cell adhesion is achieved
by the establishment of homophilic interactions between two
cadherin molecules of adjacent cells to form a homodimer [4,5]. E-
and P-cadherin mature proteins are organised in three major struc-
tural domains: a large extracellular domain, a single membrane-
spanning segment and a short cytoplasmic domain. The extracellular
domains are composed by 5 cadherin repeats (EC), which constitute a
key element for their classiﬁcation. These extracellular domains are
sequences of 110 residues, which are present only in cadherins,
commonly designated as EC1–EC5 [6]. The EC1 domain is the main
responsible for cadherins adhesive properties, which are organised
between cells in a zipper-like structure, a trademark of these proteins
[7]. The normal conformation of E- and P-cadherin molecules is only
stable in the presence of Ca2+ in the surrounding microenvironment,
whose binding with the extracellular portion of the polypeptide chain
is a prerequisite for cadherin mediated cell–cell adhesion. Calcium-
binding sites consist of short highly conserved aminoacid sequences
that are located between neighbouring EC repeats [8]. E- and
P-cadherin highly conserved cytoplasmic domain (ICD) consists of
approximately 150 aminoacids [9], interacting with β-, α-, and γ
(plakoglobin)-catenins (βctn, αctn, γctn) [8,10], forming a complex,
and being linked to the actin cytoskeleton through αctn [11]. Later,
the binding to p120-catenin (p120ctn) stabilises cadherins at the
cell membrane and promotes its correct function [12]. In Fig. 1, the
structure of human E- and P-cadherin gene and protein is represented,Fig. 1. Structure of the human CDH3 and CDH1 genes and the encoded P- and E-cadherin pr
structural similarities: both display an equal exon number (16) and a large intron after exon
large extracellular domain composed by 5 cadherin repeats (EC), a single membrane-span
cadherins interacts with actin cytoskeleton through a complex of proteins including p120-as well as the link with the actin cytoskeleton through catenins, esta-
blishing the cadherin–catenin complex. The stability of this complex is
required for providing normal cell–cell adhesion andhomeostatic tissue
architecture. Further, there is evidence that alterations in the adhesion
properties between cells endow them with an invasive and migratory
phenotype. Indeed, changes in the expression or function of cell–cell
adhesion molecules, such as E-and P-cadherin, have been implicated
in all steps of tumour progression, including detachment of tumour
cells from the primary site, intravasation into the blood stream, extrav-
asation into distant target organs, and formation of secondary lesions or
metastasis [13–15]. In this review, as ﬁrst topic, we describe the role of
bothmolecules in normal tissue homeostasis; however, alterations of E-
and P-cadherin associated to cancer are the major focus of this report.
2. E- and P-cadherin: gene structure, regulation and function
2.1. Gene structure
The genes encoding E- and P-cadherin, CDH1 and CDH3, are both
annotated to the human chromosome 16q22.1, being CDH3 32 kb up-
stream of CDH1 (Fig. 1A) [16]. Both genes harbour a 5′‐located CpG is-
land in their promoters [17,18]. The transcription start site (TSS) of
CDH1 is currently annotated at the coordinate 68,771,128 bp, where-
as the translation start site (ATG) is 194 bp downstream [19]. The ca-
nonical promoter of CDH1 starts at least 125 bp upstream of the TSS
and ends 27 bp downstream of it [20,21]. This area does not have a
TATA box, but includes several regulatory elements such as GC-
boxes, E-boxes (or E-pal box) and a CCAAT-box, all highly conserved
across mammals [21,22]. Interestingly, an Alu repeat (AluJo), that may
uncover putative new molecular mechanisms of gene regulation, is
found less than 500 bp upstream from the canonical ATG. Concerning
CDH3 gene, its TSS is currently annotated to the coordinate
68,678,739 bp on the forward strand and the ATG is found 553 bp
downstream of the TSS. The CDH3 promoter exhibits no TATA box,
as well as CDH1, but includes a CAAT box, two putative AP2-bindingoteins. (A) The CDH3 and CDH1 genes are located on chromosome 16q22.1 and exhibit
2. P- and E-cadherin mature proteins are organised in three major structural domains: a
ning segment (TM) and a short cytoplasmic domain. (B) The cytoplasmic domain of
, β- and α-catenins.
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of which highly conserved within the promoter sequence of
E-cadherin [20]. However, no sequence homologous to the palindromic
sequence E-pal, observed on the E-cadherin promoter, has been found
in the 5′ region of the P-cadherin gene [20]. Similarly to CDH1, an
AluJb repeat is found ~700 bp upstreamof the ATG, putatively enclosing
gene regulation or exonisation features [20,23].
Concerning the non-coding part of the CDH1 and CDH3 genes, the
intron 2 in both genes has more than 63 Kb and 30 kb in length, re-
spectively [24]. This large intron is a structurally conserved feature
across mammals, which may suggest the presence of common cis-
regulatory elements, yet to be described. In addition, EST and CAGE
annotations have shown interesting data, supporting new areas of
transcription within this large intron of the CDH1 gene [24–26]. As
CDH1, an interesting feature of CDH3 intron 2 is the presence of a pro-
moter associated regulatory feature, recalling the insulator element.
In addition, several EST and CAGE tags were also annotated within
this gene [19,25].
Ensembl database currently describes 4 transcripts arising from
the CDH1 gene locus [24]. Concerning CDH3, two transcripts are
currently annotated at its gene locus. In conclusion, CDH1 and CDH3
genes share a common genetic structure with several conserved
features and regulatory elements, yet to be described, within their
non-coding sequences.2.2. Transcriptional regulation
The control of E-cadherin epithelium-speciﬁc expression results
from the combined interplay of various proteins and regulatory ele-
ments. Through the binding sites located at CDH1 5′ sequence, Reti-
noblastoma (Rb), c-Myc and WT1 promote CDH1 activation [27].
Another positive CDH1 regulator is the hepatocyte nuclear factor-3
(HNF3) that synergises with AML-1 and p300 to stimulate
E-cadherin transcription [28]. At the same time, CDH1 can be nega-
tively regulated by the inactivation of the E-pal box, containing two
adjacent E-boxes in the promoter [29]. SNAIL was the ﬁrst identiﬁed
E-cadherin-speciﬁc transcriptional repressor interacting with this
E-pal element [30]. Slug (also known as SNAI2) and E12/E47 were
afterwards conﬁrmed as potent negative regulators of E-cadherin ex-
pression [31,32]. ZEB1 and ZEB2 have also emerged as key factors
negatively regulating E-cadherin [33,34]. These transcriptional re-
pressors exert their action by recruiting transcriptional corepressors,
such as CtBP and mSinA [35,36]. The transcriptional activity of
E-cadherin promoter can be repressed by the combined action of
the β-ctn-Lef1/TCF complex, in a Lef1/Tcf binding site dependent
manner [37]. Several other factors have been described to act upon
E-cadherin gene, but not in such a speciﬁc way, targeting multiple ad-
hesion and polarity genes during developmental epithelial to mesen-
chymal transition (EMT), like Twist1, HOXB7, CBF-A (HNRPAB) and
KLF8 [38–40]. Hypermethylation at the CDH1 promoter CpG island
is an important mechanism to control the expression of the gene
and, while normal epithelial cells carry unmethylated CDH1 promot-
er, the opposite occurs in many types of cancers, as has been ﬁrst
described by Graff and collaborators in 1995 [41].
Data concerning CDH3 promoter regulation by transcription fac-
tors is still very limited. Recently, it was demonstrated that CDH3
gene is a direct transcriptional target of p63 [42], playing an import
role in the regulation of expression programs involved in cell–cell ad-
hesion [43]. In addition, it was shown that β-ctn is also associated
with CDH3 promoter and activates its expression, but in a LEF/TCF
independent speciﬁc-manner. In fact, it was shown that activation
of β-ctn signalling correlates with up-regulation of P-cadherin
expression, as well as downregulation of endogenous β-ctn levels,
by RNA interference, inhibited P-cadherin promoter activity [44].
Concerning CDH3 repression, we veriﬁed that methylation of itsgene promoter was associated with negative P-cadherin expression
in normal epithelial cells [23].
2.3. Post-translational regulation
E-cadherin post-translational regulation mechanisms have been
extensively studied, but the same holds not true for P-cadherin. Intra-
cellular trafﬁcking is an important mean of regulating the levels of
E-cadherin at the cell surface (Fig. 2) [45,46].
The exocytic trafﬁc controls the delivery of newly synthesised
E-cadherin to the plasma membrane through recycling endosomes.
During this process, β-ctn binds to E-cadherin and these two pro-
teins are transported to the plasma membrane as a complex
[47,48]. Some endosome proteins, as Rab11 and Sorting Nexin 1
(SNX1), have also been implicated in cadherin recycling [49,50]. In
fact, depletion of cellular SNX1 levels by siRNA or inhibitory mutants
of Rab11 block normal E-cadherin trafﬁcking to the cell surface
[49,50]. Recently, type Iγ phosphatidylinositol phosphate kinase
(PIPKIγ) was found to bind directly to E-cadherin, modulating its
cellular trafﬁcking. Disruption of PIPKIγ binding to E-cadherin,
results in defects in E-cadherin transport and blocks adherens
junctions assembly [51].
Additionally, the endocytic pathway also controls the inter-
nalisation of E-cadherin with consequences on protein turnover,
recycling, sequestration and degradation [46,52]. p120ctn is the best
characterised inhibitor of E-cadherin endocytosis, by hampering the
binding of adaptor complexes that would recruit the clathrin-coated
pits, and by stabilising cadherins at the cell surface [53–55]. In con-
trast, although p120ctn also binds to P-cadherin [53,54], it is known
that the overexpression of this cadherin is strongly associated with
cytoplasmic accumulation of p120ctn, since it competes for its bind-
ing with endogenous E-cadherin [56] (and unpublished results).
Interestingly, when the speciﬁc binding site of p120ctn at the
juxtamembrane domain (JMD) of P-cadherin is completely absent
or mutated, P-cadherin is not functional as a pro-invasive molecule
[57].
Another key modulator of E-cadherin movement, along with the
endocytic pathway, is the ADP-ribosylation factor 6 (ARF6) [58,59].
ARF6 activation results in the internalisation of E-cadherin from
cell–cell junctions into early endosomes. ARF6-GTP interacts and re-
cruits Nm23-H1 from the cytosol to adherens junctions, leading to
endosomal dependent E-cadherin sequestration [60]. The recruit-
ment of Nm23-H1 has also been coupled to downregulation of Rac1
activity, a process that facilitates disassembly of adherens junctions
[61]. Recently, it was demonstrated that EGFR interacts speciﬁcally
with an ARF6 guanine nucleoside-exchange factor (GEP100/BRAG2),
promoting ARF6 activation and consequent E-cadherin internalisation
[62].
Tyrosine kinases, such as Src or other tyrosine kinase receptor
(RTKs), also regulate the expression, function and trafﬁcking of
E-cadherin [63]. Tyrosine phosphorylation of E-cadherin–catenin
complex results in E-cadherin endocytosis and disturbance of the ad-
hesion complex. Src activation induces EMT, targeting E-cadherin to
ubiquitination and then shuttled to the lysosome, instead of following
its normal trafﬁcking route of recycling back to the lateral plasma
membrane [64]. Furthermore, the expression of v-Src also induces
the activation of the GTPases Rab5 and Rab7, and expression of the
dominant-negative mutants of these GTPases introduces stage-
speciﬁc blocks in the trafﬁcking of E-cadherin to the lysosome [64].
Ubiquitination of E-cadherin is an additional level of protein regula-
tion and is mediated by Hakai, a c-Cbl-like E3 ubiquitin ligase. Hakai
induces the mono-ubiquitination of E-cadherin in response to Src
activation resulting in E-cadherin lysosomal degradation [65].
Another important level of post-translational regulation of E-
cadherin is by glycosylation. E-cadherin can be post-translationally
modiﬁed by O- and N-glycosylation, which modiﬁcations have been
Fig. 2. Illustration of classical cadherin trafﬁcking and post-translational regulation. Newly synthesised cadherins are trafﬁcked from the trans-Golgi network to the plasma mem-
brane in association with β-catenin. At the plasma membrane, p120-catenin binds to the cadherin juxtamembrane domain, stabilising and preventing the entry of cadherin into
degradative endocytic pathways. p120-deprived cadherin is prone to interact with other proteins, such as clathrin adaptor proteins and Hakai, promoting E-cadherin internalisation
by clathrin-dependent pathways. After internalisation, E-cadherin can be recycled back to the plasma membrane or targeted for degradation. The box in the upper ﬁgure represents
the post-translational modiﬁcation of E-cadherin by N-glycosylation. E-cadherin has four potential N-glycosylation sites at the extracellular domain and the N-glycans are crucial for
E-cadherin stability at plasma membrane and function.
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mic O-glycosylation (O-GlcNAc) of newly synthesised E-cadherin was
described to block its cell surface transport, resulting in reduced
intercellular adhesion [67]. Furthermore, N-glycans seem to be essen-
tial for E-cadherin expression, folding and trafﬁcking [68,69]. The
extracellular domain of human E-cadherin has four potential N-
glycosylation sites on the basis of amino acid sequence (Fig. 2) and
those N-glycans represent the most prominent modiﬁcation of the
molecule, contributing up to 20% of its total mass [69]. Recently,
we demonstrated that N-acetylglucosaminyltransferase III and V
(GnT-III and GnT-V) competitively modiﬁed E-cadherin N-glycans,
modifying its membranous expression [70]. GnT-III knockdown cells
revealed a membrane de-localisation of E-cadherin leading to its
cytoplasmic accumulation. Further, GnT-III knockdown also caused
modiﬁcations of E-cadherin N-glycans catalysed by GnT-III and GnT-
V. Altogether, we veriﬁed the existence of a bidirectional crosstalk
between E-cadherin and GnT-III/GnT-V contributing to E-cadherin
post-translational regulation [66,70]. Recently, we identiﬁed for the
ﬁrst time, the role of GnT-III-mediated glycosylation of E-cadherin
as a novel and major component of EMT, but also of mesenchymal
to epithelial transition (MET) signatures, using the spontaneously
immortalised normal mammary epithelial cell line EpH-4 [71]. More-
over, the core fucosylation of E-cadherin was also described to have a
role in the regulation of cell–cell adhesion in cancer [72].
2.4. Protein function
The ﬁrst description on E-cadherin's cell-to-cell adhesive proper-
ties was reported in the V79 Chinese hamster lung cell line, by
Takeichi in 1977 [73]. E- and P-cadherin are indeed the ﬁrst adhesion
molecules that are expressed in the mouse embryo. The proper devel-
opment of an embryo is assured under conditions of regulated cell–cell and cell–matrix adhesion. At one cell stage of embryogenesis,
uvomorulin, the original name of E-cadherin, has been shown to be
present [74–76]. At the 8-cell stage, E-cadherin is essential for the
compaction of the morula and the subsequent organisation of epithe-
lial tissues [77]. Using mouse models, it was clearly shown that em-
bryo implantation into the uterine epithelium involves both E- and
P-cadherin. In fetal development, E-cadherin was found to be
expressed only in the embryonic region of placenta with a sharp
boundary to the maternal region [76,78,79]. In contrast, P-cadherin
expression was observed in the placenta, both in the embryonic and
maternal regions, hence the classical denomination of placental-
cadherin. These observations suggest complementary roles of the
two cadherins during development. E-cadherin is essential in
preventing the embryonic tissues from mixing with the maternal
tissues, while P-cadherin is required for association of embryonic
and maternal tissues.
The importance of E- and P-cadherin to normal development is
well demonstrated by gene knockouts (KO) in mice. E-cadherin KO
is lethal at very early stages in embryogenesis, due to the failure of
trophoectoderm formation, the ﬁrst polarised epithelial layer in the
mouse embryo [80,81]. In contrast, germline loss of function of
P-cadherin is not lethal, but is associated to developmental defects
namely of the breast. Interestingly, it was veriﬁed that virgin
P-cadherin null female mice exhibit precocious differentiation of the
mammary gland, indicating that P-cadherin mediated adhesion or
signals derived from its cell–cell interactions are indeed important
determinants of mammary gland growth control and in the mainte-
nance of an undifferentiated state during a speciﬁc period of time
[82].
Germline mutations of E-cadherin and P-cadherin are associated
to human developmental defects. In the case of E-cadherin, germline
mutations of E-cadherin, leading to various aberrant transcripts, were
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niofacial morphogenesis. In fact, speciﬁc alterations of E-cadherin
pathway during development maybe involved in the genesis of mid-
line congenital malformations, such as lip and palate clefting [83].
P-cadherin germlinemutations have been associated to: 1) hypotrichosis
with juvenile macular dystrophy (HJMD) and 2) ectodermal dysplasia,
ectrodactyly, and macular dystrophy (EEM syndrome) [42,84,85].
In adult tissues, E-cadherin plays a major role in the formation of
epithelia, maintenance and homeostasis. Its function lies primarily
in the formation of adherens junctions, which are crucial for the initi-
ation and maintenance of a homeostatic intercellular space and cell‐
to‐cell interaction in a wide variety of tissues and cell populations
[86]. E-cadherin, besides providing epithelial cells with structural
integrity also functions as a landmark, spatially conﬁning signalling
molecules and polarity cues, as well as serving as docking sites for
vesicles [86]. P-cadherin also contributes to cell-to-cell adhesion,
but its expression is restricted to speciﬁc areas of epithelial tissues
(normally proliferating regions, like the germinative layer of the surface
epidermis), co-localising partially with E-cadherin expression [87].
3. E-cadherin and cancer
It is well accepted the E-cadherin plays an important role as an in-
vasion suppressor gene/protein, since its loss of expression, abnormal
function, or both, leads to an increased ability of cells to invade neigh-
bouring tissues, as veriﬁed in cancer [88]. In contrast, P-cadherin
expression is correlated with cell dedifferentiation and increased
cell proliferation, as well as with the connection or segregation of
epithelial cell layers [79,89,90]. Recently, P-cadherin has also been
described as an invasion promoting protein in some cancer models
[91]. In this chapter, we describe mechanisms of deregulation of
E-cadherin in cancer separated from those described for P-cadherin,
for the sake of simplicity.
3.1. CDH1 structural alterations
E-cadherin gene (CDH1) loss/abnormal expression leads neoplas-
tic cells to invade neighbouring tissues/organs, as shown in several
models of human cancer, including carcinomas of the breast and
stomach. In breast cancer, downregulation of E-cadherin is a speciﬁc
feature of lobular carcinomas [92–95], being also observed in pleo-
morphic lobular carcinomas [96]. Further, its reduced expression
can also be associated with some non-lobular breast carcinomas of
triple negative phenotype, like the metaplastic carcinomas [97,98].
In lobular breast cancer, somatic truncating mutations of the CDH1
gene occur throughout its extracellular domain [99]; however,
germline CDH1mutations were rarely found in invasive lobular breastFig. 3. Immunohistochemistry panel representing the expression pattern of E-cadherin in n
gastric mucosa, E-cadherin is expressed at the membrane of epithelial cells (magniﬁcati
E-cadherin (B) or complete loss of E-cadherin expression (C) (magniﬁcation: 200×).cancers (LBC) with or without diffuse gastric cancer associated
[100,101].
In gastric cancer, downregulation of E-cadherin is a feature of
diffuse/isolated cell carcinomas and occurs in the large majority of
the cases (Fig. 3) [102–106]. E-cadherin absence or aberrant expres-
sion may be caused, in sporadic diffuse/mixed gastric cancer cases,
by somatic mutations that cluster in the central region of CDH1
gene, leading to the skipping of exon 8 or exon 9 [102,103] in
frequencies that vary between 20 and 60% of the cases [106,107]. In
hereditary forms of diffuse gastric cancer, the well-known hereditary
diffuse gastric cancer syndrome (HDGC) described by Guilford in
1998, germline alterations of CDH1 gene are causing events [108].
Overall, around 45% of HDGC families, selected on the basis of
established clinical criteria, harbour CDH1 germline alterations
[109]. So far, over one hundred HDGC and two LBC families have
been described to harbour CDH1 germline alterations [109–111].
The most frequent type of CDH1 germline alterations are point and
small frameshift mutations. In terms of the predicted impact of
these germline CDH1 mutants, 80% result in protein truncation or
even complete lack of protein expression. The remaining 20% of
CDH1 mutations are of the missense type and the pathogenic rele-
vance of such sequence CDH1 variants implicates a series of in silico
and in vitro tests, developed by our group, to functionally characterise
their functional impact [112–118]. In 2009, Oliveira et al. described,
for the ﬁrst time, CDH1 large genomic deletions in apparently muta-
tion negative HDGC families [109]. Regarding structural alterations
leading to somatic inactivation of CDH1 alleles in HDGC tumours,
we and others have shown that 20–30% of HDGC primary tumours
carry CDH1 point mutations, intragenic deletions or LOH [119–122].
But importantly, our group has shown that LOH is the most frequent
event in lymph nodemetastases from HDGC patients and is present in
as much as 60% of all metastases analysed [121].
3.2. CDH1 transcriptional deregulation
Overexpression of E-cadherin repressors has been described to be
present in cancer [123–126]. In 2008, it was shown that CDH1 transcrip-
tional silencing could be also due to histone H3-K9 deacetylation [127].
Peinado and colleagues demonstrated that Snail represses the expres-
sion of E-cadherin through recruitment of a multimolecular complex
composed by mSin3A corepressor and HDAC1/2 to E-cadherin promot-
er. Further, Snail-expressing cells were enriched in deacetylated his-
tones H3 and H4 [123].This link between the HDAC machinery/Snail
and silencing of E-cadherinwas also corroborated, in vivo, in ametastat-
ic pancreatic cancer model [128]. Others have also showed that CDH1
repression by Snail was dependent on complexes involving histones,
namely the activity of the Polycomb repressive complex 2 (PRC2).
Snail1 represses E-cadherin expression by recruiting one componentormal gastric mucosa and in gastric carcinomas in a tissue microarray. (A) In normal
on: 200×); Diffuse gastric carcinomas showing reduced and aberrant expression of
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silencing of E-cadherin expression by trimethylation of lysine 27 on his-
tone H3 [129]. The same mechanism of E-cadherin silencing is veriﬁed
for another component of PRC2, namely EZH2, which has also been im-
plicated in cancer [124,125]. Increased levels of EZH2 have been ob-
served in aggressive tumours, and treatment of cells with HDAC
inhibitors prevents EZH2-mediated downregulation of E-cadherin and
reduces cellular invasion [124,125].
MicroRNAs (miRNAs) have also emerged as a new layer of CDH1 gene
regulation [130,131].Members of themiR-200 family ofmicroRNAs have
been implicated in the regulation of E-cadherin expression, through di-
rect targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
[132–135]. Inhibition of endogenous miR-200 expression levels lead to a
relief of ZEB1 andZEB2 repression, reductionof E-cadherinmRNAexpres-
sion levels and, consequently, to amesenchymal-likemorphology and in-
creased cell migration. In human breast cancer tissues, loss of miR-200
family expression was observed in highly aggressive, metaplastic type
of breast cancer, lacking E-cadherin expression [134]. A signiﬁcant corre-
lation between downregulation of miR-200 family members, increased
expression of ZEB1, and reduced expression of E-cadherin was observed
in primary serous papillary ovarian tumours [135].
In addition to themiR-200 family,miR-9 andmiR-101 have also been
implicated in the network of E-cadherin regulation [106,136,137]. miR-9
was initially found to be expressed in primary hepatocellular carcinomas
(HCC) with metastases when compared with HCC without metastases
[136]. Although, E-cadherin was ﬁrst postulated as a putative target of
miR-9, since its expression was increased when cells were treated with
a miR-9 inhibitor, the formal proof of miR-9 impact on E-cadherin was
only achieved very recently. It was shown that miR-9, induced by Myc
in breast cancer cells, directly targets E-cadherin and, subsequently,
activates β-ctn signalling and VEGF expression, promoting cell motility,
invasion and tumour angiogenesis [137]. Our group have recently un-
covered a pathway that causes E-cadherin dysfunction in gastric cancer
via loss of miR-101. We found that miR-101 was signiﬁcantly down-
regulated in gastric tumours in comparisonwith normal gastricmucosas
and, at least in 65% of the cases analysed, this downregulation was
caused by deletions and/or microdeletions at miR-101 genomic loci.
Moreover, around 40% of the cases showing miR-101 downregulation,
displayed concomitant EZH2 overexpression which, in turn, was associ-
ated with loss/aberrant E-cadherin expression, speciﬁcally in the
intestinal-type gastric cancer [106,137].
Apart from all these modiﬁers of E-cadherin expression and
function, the most widely studied, and probably the most frequent,
mechanism in human cancer that leads to CDH1 downregulation is
hypermethylation of its promoter. This mechanism has been described
either in epithelial, with greater emphasis on gastric cancer and non-
epithelial cancers, such as the case of acute myelogenous leukemia
(AML) [107,138]. Speciﬁcally in gastric cancer, E-cadherin methylation
has been extensively studied by our group. We have reported E-
cadherin methylation in frequencies that vary between 6% and 60%
of the cases, in different series of sporadic diffuse gastric cancer
[106,107] (and unpublished results). Although less frequently studied,
cadherin methylation has also been described in sporadic intestinal‐
type gastric cancer in approximately 15% of the cases [106] (and
unpublished results). Additionally, it was also found that themost com-
mon mechanism of biallelic inactivation of the CDH1 gene in HDGC is
promoter hypermethylation [117,119–122]. In HDGC primary tumours
from CDH1 germlinemutation carriers, CDH1methylation has been de-
scribed in 50 to 70% of the cases [117,119–122], either as a single event
(~50%) or concomitantly with LOH at the CDH1 locus (~19%) [121]. In-
terestingly, the frequency of CDH1 promoter methylation decreases in
HDGC lymph node metastasis to ~25%, almost invariably accompanied
by LOH in the same lesion. Because of the ﬁnding of somatic alter-
ation heterogeneity in HDGC neoplastic lesions, drugs targeting
only epigenetic alterations are likely to be effective only in a limited
percentage of gastric carcinomas within the setting of HDGC.3.3. Post-translational E-cadherin deregulation
Recently, E-cadherin trafﬁcking deregulation was shown to be
associated to epithelial cancer progression. The importance of
E-cadherin trafﬁcking deregulation in cancer has been explored by our
group using E-cadherin missense mutations, associated to HDGC, as
a model. We have recently shown that two HDGC-associated missense
mutations functionally inactive, R749W and E757K, are regulated by
Endoplasmic ReticulumAssociated Degradation (ERAD), and prematurely
degraded by the proteasome [139]. ERAD is the mechanism by which
newly synthesised misfolded proteins are translocated from the ER to
the cytosol and are degraded by the ubiquitin-proteasome system
[140,141]. We proposed that these R749W and E757K HDGC-associated
mutations interferewith the folding of E-cadherin andoriginatemisfolded
proteins that are recognised by the ERADmachinery, triggering their deg-
radation, and leading consequently to the loss of E-cadherin protein ex-
pression and function [139]. Nevertheless, there are other indirect
evidences showing the role of E-cadherin trafﬁcking deregulation in can-
cer progression. One example is proposed by the work of Toyoshima and
co-workers who have recently found that Hrs (Hepatocyte growth
factor-regulated tyrosine kinase substrate) is involved in the lysosomal
trafﬁcking of E-cadherin and its disruption impacts E-cadherin degrada-
tion inhibiting tumorigenesis in nude mice and metastasis formation.
Another example of an indirect regulator of E-cadherin is p120ctn,
which is an E-cadherin stabiliser. p120 alterations in cancer are frequent
[142], including its downregulation, and are correlated with E-cadherin
loss or abnormal expression in different cancer types, like in gastric can-
cer [143–145]. Even so, there are no direct evidences showing that the
alterations of p120ctn in cancer lead to E-cadherin trafﬁcking defects
in the tumour context and which are the underlying mechanisms,
timing and associated functional consequences.
Aberrant glycosylation has been also implicated as an essential
mechanism deﬁning stage and fate of tumour progression [146,147]
and it has recently been proposed that glycosylation can be a mecha-
nism of E-cadherin deregulation in cancer [66]. It has been shown
that E-cadherin displays a modiﬁed N-glycosylation pattern during
the acquisition of the malignant phenotype [148]. These cancer relat-
ed changes in the pattern of E-cadherin N-glycosylation included the
synthesis of branched N-glycans (β1,6 GlcNAc branched structures)
and an increase in sialylation (α2,3 and α2,6 linked sialic acids).
These observations support the role of N-glycans on E-cadherin-
mediated tumour progression [148]. The remodelling of E-cadherin
N-glycans catalysed by GnT-III and GnT-V was also shown to have a
potential role on E-cadherin mediated cell–cell adhesion and cancer
[149,150]. The glycosylation of E-cadherin by GnT-III seems to partic-
ipate in the suppression of metastases of melanoma cells [150]. Inter-
estingly, in an in vitro and an in vivo model of human breast and
gastric cancer, we showed that aberrant E-cadherin N-glycosylation
can be considered as a potential newmechanism of E-cadherin dereg-
ulation in cancer, operating at the post-translational level [66,70].
3.4. E-cadherin and signalling pathways
Increasing evidences indicate that E-cadherin mediated carcinogen-
esis depends on the aberrant activation of signalling pathways and in-
teraction with other molecules (such as cytoskeletal components,
integrins, and growth-factor receptors, among others) [1,151–153]. It
has been demonstrated that E-cadherin can compete with the βctn/
TCF-mediated transcriptional activity of the canonical WNT signalling
pathway, increasing in this way proliferation [154,155]. However, E-
cadherin loss of function rarely leads to a nuclear accumulation of βctn
and increased cell proliferation in primary carcinomas even in cases
with E-cadherin mutations (V832M) localised in the βctn binding do-
main [156]. Another E-cadherin-βctn associated signalling regards regu-
lation of the cytoskeletal network, which organisation is modulated by
the activity of the members of the Rho family of small GTPases with
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small GTPase subfamily are involved: Rho, Rac and Cdc42. Cdc42 induces
the formation of ﬁlipodia that are important in deﬁning the directional-
ity of the cell movement, Rac induces formation of lamellipodia at the
leading edge of migrating cells, and Rho regulates contractile forces to
move the body and the tail of a migrating cell behind the leading edge
and induces formation of actin stress ﬁbres. E-cadherin in-frame dele-
tions of exon 8 commonly found in sporadic diffuse gastric cancer
(HDGC), lead to a reduction in Rac1 activation and to an inhibition of
Rho [158]. In Hereditary diffuse gastric carcinoma, E-cadherin germline
missense mutations clustering on the extracellular domain induce in-
creased RhoA activity leading to increase of cell migration ability
[114,159,160].
Additionally, E-cadherin has been shown to colocalise with several
RTKs to basolateral areas of polarised epithelial cells and to formmul-
ticomponent complexes with them [161,162]. Numerous studies indi-
cate that several RTKs can downregulate and inhibit E-cadherin-
dependent adhesion and induce the morphologic transformation,
known as EMT [65,163]. On the other hand, E-cadherin can inhibit
the activation and signalling through RTKs, important for cellular ho-
meostasis, implying a bidirectional regulation [164]. In particular,
EGFR has been reported to be involved in a bidirectional crosstalk
with E-cadherin. EGF-dependent activation of EGFR can be inhibited
in an E-cadherin adhesion-dependent manner [165], but E-cadherin
has also been found to activate transiently EGFR when cell–cell con-
tacts are formed [162]. It was demonstrated that E-cadherin alters
the ligand (EGF) binding afﬁnity to EGFR and, whenever E-cadherin
is deleted (E-cad Δβ-ctn, Ecad AAA(764) and E-cad ΔNT), the interac-
tion of E-cadherin with EGFR is perturbed. In this context E-cadherin
impairs EGFR, c-Met and IGF-1R signalling through their cognate re-
ceptors [164]. In addition, studies performed using E-cadherin
germline missense mutations found in HDGC patients, which are
spread throughout the protein, demonstrate that the extracellular
domain of E-cadherin is required to interact with EGFR and that this
interaction impairs the activation of the receptor by its ligand
[159,160]. Binding of E-cadherin to EGFR blocks therefore its down-
stream signalling, which lead to activation of GTPase RhoA and in
consequence increased cell motility [159,160].
Loss of E-cadherin function is also strongly associated with an in-
creased invasive behaviour of the cells. Consistent with this notion,
many clinical studies have shown that expression levels of meta-
lloproteases MMP2 and MMP9 correlate with tumour progression
[166]. Our group has shown, using in vitro models, an involvement
of E-cadherin in the regulation of MMP activity. In our case, mutant
E-cadherin cells when compared to wild-type cells, endogenously se-
crete MMP9 (unpublished data). This result is in agreement with pre-
vious studies suggesting a relation between E-cadherin and MMP
expression [167]. It is interesting to notice that, besides the direct
role in cell invasion, MMP activity is known to inactivate E-cadherin
by cleavage of its extracellular domain, in a process designated by
ectodomain shedding [168–171]. Proteolytic ectodomain fragments
of E-cadherin have been proposed to promote cancer cell invasion
by interfering with E-cadherin function in cells containing intact
E-cadherin/catenin complexes [170,171].
In the process of cellular invasion, and once tumour cells detach
from the original tissue, penetrate the basement membrane and in-
vade the interstitial matrix, cell survival depends on signals from
the environment, such as those provided by adhesion molecules
that mediate contacts between cells or between cells and the sur-
rounding medium [172]. We have demonstrated that loss of func-
tional E-cadherin renders cells more resistant to apoptotic stimuli
[173,174]. Cells expressing mutant E-cadherins are not only capable
of invading, but are also able to survive in the absence of contact
with other cells in a Notch-1 dependent manner [174]. Further,
we showed in our in vitro model that cells expressing wild-type
E-cadherin have a decreased level of the anti-apoptotic Bcl-2, incontrast to mutant forms of the protein, proving the existence of
an interplay between E-cadherin and Bcl-2 regulation. Recently,
we demonstrated that aberrant expression of Bcl-2 in E-cadherin
mutants is dependent on Notch-1 activation [174]. This supports
the hypothesis that E-cadherin is also involved in the control of
programmed cell death, and thus has a dual role in cancer preven-
tion. Because of the potential therapeutic relevance of this ﬁnding,
further studies aiming at elucidating its molecular mechanisms are
warranted.
3.5. E-cadherin and Helicobacter pylori infection
H. pylori is a bacterial pathogen with a major etiological role in gas-
tric cancer development. Studies have shown that H. pylori targets E-
cadherin by several mechanisms. Epigenetic silencing of CDH1 promot-
er in the context of H. pylori infection has been shown using in vitro
models and in the gastric mucosa of infected patients.H. pylori infection
of gastric cancer cell lines or treatment with interleukin-1β, a cytokine
up-regulated in the context of the infection, induce CDH1 promoter
methylation, leading to decreased E-cadherin expression and concomi-
tant increase in DNA methyltransferase activity [175]. In agreement
with the in vitro data, CDH1 promoter methylation has been frequently
observed in the gastric mucosa of H. pylori-infected patients [176–178],
and eradication treatment of the infection reduces CDH1 promoter
methylation levels [177–179]. No CDH1mutations have been described
to date associated to H. pylori infection.
In addition to epigenetic silencing of E-cadherin, H. pylori has been
associated with other mechanisms of disturbance of E-cadherin
functions. H. pylori induces extracellular domain cleavage of E-cadherin
and both, the host disintegrin metalloproteinase ADAM10 and the H.
pylori serine protease HtrA, have been implicated in this process
[180,181]. These ﬁndings are in keeping with a recent report showing
that H. pylori-positive patients have signiﬁcantly higher serum levels
of soluble E-cadherin than uninfected controls [182].
H. pylori is also involved in the translocation of proteins of the
E-cadherin/catenin complex, such as E-cadherin, βctn, and p120ctn,
from the cell membrane to intracellular locations in mouse models,
primary gastric cells, and different cell lines [183,184]. H. pylori
induces βctn and p120ctn translocation into the nucleus and
transcriptional activation of several LEF/TCF target genes which are
important for tumorigenesis [185–188]. These results are, however,
not supported by the ﬁndings in gastric biopsy specimens from
patients with and without H. pylori infection, in which no differences
were detected in E-cadherin/catenin proteins [189].
Studies from our group have shown that in E-cadherin wild-type
cells, H. pylori infection promotes the formation of a multiproteic
complex containing c-Met and E-cadherin, impairing H. pylori-
induced c-Met-mediated signalling [190]. In contrast, in E-cadherin
defective gastric cancer cells H. pylori induces c-Met activation and
increases the activity of MMP2 and MMP9, leading to extracellular
matrix degradation and subsequent cell invasion [191]. H. pylori
targeting of the E-cadherin/catenin complex, with loss of cell–
cell adhesion and increased cell invasion, may contribute to in-
crease the risk for H. pylori-infected individuals to develop gastric
cancer.
3.6. E-cadherin in vivo cancer models
The Drosophila model has been helpful to uncover the E-cadherin
role in invasion. Indeed, when Drosophila E-cadherin was over-
expressed in srcib−RasV12 cells that had lost E-cadherin expression,
it suppressed invasion in vivo [192]. Another study from our group
has taken advantage of theﬂy system to effectively direct the expression
of different human E-cadherin forms (wild-type or HDGC‐associated
missense mutants) in the Drosophila epithelium, in order to evaluate
their biological signiﬁcance in vivo. When HDGC‐associated missense
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mimicked previous results obtained in vitro regarding migration and
invasion. Moreover, this study sheds new lights on the putative inhibi-
tion of Notch signalling by E-cadherin, at least at the level of cut, the
Drosophila orthologue of Cux1 [193]. A similar approach is currently
being used in our laboratory to screen for pathways affected by the
same human E-cadherin missense mutations in a tissue context [194].
The most compelling evidence for the causal relationship between
E-cadherin loss and diffuse gastric cancer initiation, in vivo, was
reported by Humar et al. in 2009. For the ﬁrst time, they have success-
fully induced signet-ring cell carcinomas (SRCCs) in CDH1+/− mice,
using a known stomach carcinogen (N-methyl-N-nitrosourea) [195].
Another level of interest was the use of in vivo studies unveiling
how E-cadherin's loss leads to cancer metastases [21,196,197]. The
ﬁrst evidences showed that nude mice with MDA-MB-231 human
breast cancer cells without E-cadherin had a striking enhancement
of bone metastases [196]. Also HDGC patients show a high chance of
developing ovary metastases. In mice, human cancer cell lines that
had lost or downregulated E-cadherin expression were able to meta-
stasise to mice ovaries and the restoring E-cadherin expression led to
the complete rescue of the ovarian-metastatic phenotype, but did not
interfere with the metastatic capacity to other organs. This data, in
mice, showed that E-cadherin regulation is a key step in tissue speciﬁc
metastases formation, at least in the ovary [198].
4. P-cadherin and cancer
The clinical interest on P-cadherin started some years ago, when
Shimoyama et al. examined a large series of lung carcinomas, by immu-
nohistochemistry, and found that P- and E-cadherin were co-expressed
in all of them, suggesting that P-cadherin expression was closely related
to the differentiation of carcinomas. In contrast to E-cadherin,
P-cadherin seemed to be frequently up‐regulated in tumours, being re-
duced when tumour cells were more differentiated [199].
4.1. P-cadherin overexpression
P-cadherin aberrant expression has been already described in
many types of tumours, such as oral and oesophageal squamous car-
cinomas [200], mucoepidermoid carcinomas of the thyroid [201],
gastric and pancreatic carcinomas [56,202,203], basal and squamous
cell carcinomas of the skin [204], squamous intraepithelial lesions
and glandular tumours of the uterine cervix [205,206], endometrial
and ovarian carcinomas [207–210], prostate and bladder carcinomas
[211,212]. In all these tumours, P-cadherinwas preferentially expressed
in invasive rather than in in situ lesions, showing that aberrant
expression of P-cadherin could be a useful marker of invasion capacity
of tumour cells.Fig. 4. Immunohistochemistry panel representing the expression pattern of P-cadherin in no
the membrane of the myoepithelial cell layer of normal mammary ducts (magniﬁcation: 20
presented throughout the tumour area (magniﬁcation: 200×); (C) In higher magniﬁcation,
(magniﬁcation: 400×).In this review, special attention is given to the role of P-cadherin
in breast cancer, where a high volume of knowledge exists. In breast
cancer, P-cadherin is preferentially expressed in breast lesions
that show characteristics found in basal-like carcinomas (Fig. 4)
[213,214]. We and others have reported that P-cadherin expression
in breast carcinomas is inversely related with hormonal receptors
content (the majority of the cases are ER and PgR negative)
[23,57,215–217], and directly related with the expression of EGFR
[218], HER2, p53 expression [23], high proliferation rates (MIB-1)
and mitotic index, and decreased cell differentiation, which are bio-
logical parameters related with poor prognosis [23,216,219]. In fact,
P-cadherin expression is strongly related in breast cancer with a de-
creased patient survival, especially in a short-term follow-up (ﬁrst
ﬁve years), being considered a valuable prognostic factor: the proba-
bilities of disease-free and overall survival were signiﬁcantly lower
for patients with P-cadherin positive tumours [57]. Recently, we
also demonstrated that P-cadherin expression has a relevant role in
the prognosis of invasive breast cancer that maintains E-cadherin ex-
pression, thus can be classiﬁed as a biomarker of poor prognosis in E-
cadherin positive breast carcinomas. Aberrant P-cadherin expression
in E-cadherin positive breast cancer cells is correlated with des-
tabilisation of the normal cadherin/catenin complex, because it is es-
sentially related to p120ctn cytoplasmic expression [220]. Once in
the cytoplasm, p120ctn can inhibit RhoA and activate other Rho
GTPases, Rac1 and Cdc42, altering the actin cytoskeleton polymerisa-
tion and promoting cell migration and motility [56]. This probably ex-
plains in part the invasive phenotype of these cells and the poor
prognosis. It was also demonstrated that P-cadherin expression is asso-
ciated to overexpression of matrix metalloproteinases that are relevant
in invasion and related with poor prognosis in cancer [91].
As an important pre-screening molecular marker, to suspect from
an hereditary form of breast cancer, P-cadherin expression can also be
used to distinguish patients who are likely to carry a BRCA1 germline
mutation, thus indicating who should be screened ﬁrst in families
with a high incidence of breast and ovarian cancer [214,221–225].
Gorski et al. demonstrated that BRCA1 is able to regulate the basal
phenotype by a transcriptional mechanism, since it represses genes
like CK5, CK17, and also CDH3 (P-cadherin gene). In breast cancer
cells with a BRCA1 mutation, this repression does not occur and
these genes are codiﬁed and expressed [225].
4.2. CDH3 transcriptional deregulation
In 2004, our group explored the link between ER (estrogen recep-
tor) signalling and the regulation of P-cadherin expression in breast
cancer cell lines, since we found that breast tumours positive for
P-cadherin expression were essentially ER negative. P-cadherin de
novo expression was shown to result from a lack of ERα signalling.
In fact, we veriﬁed that P-cadherin expression is able to be inducedrmal breast tissue and in a breast carcinoma. (A) P-cadherin expression is restricted to
0×); (B) In high grade breast carcinomas, P-cadherin overexpression is homogeneously
it is clear that P-cadherin is overexpressed at the cell membrane of breast tumour cells
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oestradiol (E2) [57]. Cell lines treated with ICI showed a two to three-
fold increase of P-cadherin mRNA and protein levels in a time and
dose dependent manner, importantly establishing that the lack of
ERα signalling is responsible for the increase of P-cadherin and,
therefore, categorising CDH3 as a putative oestrogen-repressed gene
[57]. Very recently, and deeply exploring the ICI-mediated mecha-
nism, we described a cellular adaptation process where ICI is able to
induce a chromatin structural remodelling, which leads with the acti-
vation of CDH3 gene and overexpression of P-cadherin protein [226].
Such genomic de-repression effect may contribute to an augmented
invasive phenotype of breast cancer cells, which is typically acquired
upon endocrine therapy resistance and disease progression. This epi-
genetic regulatory mechanism contributes to clarify the ability of
selective ERmodulators and steroidal anti-oestrogens, like fulvestrant
(ICI), to induce the inappropriate expression of genes normally
repressed by oestrogen/ER signalling pathway.
In 2005, we veriﬁed, for the ﬁrst time, the existence of a signif-
icant correlation between hypomethylation of a speciﬁc region of
CDH3 gene promoter and P-cadherin overexpression in breast can-
cer [23]. Moreover, we were able to study normal P-cadherin
negative epithelial/luminal breast cells, which were found to be
consistently methylated at this CDH3 promoter region [23]. Inter-
estingly, we showed that, during breast cancer progression, aber-
rant expression of P-cadherin is due to cytosine demethylation of
CDH3 gene promoter. Using a large series of invasive breast
carcinomas, we found that 71% of P-cadherin-negative breast cancer
cases were methylated for the CDH3 gene, whereas 65% of
P-cadherin-positive cases were unmethylated [23]. Recently, the
epigenetic deregulation of P-cadherin was also demonstrated in
other cancer models. Sato et al. identiﬁed CDH3 gene promoter to
be aberrantly methylated in 20% of pancreatic cancers, but not in
normal pancreatic epithelia [227]. CDH3 was also shown to be
epigenetically deregulated in colorectal cancer; however, in contrast
with the pancreatic model, the CDH3 promoter was found
hypomethylated in colonic aberrant crypt foci, in colorectal cancer,
and, occasionally, in the normal epithelium adjacent to cancer.
This hypomethylation pattern was associated with the induction
of P-cadherin expression in the neoplastic colon. Finally, demethyl-
ation of the CDH3 gene was recently detected in 69% of primary
gastric carcinomas and was signiﬁcantly associated with increasing
TNM stage, suggesting that the aberrant demethylation of CDH3 is
also a frequent event in gastric carcinomas [228].
Interestingly, it is likely that, in carcinomas with overexpression of
P-cadherin, the pivotal molecular mechanism involved in its deregu-
lation is mainly occurring at the promoter region of the gene and not
by structural alterations of its coding sequences. Recently, we still
found that the CCAAT/enhancer-binding protein β (C/EBPβ) tran-
scription factor was able to activate CDH3 promoter in breast cancer
cells. We showed that this novel activator of CDH3 promoter activity
exerts its action preferably through its truncated LIP isoform, being
the abundance of Sp1 sites within the CDH3 promoter a feature
which potentiate the C/EBPβ-LIP activation role on CDH3 gene
[226]. Shimomura and colleagues described p63, a p53-family related
transcription factor, as a key regulator of P-cadherin expression [42].
CDH3/P-cadherin gene was recently described to be also transcrip-
tionally repressed by functional BRCA1 protein in breast cancer cell
lines, at both mRNA and protein levels. Together with BRCA1, the
oncogene c-Myc forms a repressor complex on the promoter region
of CDH3 gene [225].
4.3. P-cadherin and signalling pathways
E-cadherin induced signalling pathways have been far studied in
cancer; still, little is known about the signalling pathways activated
by P-cadherin in cancer. The ﬁrst limitation is due to P-cadherindual role, as an invasion promoter or invasion suppressor depending
on the cell model under study [56,57,229]. In fact, it has been previ-
ously shown that in highly invasive melanoma cell lines (that lack
E-cadherin expression), P-cadherin overexpression was able to pro-
mote the formation of cell–cell contacts and counteract invasion,
like E-cadherin does [229]. It is somehow expected that P-cadherin,
acting as an invasion suppressor, share common signalling pathways
with the suppressive function of E‐cadherin; however, it is not known
whether the pathways are triggered in the same way. Interestingly,
Sarrió et al. demonstrated that E-cadherin negative breast cancer
cells, transfected with E- or P-cadherin, showed an increased number
of similarities [230]. According to their data bases, P- or E-cadherin
expression in cadherin negative cells had an important impact on
the overall genetic program, altering the expression of genes belong-
ing to a wide range of biological functions, including signal transduc-
tion and growth factors (VEGFC, FGFR4), cell cycle (CCNA2), cell
adhesion and extracellular matrix (CDH4, COL12A1), or cytokines
and inﬂammation (IL24), among others. More recently, the role of
P-cadherin was investigated in an oral squamous cancer cell line
that was deﬁcient for classical cadherins [231]. After P-cadherin over-
expression, GSK-3β was activated leading to phosphorylated Snail
and to its cytoplasmic translocation [231]. In the same model system,
it was shown that Slit-2, a secreted ECM glycoprotein, facilitates the
interaction of P-cadherin with Robo-3, its receptor, and inhibits cell
migration [232]. However, in cell systems with endogenous expres-
sion of E-cadherin, like breast carcinomas, we noticed that over-
expression of P-cadherin induces invasion. The same holds true in
situations where there is co-expression of N-cadherin, like HEK293T
cells and PDAC pancreatic cancer cells [57]. Using in vitro breast can-
cer cell models, we found that overexpression of P-cadherin promotes
single cell motility, directional cell migration, as well as, invasion ca-
pacity through Matrigel (unpublished data). This same migratory
phenotype was observed in bladder and in pancreatic cancer cell
lines [56,233]. One of the molecules that have been several times
referred has having a speciﬁc role in signalling related to P-cadherin
is p120ctn. We demonstrated that the pro-invasive activity of
P-cadherin requires the JMD of its cytoplasmic tail. Cells transfected
with several mutants of P-cadherin showed that P-cadherin JMD
was essential for its invasive behaviour in vitro [57]. Moreover, we
observed, in tumour samples, that breast carcinomas co-expressing E-
and P‐cadherin were associated with p120ctn cytoplasmic localisation
and poor patient survival, probably because P-cadherin interferes with
the normal binding of p120ctn to E-cadherin [220]. From then until
now, several other reports have been exploring that pathway. Indeed,
Taniuchi et al. showed that the induced cell migration by P-cadherin
expression was due to activation of the Rho GTPases, Rac1 and Cdc42,
through accumulation of p120ctn in the cytoplasm and cadherin
switching in a pancreatic cancer cell model [56]. Very recently,
P-cadherin has been also shown to cooperate with insulin-like growth
factor-1 receptor to promote metastatic signalling of gonadotropin-
releasing hormone in ovarian cancer via p120ctn [234]. These same
authors had previously shown that this p120ctn signalling mediated
by P-cadherin expression also lead to increased activity levels of Rac1
and Cdc42 [234].
Although binding of proteins at P-cadherin JMD has just been
documented for p120ctn [235], other molecules, like Hakai and
presenilin-1 (PS-1), have been reported to bind to the JMD of classical
cadherins as well, to a sequence adjacent to or overlapping the
p120ctn-binding domain, thereby competing with p120ctn for bind-
ing [65,236]. Although the signiﬁcance of these interactions is not
well known, we cannot exclude the possibility that disruption of the
p120ctn‐binding sequence introduces conformational changes and/
or uncouples the interaction of these or other proteins, which could
be responsible for our observations.
Recently, it has been shown that the regulatory role that P-
cadherin has in cell migration is also related with the organisation
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molecular motor protein that can interact with and contract ﬁlamen-
tous actin (F-actin).These results implicate that there is a coordinated
crosstalk between adhesion molecules and cellular migration-related
proteins [237].
Additionally, in terms of breast cancer cell invasion, we found that
the presence of P-cadherin, in an E-cadherin positive cellular back-
ground, is able to provoke the secretion of pro-invasive factors, such
as MMP1 and MMP2, which lead to P-cadherin ectodomain cleavage
(sP-cad) that also has pro-invasive activity by itself [91]. This study
clariﬁed the mechanism associated to invasion and may explain the
poor prognosis of breast tumours over‐expressing P-cadherin.
For sure, different signalling pathways should be triggered in the
different cell models, thus it will be crucial to identify new interaction
partners of P-cadherin, as well as to study whether the interaction of
known partner molecules differ between cadherins. Finally, it is
important to highlight that the effect of cadherins on the overall
gene expression program of cancer cells is highly dependent on the
cellular type and the biological context. Thus, P-cadherin regulation
of speciﬁc transcriptional factors may depend on the activation of
other signalling pathways, or the presence of additional molecular
alterations.4.4. P-cadherin in vivo cancer models
As previously described, several in vivo models have been used to
study the role of E-cadherin in cancer; however, for studying the role
and function of P-cadherin, only mouse models have been created.
Radice and collaborators have done much in trying to investigate
the functions of P-cadherin in vivo. For that, they mutated the gene
encoding this cell adhesion receptor in mice. Interestingly, in contrast
to E- and N-cadherin-deﬁcient mice, mice homozygous for the
P-cadherin mutation are viable, but develop hyperplasia and dyspla-
sia of the mammary epithelium with age [82]. The same authors
developed a transgenic mouse model with forced expression of
P-cadherin in the mammary epithelium, under control of the
MMTV ?thyc=5?> promoter [238]. These mice did not develop
mammary tumours spontaneously, indicating that P-cadherin mis-
expression by mammary epithelial cells does not induce tumours.
However, when mammary tumours were induced in the P-cadherin
transgenic mice through a breeding strategy using a transgenic
mouse over-expressing ErbB2/HER-2/neu under control of the
MMTV promoter, no tumours exhibited P-cadherin expression. This
result might have been due to competition between the two MMTV
driven transgenes for transcriptional co-factors or to increased
adhesion by P-cadherin, acting as a tumour suppressor. Either way,
this mouse model did not allow testing the ability of P-cadherin to
affect tumour cell behaviour. A future mouse model with an inducible
promoter for P-cadherin might resolve the issue of whether or not P-
cadherin can enhance tumour cell aggressiveness.
The most recent and different approach was used to study
P-cadherin function in colon. A transgenic mice that overexpress
P-cadherin speciﬁcally in the intestinal and colonic epithelium,
under the liver fatty acid binding protein (L-FABP) promoter, was
created. Forced ectopic expression of P-cadherin accompanied by
Indomethacin-induced inﬂammation resulted in a three-fold higher
crypt ﬁssion rate within the small and large intestines in the homo-
zygous mice compared to the wild-type animals (pb0.02). The
authors concluded that epigenetic demethylation of the P-cadherin
promoter in the human intestine permits its ectopic expression
very early in the colorectal adenoma-carcinoma sequence and
persists during invasive cancer. Induced P-cadherin expression,
especially in mucosal damage, leads to an increased rate of crypt
ﬁssion, a common feature of clonal expansion in gastrointestinal
dysplasia [228].5. E- and P-cadherin related molecules for therapeutic use
in cancer
Addressing novel targets and the application of individualised
management should be the way to improve the long term survival
and quality of life for cancer patients, namely those associated to
complete E-cadherin loss of function. An apparent attractive ap-
proach for treatment of the disease would be the reconstitution
of E-cadherin expression. This would be possible in cases with
E-cadherin promotermethylation using eitherwell described pleotropic
epigenetic drugs, which constitute an attractive possibility for disease
control, because they inhibit histone deacetylases (HDAC) andDNAmet-
hyltransferases and restore gene expression, or the recently described
strategy for speciﬁc gene promoter demethylation [239]. The later is
based on direct targeting of thymine-DNA-glycosylase (TDG) to speciﬁc
sequences in the DNA and result in local DNA demethylation at potential
regulatory sequences and lead to enhanced gene induction [239]. The
identiﬁcation of E-cadherin molecular targets is therefore mandatory.
Despite that, the signalling pathways that are aberrantly activated in
consequence of E-cadherin loss, observed in the progression of epithelial
cancers, remain elusive in a signiﬁcant percentage of cases. In this report,
we describe that HER receptors (HER2/neu and EGFR) and Notch down-
stream targets are aberrantly activated in primary gastric cancer with
loss of E-cadherin. Aberrantly activated signalling molecules interacting
with E-cadherin represent the ideal targets for the development of
therapeutic agents. Since EGFR and Notch inhibitors, as well as for their
downstream molecules, are already commercially available and some
of them in clinical use for the treatment of diverse tumour models,
we strongly believe that these targets and associated pathways will
create the basis for the development of new therapeutic control in
E-cadherin-mediated cancer.
In contrast to the suppressor role of E-cadherin in its wild-type
form, we describe P-cadherin as a pro-invasive molecule in the con-
text of tumours with wild-type E-cadherin expression at the mem-
brane of the same cell, as veriﬁed in breast carcinomas with poor
prognosis. In this particular case, we are strongly convinced that
P-cadherin itself or speciﬁc targets of P-cadherin are likely to contrib-
ute to improve the long term survival and quality of life of cancer pa-
tients. Recently, a novel and highly selective human monoclonal
antibody against P-cadherin was produced—PF-03732010, which has
showed anti-tumour and anti-metastatic activity in a diverse panel of
P-cadherin‐over‐expressing tumour models, without introducing any
adverse secondary effects in mice [240]. This IgG failed to bind to the
most closely target-related family members, including E-cadherin,
N-cadherin, and VE-cadherin. PF-03732010 reduced lymph node
metastases and lowered the levels of circulating tumour cells (CTC)
in whole blood of P-cadherin-positive tumour bearing mice. The anti‐
metastatic property of the antibodywas remarkable, since it signiﬁcant-
ly inhibited tumour cell inﬁltration into the lungs. PF-03732010 still
suppressed βctn, cyclin D1, Vimentin, Bcl-2 and survivin expression,
decreased the Ki67 levels, and increased caspase-3 expression [240].
Taking all data collected till now, we propose that signalling path-
ways aberrantly activated in cancer by overexpression of P-cadherin
in an E-cadherin cell background or by loss of E-cadherin, both
leading to E-cadherin dysfunction, represent the ideal targets for the
development of novel therapeutic biological agents.
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